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This thesis uses a combination of cognitive-neurophysiological and genetically-
sensitive longitudinal designs to study the associations of attention-
deficit/hyperactivity disorder (ADHD) with bipolar disorder (BD) and preterm 
birth, as well as with the risk or protective factors IQ and physical activity. 
Previous research on preterm-born individuals and individuals with BD suggests 
ADHD-like symptoms and cognitive impairments, but direct comparisons are 
limited. Here, we first examine how cortical activity patterns differ between 
women with adult ADHD and women with BD during rest and task conditions to 
identify impairments that are specific to or shared between the disorders. The 
findings provide evidence for commonalities in brain dysfunction between 
ADHD and BD: frontal theta power may play a role as a marker of 
neurobiological processes in both disorders. Second, we investigate whether 
the ADHD-like symptoms and cognitive-neurophysiological impairments seen in 
preterm-born adolescents are identical to those in ADHD by directly comparing 
ADHD symptom scores and performance on a cognitive-neurophysiological test 
battery sensitive to impairments in ADHD across preterm-born adolescents, 
term-born adolescents with ADHD and term-born controls. We find that ADHD 
symptoms are increased in the preterm group compared to controls. The 
analyses further indicate similarities in brain function between ADHD and 
preterm birth, as well as unique impairments in the preterm group. Taken 
together, these results suggest that preterm birth may present a risk factor for 
both ADHD and additional impairments. Third, using twin data we carry out a 
developmental-genetic analysis of the association between ADHD and IQ, 
showing that ADHD symptoms and IQ scores significantly predict each other 
over time. Finally, we explore a putative protective factor for ADHD by 
investigating the effect of physical activity on ADHD symptoms. Using a 
population-based sample of twins, we show that physical activity is inversely 
associated with ADHD symptoms, even after adjusting for unmeasured 
confounding. Overall, we demonstrate certain commonalities in brain 
dysfunction between ADHD and BD. Whereas preterm birth and lower IQ 
present risk factors for ADHD, physical activity emerges as a potential 
protective factor.   
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Chapter 1. Introduction 
Attention-deficit/hyperactivity disorder (ADHD) is a complex 
neurodevelopmental disorder, characterised by developmentally inappropriate 
and impairing levels of hyperactivity, impulsivity and/or inattention (American 
Psychiatric Association, 2013). This conceptualisation of ADHD, as presently 
defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM, 
American Psychiatric Association 2013), has evolved gradually over the 
centuries and still bears a notable resemblance to its origins today (Barkley & 
Peters, 2012; Taylor, 2011). The idea of inattentive, overactive and impulsive 
behaviour as a medical problem first arose in 1775 in a textbook written by 
Melchior Adam Weikard (Barkley & Peters, 2012). The universal and impairing 
qualities of these symptoms were then further outlined in eighteenth and 
nineteenth century accounts of the disorder (Crichton, 1798; Still, 1902).  
 
Following these early descriptions, efforts were made to advance the key ideas 
of ADHD with the help of empirical evidence. This endeavour gave rise to the 
first mention of ADHD in the DSM-II, referring to the disorder as ‘hyperactive 
child syndrome’ (American Psychiatric Association, 1968). DSM-III brought 
about a paradigm shift both for child psychiatry more generally, by replacing 
aetiological formulations with simple description of observable behaviours, and 
ADHD more specifically, by placing equal emphasis on the inattentive, 
hyperactive and impulsive components of the disorder (American Psychiatric 
Association, 1980). As a consequence of recognising the heterogeneity in the 
behavioural manifestation of the disorder, two subtypes of ADHD – the 
inattentive and the hyperactive-impulsive subtype – were subsequently 
incorporated into the description of ADHD in the DSM-IV, yielding three 
subtypes of ADHD: the inattentive, the hyperactive-impulsive and the combined 
subtypes (American Psychiatric Association, 1994). Most recently, the DSM-5 
(American Psychiatric Association, 2013) has been updated to include, among 
other things, appropriate diagnostic criteria for adults and frequently co-
occurring disorders.  
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1.1 Clinical symptoms and diagnosis of ADHD 
The diagnostic criteria for ADHD employed in this thesis are based on the DSM-
IV. The DSM-IV delineates nine inattention symptoms, six hyperactivity 
symptoms and three impulsivity symptoms, which are grouped into the 
inattentive and hyperactive-impulsive subscales of ADHD respectively 
(American Psychiatric Association, 2000) (see Table 1.1). DSM-IV criteria 
stipulate that a child is diagnosed with ADHD if he/she meets six or more 
symptoms on at least one of the two subscales. These symptoms have to have 
been present for at least six months and before the age of seven, and must 
occur across at least two settings (e.g. at home and at school) to a degree that 
is developmentally deviant and impairing. Finally, an ADHD diagnosis is made if 
these symptoms do not occur exclusively during the course of a pervasive 
developmental or psychotic disorder, and if they cannot be better explained by 
other psychiatric disorders. ADHD can be diagnosed as one of three subtypes: 
ADHD combined-type (ADHD-C) is diagnosed when at least six symptoms are 
present on both subscales, predominantly inattentive-type (ADHD-IA) is 
diagnosed when at least six inattentive symptoms are present; and 
predominantly hyperactive-impulsive type (ADHD-HI) is diagnosed when at 
least six hyperactive-impulsive symptoms are present. Based on the DSM-IV, 
adults can only be diagnosed with ADHD if they met diagnostic criteria for 
ADHD in childhood and continue to show symptoms and associated 
impairments of the disorder during adulthood. While much of the DSM-IV 
structure is retained in the most recent update of the ADHD classification in 
DSM-5 (American Psychiatric Association, 2013), changes have been made to 
more accurately characterise the experience of adults affected by ADHD.  
 
In the DSM-5, symptoms required to meet diagnostic criteria depend on an 
individual’s age, such that individuals aged 17 years and older must display five 
or more symptoms on at least one of the two ADHD subscales to receive an 
ADHD diagnosis, while children aged 16 years and younger continue to require 
six or more symptoms for an ADHD diagnosis. The age of onset has been 
raised from seven to 12 years of age (American Psychiatric Association, 2013).   
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Table 1.1. Diagnostic items for ADHD based on DSM-IV-TR. 
Inattention 
1 Often fails to give close attention to details or makes careless mistakes in 
schoolwork, work, or other activities 
2 Often has difficulty sustaining attention in tasks or play activities 
3 Often does not seem to listen when spoken to directly 
4 Often does not follow through on instructions and fails to finish 
schoolwork, chores, or duties in the workplace (not due to oppositional 
behaviour or failure of comprehension) 
5 Often has difficulty organizing tasks and activities 
6 Often avoids, dislikes, or is reluctant to engage in tasks that require 
sustained mental effort (such as schoolwork or homework) 
7 Often loses things necessary for tasks or activities at school or at home 
(e.g. toys, pencils, books, assignments) 
8 Is often easily distracted by extraneous stimuli 
9 Is often forgetful in daily activities 
Hyperactivity 
10 Often fidgets with hands or feet or squirms in seat 
11 Often leaves seat in classroom or in other situations in which remaining 
seated is expected 
12 Often runs about or climbs excessively in situations in which it is 
inappropriate (in adolescents or adults, may be limited to subjective 
feelings of restlessness) 
13 Often has difficulty playing or engaging in leisure activities quietly 
14 Often talks excessively 
15 Is often ‘on the go’ or often acts as if ‘driven by a motor’ 
Impulsivity 
16 Often has difficulty awaiting turn in games or group situations 
17 Often blurts out answers to questions before they have been completed 
18 Often interrupts or intrudes on others, e.g. butts into other children's 
games 
Note: Items replicated from the revised version of the DSM-IV (DSM-IV-TR; 
American Psychiatric Association 2000). 
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DSM criteria are similar, though not identical, to those of the International 
Classification of Diseases (ICD-10), which is a more stringent diagnostic tool 
(Sørensen, Mors, & Thomsen, 2005). In the ICD-10 (World Health Organization, 
1992), which refers to ADHD as hyperkinetic disorder, ADHD is defined by the 
key features impaired attention and overactivity. Both impaired attention and 
overactivity are necessary for a diagnosis and are required to be present in 
more than one setting (e.g. at home and at school).  
 
1.1.1 Categorical vs. dimensional approach 
Diagnostic manuals such as the DSM (American Psychiatric Association, 2000, 
2013) or the ICD (World Health Organization, 1992) define clinical diagnoses in 
a categorical system based on the description of behavioural symptoms 
because a decision to treat is of binary nature. However, taxometric analyses 
have shown that an ADHD diagnosis represents the extreme of a trait that 
varies continuously throughout the population rather than being qualitatively 
different (Frazier, Youngstrom, & Naugle, 2007; Haslam et al., 2006; Larsson, 
Anckarsater, Råstam, Chang, & Lichtenstein, 2012; Lubke, Hudziak, Derks, van 
Bijsterveldt, & Boomsma, 2009). These findings are substantiated by 
longitudinal neuroimaging research showing an association of cortical thinning 
during adolescence with the entire spectrum of ADHD symptoms and the ADHD 
diagnosis at its extreme end (Shaw et al., 2011). Further support for the view 
that ADHD represents the extreme end of a normally-distributed spectrum of 
symptoms comes from research that indicates that the aetiological contribution 
of genetic influences is the same for categorical and dimensional definitions of 
ADHD behaviours (Chen & Taylor, 2006; Chen et al., 2008; Larsson et al., 
2012; Levy, Hay, McStephen, Wood, & Waldman, 1997). A genetic overlap 
between the categorical ADHD diagnosis and attention problems assessed as a 
continuous trait in the general population has also been demonstrated using 
polygenic risk scores derived from a discovery sample of individuals diagnosed 
with ADHD, which significantly predicted parent- and teacher-rated attention 
problems in independent population-based samples of children (Groen-Blokhuis 
et al., 2014; Martin, Hamshere, Stergiakouli, O’Donovan, & Thapar, 2014). The 
implications of these findings are that many genes and environmental 
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influences of small effect contribute to the spectrum of symptoms with no single 
factor being either necessary or sufficient for diagnosis. 
 
A dimensional approach to ADHD is useful as it decreases the risk of possible 
selection biases associated with clinical samples (Rutter et al., 1990). 
Furthermore, investigating ADHD as a continuum enables the study of the 
subclinical expressions of ADHD symptoms. The categorical approach, on the 
other hand, affords ease of use, practicality in planning informed treatment and 
value in improving communication and consistency between clinicians as well 
as researchers (Mullins-Sweatt & Widiger, 2009). Consequently, both 
categorical and dimensional approaches to ADHD are valuable to studying the 
disorder and its underlying pathophysiology. This thesis employs both 
categorical and dimensional definitions of ADHD.  
 
1.1.2 Parent-, teacher- and self-report 
Clinical guidelines recommend that a systematic evaluation of ADHD symptoms 
in childhood should draw on accounts by multiple informers such as parents, 
teachers and the individual concerned (Taylor et al., 2004). Multiple-informant 
accounts are also useful to establish the pervasiveness of ADHD symptoms 
across settings, which is one of the criteria for a diagnosis of ADHD (American 
Psychiatric Association, 2013; World Health Organization, 1992). However, 
relatively low agreement between parent-, teacher- and self-ratings of ADHD 
symptoms has been reported, with correlations ranging from 0.3 to 0.5 
(Achenbach & Rescorla, 2001; Goodman, 2001; Sollie, Larsson, & Mørch, 
2013; Wolraich et al., 2004). Importantly, the methods employed to evaluate 
ADHD symptoms usually vary across the lifespan. While parents and teachers 
typically rate ADHD symptoms in childhood, ADHD symptoms in late 
adolescence and adulthood are usually self-rated (Asherson, 2005).  
 
Twin studies have reported informer-specific heritability estimates for ADHD 
symptoms. While high heritability estimates are obtained from parent-rated 
ADHD symptom scores (h2=70-80%) (Nikolas & Burt, 2010), heritability 
estimates based on self-ratings in adolescence (Ehringer, Rhee, Young, Corley, 
& Hewitt, 2006; Martin, Scourfield, & McGuffin, 2002; Merwood et al., 2013; 
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Young, Stallings, Corley, Krauter, & Hewitt, 2000) and adulthood (Boomsma et 
al., 2010; Haberstick et al., 2008; Larsson et al., 2013; Schultz, Rabi, Faraone, 
Kremen, & Lyons, 2006; van den Berg, Willemsen, de Geus, & Boomsma, 
2006) are consistently lower (h2≤50%). Teacher-rated ADHD symptoms also 
generally yield lower (h2≤60%) (Kan, van Beijsterveldt, Bartels, & Boomsma, 
2014; Kuntsi & Stevenson, 2000; Merwood et al., 2013; Thapar, Harrington, 
Ross, & McGuffin, 2000; Wood, Rijsdijk, Saudino, Asherson, & Kuntsi, 2008) 
and more varied (Thapar et al., 2000; Wood et al., 2008) heritability estimates, 
especially when different teachers rate the behaviours of each twin from a pair 
(Derks, Hudziak, Van Beijsterveldt, Dolan, & Boomsma, 2006; Hartman, Rhee, 
Willcutt, & Pennington, 2007; Kan et al., 2014; Merwood et al., 2013; Saudino, 
Ronald, & Plomin, 2005). Since individuals with ADHD may lack insight into 
their problems (Hoza et al., 2005; Knouse, Bagwell, Barkley, & Murphy, 2005; 
Murphy & Schachar, 2000; Owens, Goldfine, Evangelista, Hoza, & Kaiser, 
2007), self-ratings of ADHD may provide a less reliable measure of behaviour. 
One plausible explanation for the findings of lower heritability estimates for self-
ratings is, therefore, greater measurement error resulting from less reliable 
ratings (Franke et al., 2012; Martin et al., 2002; Merwood et al., 2013). In 
classical twin modelling, measurement error is contained in the non-shared 
environmental component. As a result, measurement error can lead to an 
inflation of the non-shared environmental component and a decrease in the 
heritability estimates because the genetic, shared and non-shared 
environmental factors are statistically dependent components of the phenotypic 
variance (Rijsdijk & Sham, 2002).  
 
Different-teacher ratings have yielded similarly low heritability estimates as self-
ratings (Kan et al., 2014; Merwood et al., 2013). Consequently, another 
explanation for the lower heritability estimates for self-ratings is the reliance on 
different informants for each twin in a pair when using self-ratings (i.e., each 
twin rates themselves), as opposed to one informant when the same parent or 
teacher rates both twins in a pair (Brikell, Kuja-Halkola, & Larsson, 2015). This 
explanation implicates rater effects, which could reflect true rater specific 
variance (Bartels, Boomsma, Hudziak, van Beijsterveldt, & van den Oord, 2007; 
Hartman et al., 2007) or rater bias (Freitag, Rohde, Lempp, & Romanos, 2010). 
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While parent-ratings of ADHD symptoms have yielded consistent heritability 
estimates (Nikolas & Burt, 2010), they often show low dizygotic (DZ) twin 
correlations of less than half the monozygotic (MZ) correlations (Kuntsi & 
Stevenson, 2000, 2001; Martin et al., 2002; Saudino et al., 2005; Thapar et al., 
2000). This finding may be interpreted as reflecting dominant genetic factors, 
but may also represent influences from rater contrast effects. Contrast effects 
stem from an overestimation of the differences between twins, which generally 
reduce twin similarity more strongly in DZ compared to MZ twins (Rietveld, 
Posthuma, Dolan, & Boomsma, 2003; Wood, Buitelaar, Rijsdijk, Asherson, & 
Kuntsi, 2010). In addition to low DZ correlations, contrast effects are further 
signified by significantly greater phenotypic variances for DZ than MZ twins, 
which aid the distinction between contrast effects and non-additive genetic 
effects. Some twin studies of ADHD have indeed identified contrast effects 
(Freitag et al., 2010; Rietveld et al., 2003; Stevenson et al., 2005). Undetected 
contrast effects have also been hypothesized to account for some of the non-
additive genetic influences reported in ADHD (Wood, Buitelaar, et al., 2010). 
Short rating scales for ADHD symptoms (e.g. the 5-item SDQ hyperactivity 
scale or the 3-item Rutter A scale) may be more likely to elicit these contrast 
effects (Price et al., 2005). Consequently, longer rating scales may provide a 
more objective measure of ADHD symptoms. Furthermore, teacher-ratings may 
be less susceptible to contrast effects due to their relatively greater experience 
of same-age children to which they can compare the twins’ behaviours 
(Hartman et al., 2007; Simonoff et al., 1998). 
 
Both common and unique genetic influences on parent-, teacher- and self-
ratings of ADHD symptoms have been reported (Derks et al., 2006; Hartman et 
al., 2007; Martin et al., 2002; McLoughlin, Rijsdijk, Asherson, & Kuntsi, 2011; 
Merwood et al., 2013; Nadder, Rutter, Silberg, Maes, & Eaves, 2002; Thapar et 
al., 2000). A recent multivariate twin analysis found that the similarities among 
raters could largely be attributed to genetic influences (84%) and proposed that 
the difference between informants may either represent genuine non-shared 
environmental influences, gene-environment interaction or increased 
measurement error (Merwood et al., 2013). The implications of these findings 
are that a composite measure combing multiple-informant accounts creates a 
pervasive and highly heritable phenotype, which decreases the likelihood of 
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measurement error. Although it is apparent that rater effects impact heritability 
estimates for ADHD, the question of which rater assessment offers the most 
accurate heritability estimate is not resolved (Brikell et al., 2015). In childhood 
and adolescence, parent-reports seem to be the most reliable measure of 
ADHD symptoms. Not only do parent-rated ADHD symptoms demonstrate the 
highest and most consistent heritability estimates in childhood and adolescence 
(Nikolas & Burt, 2010), the predictive validity of parent-report with regards to 
long-term outcome is also more accurate than that of childhood self-report 
(Barkley, Fischer, Smallish, & Fletcher, 2002). For the assessment of adult 
ADHD, cross-informant ratings (i.e. parent- and self-ratings or clinician-, close 
relation- and self-ratings) have been recommended since heritability estimates 
and twin correlations from cross-informant studies of ADHD in adults have been 
in line with findings from childhood twin studies using same parent-/teacher-
ratings (Brikell et al., 2015; Chang, Lichtenstein, Asherson, & Larsson, 2013; 
Larsson et al., 2013). However, considering cross-informant ratings for adults 
with ADHD may not always be feasible. The idea that lower heritability 
estimates for self-ratings of adult ADHD stem from the reliance on different 
informants for each twin in a pair (i.e., each twin rates themselves), rather than 
from a less reliable measure of behaviour (Brikell et al., 2015), may suggest that 
basing adult ADHD symptoms on self-ratings is viable. 
 
The ADHD sample in chapter 2 was obtained from an adult ADHD clinic where 
ADHD diagnosis was established by a clinician based on self-report. For 
consistency between samples (Cheung et al., 2015a; Cheung, Rijdijk, 
McLoughlin, Asherson, & Kuntsi, 2015b; Kitsune et al., 2015), diagnostic status 
in chapters 3 and 4 of this thesis was based on ADHD symptoms reported by 
one parent during a structured clinical interview. In chapters 5 and 6, ADHD 
symptoms were established using parent-ratings of DSM-IV ADHD symptoms. 
  
1.1.3 Summary 
ADHD is a neurodevelopmental disorder that is characterised by age-
inappropriate levels of inattention, hyperactivity and impulsivity. While 
diagnostic tools such as the DSM or the ICD define ADHD as binary, ADHD 
represents the extreme of a behaviour that varies continuously throughout the 
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population. A dimensional approach to ADHD may be beneficial for decreasing 
the risk of possible selection biases associated with clinical samples (Rutter et 
al., 1990) and for the investigation of the subclinical expressions of ADHD 
symptoms. A categorical approach may be adopted to study the clinical extreme 
as well as for ease of use, improved communication and consistency between 
clinicians and researchers. While parents and teachers typically rate ADHD 
symptoms in childhood and early adolescence, ADHD symptoms in late 
adolescence and adulthood are typically self-rated (Asherson, 2005).  
 
1.2 Epidemiology 
ADHD is one of the most common psychiatric disorders worldwide, with the 
prevalence in children estimated at around 5-7% (Polanczyk, Willcutt, Salum, 
Kieling, & Rohde, 2014; Thomas, Sanders, Doust, Beller, & Glasziou, 2015; 
Willcutt, 2012). Two recent meta-analyses concluded that, over the last thirty 
years, the number of children diagnosed with ADHD worldwide has remained 
constant (Polanczyk et al., 2014; Thomas et al., 2015).  
 
As symptoms of ADHD tend to decline with age (Biederman, 2000; Faraone, 
Biederman, & Mick, 2006), ADHD was initially believed to be a childhood 
disorder (Barkley, 2008). However, ADHD is now recognised as frequently 
spanning from childhood into adolescence and adulthood (Cheung et al., 
2015b; Faraone et al., 2006; Langley et al., 2010), with worldwide prevalence 
rates for adult ADHD ranging from 2.5% to 5% (Fayyad et al., 2007; Simon, 
Czobor, Bálint, Mészáros, & Bitter, 2009). The lower prevalence rates of adult 
ADHD compared to childhood ADHD may represent an underdiagnosis 
(Ginsberg, Quintero, Anand, Casillas, & Upadhyaya, 2014) and may be 
explained by methodological and diagnostic differences: ADHD symptoms in 
adult samples is often established using self-report measures only, diagnostic 
tools vary between studies and the mean age (20-30 years), as well as gender 
proportions, of most studies may not be representative of a typical adult 
population (Simon et al., 2009). In addition, until the publication of the DSM-5 
(American Psychiatric Association, 2013), an adult ADHD diagnosis was based 
on symptom descriptions developed for children. This apparent lack of age-
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appropriate ADHD symptom assessment has not only impeded clinical practice, 
but also research efforts (Brikell et al., 2015). 
 
1.2.1 Gender differences 
Gender differences in the prevalence of childhood ADHD are well documented 
in the literature, with higher rates of ADHD symptoms and diagnoses 
consistently reported for boys (Willcutt, 2012). Estimates of the worldwide male-
to-female ratio in children with ADHD range from around 9:1 to 3:1 depending 
on whether the sample is a clinic-referred or population-based sample (Erskine 
et al., 2013; Gaub & Carlson, 1997; Polanczyk, de Lima, Horta, Biederman, & 
Rohde, 2007). Compared to studies of children with ADHD, there is an 
increased representation of females, and approximately equal distribution of 
males and females meeting diagnostic criteria, in studies of adult ADHD 
(Biederman et al., 1994; Biederman, Faraone, Monuteaux, Bober, & Cadogen, 
2004; Rucklidge, 2010). One interpretation of these findings is that higher male-
to-female ratios in childhood may represent the inadequacy of current 
diagnostic tools to ascertain ADHD in girls (Nussbaum, 2012). Current 
diagnostic criteria for ADHD have been developed on predominately male 
samples, which decreases their generalisability to female populations (Staller & 
Faraone, 2006).  
 
An alternative explanation is that the underrepresentation of girls with ADHD 
arises from a gender-based referral bias. Girls, regardless of their diagnostic 
ADHD status, exhibit fewer disruptive behaviours and learning disabilities than 
boys (Biederman et al., 2002; Brassett-Harknett & Butler, 2007). Since these 
problems usually drive clinical referral, ADHD in girls may remain 
underidentified (Biederman et al., 2002; Brassett-Harknett & Butler, 2007). 
Support for this hypothesis comes from the finding that females are more likely 
than males to meet diagnostic criteria for ADHD-IA, whereas a larger proportion 
of males than females meet diagnostic criteria for ADHD-C (Willcutt, 2012). 
Inattentive symptoms may supposedly be less disruptive than combined-type or 
hyperactive-impulsive symptoms. As adults, however, an increasing number of 
women may self-refer to mental health services for attention problems (Arcia & 
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Conners, 1998; Biederman et al., 1994; Biederman et al., 2004), resulting in a 
more balanced gender distribution in clinical samples.  
 
It is unclear whether gender differences in symptom severity exist. Whereas 
some studies have suggested that ADHD symptom severity is generally lower in 
females compared to males (Arnett, Pennington, Willcutt, DeFries, & Olson, 
2015; Gaub & Carlson, 1997; Gershon, 2002), others have found either no 
differences (Das, Cherbuin, Butterworth, Anstey, & Easteal, 2012; de Zwaan et 
al., 2012; Rasmussen & Levander, 2009; Retz-Junginger, Rösler, Müller, & 
Retz, 2012; Wilens et al., 2009) or increased symptom severity in females 
(Elkins, Malone, Keyes, Iacono, & McGue, 2011; Fedele, Lefler, Hartung, & 
Canu, 2010; Robison et al., 2008). It is conceivable that these inconsistencies 
result from the limited data available on female samples with ADHD. 
 
1.2.2 Co-occurring symptoms and disorders 
A high incidence of associated symptoms and disorders has been reported in 
both clinic-referred (Ghanizadeh, 2009; Skirrow & Asherson, 2013) and general 
population samples (Kadesjö & Gillberg, 2001; Kraut et al., 2013; Larson, Russ, 
Kahn, & Halfon, 2011). A recent study investigated co-occurring disorders of 
ADHD in 2,150,362 German insurees aged 3 to 17 years (Kraut et al., 2013). 
This study found that over 80% of methylphenidate users (a proxy for ADHD 
diagnosis; n=17,297) had at least one psychiatric comorbidity, compared to 
20% of controls (Kraut et al., 2013). The most frequently co-occurring disorders 
in children and adolescents with ADHD were conduct disorder (CD) and 
oppositional defiant disorder (ODD). CD comprises a pattern of disruptive and 
violent behaviours, as well as recurrent violation of societal norms and rules 
(American Psychiatric Association, 2013). ODD describes an on-going pattern 
of uncooperative, defiant and hostile behaviours (American Psychiatric 
Association, 2013). Both clinical and epidemiological studies have investigated 
the association of CD and ODD with ADHD and found these disorders to co-
occur in around 10-70% of children and adolescents with ADHD (Bauermeister 
et al., 2007; Freitag et al., 2012; Ghanizadeh, 2009, 2015; Jensen & 
Steinhausen, 2015; Kadesjö & Gillberg, 2001; Larson et al., 2011). While CD 
and ODD symptoms have been found to decline with age (Biederman et al., 
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2008; Cumyn, French, & Hechtman, 2009), childhood CD and ODD are linked 
to worse long-term outcome with regards to academic and vocational 
achievement, rates of psychiatric comorbidities, ADHD symptom severity and 
functional impairment in adults with ADHD (Biederman et al., 2008; Harpold et 
al., 2007; Vitola et al., 2012).  
 
Impairments in social communication and functioning are also common in both 
children and adults with ADHD. These impairments likely reflect the high rate of 
co-occurrence between ADHD and autism spectrum disorder (ASD), with 20-
50% of those with ADHD also displaying ASD symptoms (Banaschewski, 
Poustka, & Holtmann, 2011; Lai, Lombardo, & Baron-Cohen, 2014; Polderman, 
Hoekstra, Posthuma, & Larsson, 2014; Rommelse, Geurts, Franke, Buitelaar, & 
Hartman, 2011). Additionally, across the lifespan, ADHD is associated with 
anxiety and depression, which are characterised by excessive worry and fear 
and a disturbance in an individual’s mood respectively (American Psychiatric 
Association, 2013). Anxiety disorders have been demonstrated in 20-35% of 
individuals with ADHD from both general population and clinical samples, while 
depressive disorders were found in 10-30% (Bauermeister et al., 2007; 
Biederman et al., 2012; Bloemsma et al., 2013; Hesson & Fowler, 2015). 
Furthermore, a systematic review suggested that 5-20% of adults with ADHD 
also meet diagnostic criteria for bipolar disorder (BD) (Asherson et al., 2014), 
but higher rates of 32% have also been reported (Halmøy et al., 2010). This 
discrepancy may arise because adult ADHD can resemble BD, especially the 
broader spectrum of BD, and vice versa. Consequently, ADHD and BD may be 
mistaken for one another or misdiagnosed as comorbid ADHD-BD due to the 
substantial symptomatic overlap (Asherson et al., 2014). The commonalities 
and differences between ADHD and BD are one of the topics of investigation in 
this thesis, and are discussed in more detail below (section 1.6 and chapter 2).  
 
Children and adolescents with ADHD frequently exhibit difficulties with 
academic performance and achievement (Barkley, Murphy, & Fischer, 2010; 
Barry, Lyman, & Klinger, 2002; Frazier, Youngstrom, Glutting, & Watkins, 2007). 
In addition to behavioural problems, academic underachievement in individuals 
with ADHD may be attributed to specific learning difficulties such dyslexia, 
dyscalculia and dysgraphia. A recent review found reading and numerical 
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disorders to occur in 24% to 38% and writing disorder to occur in 59% to 65% of 
children with ADHD (DuPaul, Gormley, & Laracy, 2013). ADHD is also 
associated with lower mean IQ scores. A meta-analysis of 123 studies 
estimated a 7–11-point difference in full-scale IQ between control individuals 
and individuals diagnosed with ADHD (Frazier, Demaree, & Youngstrom, 2004). 
The relationship between ADHD symptoms and IQ is a focus of this thesis and 
is discussed in more detail below (section 1.5.1 and chapter 5).  
 
1.2.3 Summary 
ADHD is one of the most common psychiatric disorders worldwide and 
frequently spans from childhood into adolescence and adulthood. While more 
boys than girls are diagnosed with ADHD, females make up approximately half 
of the ADHD population in adulthood. Reasons for this shift in male-to-female 
ratio from paediatric to adult samples remain elusive. A high incidence of co-
occurring symptoms and disorders has been found in individuals with ADHD.  
 
1.3 Treatments and interventions  
Since ADHD symptoms and impairments often persist from childhood into 
adolescence and adulthood, there is a continued need for treatment and 
management of the disorder across the lifespan. The National Institute for 
Health and Care Excellence (NICE) recommends group-based parent-
training/education programmes and group-based psychological treatment, such 
as cognitive behavioural therapy (CBT) and/or social skills training, as first-line 
treatment for children with ADHD and moderate impairment (National 
Collaborating Centre for Mental Health, 2013). In adolescence, individual 
psychological treatment is recommended. Drug treatment may be considered 
as an alternative for children and adolescents with moderate impairment levels, 
who have refused non-drug interventions, or whose symptoms have not 
responded sufficiently to parent-training/education programmes or group 
psychological treatment. While drug treatment is not indicated as the first-line 
treatment for children and adolescents with ADHD, it is recommended as the 
first-line treatment for adults with ADHD with either moderate or severe levels of 
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impairment. The psychostimulant methylphenidate is recommended as the first-
line drug (National Collaborating Centre for Mental Health, 2013).  
 
A robust evidence base stemming from randomised control trials attests to the 
efficacy of psychostimulant drugs as well as non-psychostimulant medication, 
such as atomoxetine, in reducing the symptoms and cognitive impairments 
associated with ADHD in children and adolescents (Abikoff et al., 2004; Brown 
et al., 2005; Garnock-Jones & Keating, 2009), as well as in adults (Faraone & 
Glatt, 2010; Moriyama, Polanczyk, Terzi, Faria, & Rohde, 2013; Surman, 
Hammerness, Pion, & Faraone, 2013). Some individuals may not respond to 
stimulant medication or atomoxetine and complete normalisation of symptoms 
is rare (Banaschewski et al., 2006). Stimulant medication and atomoxetine may 
also be less effective for treating disorders and symptoms that frequently co-
occur with ADHD, such as conduct problems or anxiety disorders (see section 
1.2.2 for more detail). Consequently, multimodal treatment plans including 
medication and psychological interventions, tailored to the specific needs of the 
patient, should be considered for the treatment of ADHD (National Collaborating 
Centre for Mental Health, 2013). While the benefits of multimodal treatment 
plans have been established in the Multimodal Treatment study of ADHD 
(MTA), the effects seem to dissipate on or shortly after termination of the 
treatment (Hinshaw & Arnold, 2015).  
 
A variety of non-pharmacological interventions, such as psychological (cognitive 
training, neurofeedback, and behavioural training) and dietary (restricted 
elimination diets, artificial food colour exclusions, and free fatty acid 
supplementation) interventions, are also available. A recent meta-analysis 
found blinded evidence that behavioural interventions used to treat children and 
adolescents with ADHD, including behavioural training, social skills training and 
CBT, had beneficial effects on important aspects of child and parent functioning, 
namely decreasing comorbid childhood conduct problems and increasing 
positive parenting (Daley et al., 2014). Yet, the evidence for the efficacy of non-
pharmacological treatment interventions on reducing ADHD symptoms is far 
from clear and limited by the unblind status of researchers and raters of 
behaviour (Sonuga-Barke et al., 2013). Blinded evidence for small but 
significant reductions in ADHD symptoms has so far only been found for free 
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fatty acid supplementation and artificial food colour exclusion (Sonuga-Barke et 
al., 2013). Identifying alternative non-pharmacological treatments on the basis 
of our growing understanding of the pathophysiology, as well as risk and 
protective factors of ADHD, is therefore essential.  
 
One alternative treatment for ADHD that has gained increasing attention over 
the past few years is neurofeedback, which is rooted in findings of 
neurophysiological impairments in ADHD. In neurofeedback training, individuals 
with ADHD learn to match their neurophysiological profile more closely to that of 
typically developing children and to control certain aspects of their neural 
activity, such as attentional states, to modulate them on demand (Arns, 
Heinrich, & Strehl, 2014; Gevensleben et al., 2014). A meta-analysis including 
data from 10 prospective, controlled trials on children with ADHD (n=467) 
reported large effect sizes for the effect of neurofeedback on inattention and 
impulsivity (Cohen’s d=0.81, d=0.68 respectively) and a moderate effect size for 
the effect of neurofeedback on hyperactivity (d=0.39) (Arns, de Ridder, Strehl, 
Breteler, & Coenen, 2009). However, some of the studies included have been 
criticised for their methodological short-comings with regards to randomisation, 
appropriateness of the control groups, diagnostic criteria and blinding procedure 
(Holtmann, Sonuga-Barke, Cortese, & Brandeis, 2014). A more recent meta-
analysis, therefore, applied a more stringent, selective approach and included 
only eight studies meeting high methodological standards (Sonuga-Barke et al., 
2013). Results from this meta-analysis showed a moderate to large effect size 
(standard mean difference=0.59) for treatment effects of neurofeedback. This 
effect was reduced to moderate (standard mean difference=0.29) and trend 
level significance (p=0.07) when properly blinded ratings were applied. Since 
these meta-analyses, several neurofeedback studies have been published with 
inconsistent results. While the quality of study design may have improved, non-
standardised protocols and equipment still complicate the interpretation of these 
inconsistencies (Holtmann et al., 2014) and the efficacy of neurofeedback 
remains to be elucidated.  
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1.3.1 Physical activity 
Another putative treatment target for ADHD that has garnered growing interest 
is physical activity (PA) (Rommel, Halperin, Mill, Asherson, & Kuntsi, 2013, see 
Appendix 1 for full publication). Animal research, as well as studies of typically 
developing children, adolescents and adults suggest that PA has the potential 
to improve ADHD symptoms and impairments associated with the disorder 
(Rommel et al., 2013). Both chronic and acute PA have been associated with 
improved EF in school-aged children with ADHD. One study investigating the 
effects of acute PA on EF reported that 30 minutes of moderate-intensity 
running facilitated performance on the colour-word condition of the Stroop task 
and certain aspects of the Wisconsin Card Sorting Test in 20 children with 
ADHD randomly assigned to the PA group, relative to 20 children with ADHD 
assigned to the control condition of watching an PA-related video (Chang, Liu, 
Yu, & Lee, 2012). However, PA did not have an effect on all measures of EF 
and effect sizes were small to moderate. Another study examining the impact of 
acute PA used a within-participant design to assess the effect of a 20-minute 
moderate-intensity bout of PA in 20 children diagnosed with ADHD and 20 
healthy-matched controls (Pontifex, Saliba, Raine, Picchietti, & Hillman, 2012). 
Following PA, both the ADHD and the control group exhibited greater response 
accuracy on a version of the Eriksen flanker task, measuring inhibitory control, 
relative to a seated reading condition. Acute PA, therefore, seems to have at 
least some effect on certain tasks assessing EF. The effect of PA on EF seems 
to be universal and not specific to ADHD.  
 
The impact of chronic PA on EF has been assessed by measuring the amount 
of moderate- to high-intensity PA performed by children with ADHD each day 
over a period of one week using an accelerometer (Gapin & Etnier, 2010). PA 
quantity significantly predicted performance on the Tower of London task, and 
was positively associated with working memory, inhibition and information 
processing in 18 boys with ADHD. Similarly, a six-week prospective trial of 12 
bi-weekly sessions demonstrated that EF, as measured by the digit symbol test, 
as well as co-operativeness were significantly improved by PA relative to 
behavioural educational sessions in 28 boys with ADHD. While no significant 
changes were found with regards to hyperactivity scores, inattention scores 
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improved in the PA group (Kang, Choi, Kang, & Han, 2011). Furthermore, 
compared to 42 individuals with ADHD who did not receive an intervention, 42 
individuals with ADHD partaking in a moderate-intensity 10-week PA 
programme of three sessions per week significantly improved on teacher-
ratings of attention, motor skills and academic and classroom behaviour 
(Ahmed & Mohamed, 2011). Correspondingly, another study of the effects of a 
10-week moderate-to-high-intensity PA programme on fitness, cognitive 
functions and ADHD-related behaviour in 10 children with ADHD reported 
significant improvements in muscular capacities, motor skills, level of 
information processing and parent- and teacher-rated social, thought and 
attention problems following the intervention compared a no-intervention control 
group consisting of 11 children with ADHD (Verret, Guay, Berthiaume, Gardiner, 
& Béliveau, 2012). The findings from studies investigating the effect of PA on 
ADHD suggest that PA may be beneficial for individuals with high levels of 
ADHD symptoms and associated impairments. Yet, more and better-quality 
evidence is needed to establish the impact of PA on ADHD symptoms and its 
efficacy in alleviating the symptoms and impairments associated with the 
disorder. The effect of PA on ADHD is a key focus of this thesis and is 
discussed in more detail in chapter 6. 
 
1.3.2 Summary 
While psychostimulant drugs and atomoxetine are efficacious in reducing the 
symptoms and cognitive impairments associated with ADHD across the 
lifespan, medication is less effective in treating the co-occurring disorders and 
symptoms. Moreover, medication does not develop vital organisational and 
social skills in individuals with ADHD, which could be applied upon completion 
of treatment. As a result of these shortcomings, the interest in alternative 
treatments, such as neurofeedback and physical activity, are growing. However, 
their efficacy and clinical value are still under investigation. 
 
1.4 Aetiology of ADHD 
The past two decades have seen an upsurge in studies investigating the 
genetic and environmental factors influencing ADHD, its symptoms and 
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associated impairments. While quantitative and molecular genetic research has 
played a significant role in shaping our understanding of ADHD, results from 
these studies have also brought to light the aetiological complexity of the 
disorder. Findings from quantitative genetic studies have firmly established the 
high heritability of ADHD and provided insight into the aetiology of 
developmental effects, the underlying neurophysiology and the co-occurrence 
of ADHD with other disorders. The combined effect of environmental factors 
and multiple common genetic variants is hypothesised to contribute to ADHD 
risk. This chapter offers an overview of these issues, outlining molecular and 
quantitative genetic methods as well as summarising the overall pattern of 
findings. 
 
1.4.1 Quantitative genetics 
1.4.1.1 Sibling design 
Sibling studies have consistently reported a higher prevalence of ADHD 
symptoms and diagnoses in siblings of affected individuals, compared to 
siblings of typically developing children (Biederman, 2005), supporting the idea 
that familial factors play a significant role in mediating the susceptibility to 
ADHD. The sibling design allows the partitioning of variance in ADHD 
symptoms into familial and non-shared, based on the fact that siblings share, on 
average, 50% of their DNA, as well as sharing many aspects of their 
environment due to growing up in the same family (shared environment). An 
extension of the sibling design, the twin method (outlined below), allows a 
further separation of familial factors into genetic and shared environmental 
influences and also affords the investigation of non-shared environmental 
factors. 
 
1.4.1.2 Twin design 
Twin studies constitute a powerful tool for disentangling the relative importance 
of environmental and genetic influences on ADHD. The classical twin design 
compares MZ twins with DZ twins (Rijsdijk & Sham, 2002). Both kinds of twin 
pairs experience the same amount of environmental similarity but their genetic 
resemblance differs. Whereas DZ twins share roughly half of their genetic 
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material, MZ twins are genetically identical at the DNA sequence level. Yet, 
both MZ and DZ twins are assumed to share many aspects of their environment 
by virtue of being born at the same time and place (shared environment, C). 
Thus, any difference between MZ twins can be attributed to so-called non-
shared environmental influences (E; i.e. everything that makes MZ twins 
growing up in the same family different). E also includes measurement error. In 
accordance with these assumptions and definitions, twice the difference 
between MZ and DZ twin correlations allows for an estimation of the additive 
genetic effects (A) playing a role in shaping a certain phenotype. Moreover, a 
DZ similarity less than half the MZ similarity yields an estimate of the non-
additive genetic effects (D) involved. Whereas univariate twin analysis can help 
disentangle environmental and genetic influences on ADHD, multivariate 
genetic analyses allow insights into the environmental and genetic effects on 
the overlap between ADHD and different traits. In multivariate twin analysis, MZ 
and DZ correlations are compared across traits: i.e. the correlation of one twin’s 
score on a trait is compared with the co-twin’s score on another trait. If the 
cross-trait cross-twin correlations are greater for MZ than for DZ twins, the 
implication is that genetic factors contribute to the phenotypic correlation 
between the two traits. This type of analysis also generates genetic and 
environmental correlations (rA, rC, rE), which can range from −1 to 1, and 
represent the extent to which genetic and environmental influences on two traits 
overlap (regardless of their individual heritabilities). Phenotypic correlations can 
also be attributed to genetic and environmental influences. The twin design will 
be applied in chapter 5 and its assumptions underlie the analysis in chapter 6. 
 
1.4.1.3 Quantitative genetic findings in ADHD 
Family studies have consistently reported higher prevalence of ADHD in 
parents and siblings of individuals diagnosed with ADHD compared to parents 
and siblings of typically developing children (Biederman, 2005). Adoption 
studies have also shown increased rates of ADHD in the biological parents of 
children with ADHD compared to both adoptive parents and parents of children 
without ADHD (Sprich, Biederman, Crawford, Mundy, & Faraone, 2000). 
Moreover, research has reported much higher concordance rates for ADHD in 
MZ than DZ twins (Thapar, Holmes, Poulton, & Harrington, 1999). Taken 
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together, these findings suggest that ADHD is a strongly heritable disorder. A 
review of 20 twin studies estimated the heritability of ADHD in children and 
adolescents at around 76% (Faraone et al., 2005). A subsequent meta-analysis 
provided a very similar estimate for broad (A+D) heritability of ADHD at around 
70% (Burt, 2009). Lower heritability estimates (h2<50%) found in adult 
populations have been attributed to potential self-rater measurement error 
(Larsson et al., 2013; Merwood et al., 2013; see section 1.1.2 for discussion). 
When self- and parent-ratings were combined to assess the heritability of ADHD 
symptoms in a large population-based sample of twins, heritability estimates at 
age 19-20 years (h2=0.77-0.82) mirrored those in childhood (Chang et al., 
2013). Yet, many new genetic influences on ADHD symptoms appear to arise 
over the developmental course from childhood to adolescence, and may be 
contributing to some children remitting from ADHD, while others persist 
(Pingault et al., 2015).  
 
Comparable heritability estimates for inattentiveness (h2=71%) and 
hyperactivity-impulsivity symptoms (h2=72%) have been established (Nikolas & 
Burt, 2010). With a genetic correlation of 0.55, over half of the genetic 
influences are shared between the two symptom dimension of ADHD, 
inattentiveness and hyperactivity-impulsivity (Greven, Asherson, Rijsdijk, & 
Plomin, 2011; Larsson et al., 2013; McLoughlin, Ronald, Kuntsi, Asherson, & 
Plomin, 2007), while around 45% of the genetic influences are unique to each of 
the two symptom dimensions. These findings suggest that the two behavioural 
domains represent partially overlapping but partially separable symptom 
domains. 
 
1.4.2 Molecular genetics 
Quantitative genetic studies have conclusively demonstrated that genetic 
influences play a key role in the aetiology of ADHD. Consequently, a vast 
number of molecular genetic studies have set out to examine the way the 
ADHD phenotype could be mapped on to a genotype. Early research explored 
candidate genes from association or linkage studies to examine the relationship 
between a pre-specified gene of interest and ADHD. Most of these studies 
focused on genes associated with dopaminergic pathways known to be involved 
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in the clinical response to psychostimulant medication, or serotonergic systems 
which are implicated in brain networks of attention, memory and motor activities 
(Gizer, Ficks, & Waldman, 2009). A meta-analysis revealed that while 
significant associations were identified between ADHD and several candidate 
genes (e.g. DAT1, DRD4, DRD5 and 5-HTT), the effect sizes of these 
associations were small, with odds ratios ranging from 1.12 to 1.33 (Gizer et al., 
2009). 
 
Another approach taken to explore the genetic architecture of ADHD is the 
scanning of markers across the complete sets of DNA, or genome, of a large 
number of people to discover genetic variations associated with the disorder. 
This method, known as genome-wide association study (GWAS), has the 
potential to detect completely novel associations without the need for a priori 
hypotheses. Yet, childhood (Hinney et al., 2011; Lasky-Su et al., 2008; Mick et 
al., 2010; Neale et al., 2008; Neale, Medland, Ripke, Anney, et al., 2010; 
Stergiakouli et al., 2012; Yang et al., 2013) and adult GWAS (Lesch et al., 2008; 
Zayats et al., 2015), as well as a meta-analysis of the childhood studies (Ebejer 
et al., 2013; Neale, Medland, Ripke, Asherson, et al., 2010), have so far failed 
to identify common risk variants of genome-wide significance (p≤ 5 × 10−8). A 
limitation of GWAS is that statistical power to detect associations is generally 
very low (≥80% power) and, therefore, extremely large samples are required 
(Visscher, 2008). Consequently, the failure of ten ADHD-GWAS and one meta-
analysis to uncover significant associations may, at least partly, be ascribed to 
too small samples, severe multiple testing corrections and the small effect sizes 
of individual risk loci (Hawi et al., 2015). 
 
As a result, research on common genetic variants in ADHD has begun to 
consider common variants from GWAS as an aggregate, employing polygenic 
risk score analysis. Polygenic scores derived from individuals diagnosed with 
ADHD have been shown to predict affection status in an independent sample 
(Hamshere et al., 2013) and ADHD trait levels in a general population sample 
(Groen-Blokhuis et al., 2014; Martin et al., 2014). Furthermore, polygenic scores 
for ADHD trait levels in the general population are associated with ADHD 
diagnosis and symptom severity in individuals diagnosed with ADHD 
(Stergiakouli et al., 2015). This multi-factorial, or polygenic, approach to ADHD 
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is consistent with the high prevalence of ADHD in the general population, as 
well as with the high concordance rate in MZ twins (70-80%) but modest risk to 
first-degree relatives (~20%) (Hawi et al., 2015). 
 
The limited success of GWAS has also spurred interest in rare genetic variation 
such as copy number variants (CNVs), which may contribute to ADHD. CNVs 
are large rare chromosomal structural abnormalities, i.e. gains and losses of 
large chunks of DNA sequence arising through non-allelic recombination or 
replication, that account for about 13% of the human genome (Stankiewicz & 
Lupski, 2010). These variations have been found to play a significant role in the 
aetiology of psychiatric disorders such as schizophrenia, BD and ASD (Cook & 
Scherer, 2008). Although existing research provides evidence for a role of 
CNVs in the aetiology of ADHD, the particulars of this role are yet to be 
established (Hawi et al., 2015). 
  
1.4.3 Environment 
Various environmental factors, such as maternal smoking and stress, as well as 
preterm birth and environmental toxins, are reportedly implicated in the 
aetiology of ADHD (Thapar, Cooper, Eyre, & Langley, 2013). Yet, these 
observed relationships may not be causal, but instead may arise from 
confounding genetic or familial factors (since parents provide both genetic and 
shared environmental influences). The consistently reported association 
between maternal smoking during pregnancy and increased risk for ADHD in 
the offspring, for example, can be attributed to unmeasured familial confounding 
(Skoglund, Chen, D’Onofrio, Lichtenstein, & Larsson, 2014). The relationship 
between maternal smoking during pregnancy and ADHD in the offspring was 
investigated in 813,030 individuals born in Sweden between 1992 and 2000. 
While maternal smoking predicted ADHD in the offspring, with hazard ratios 
(HRs) of 1.89 and 2.50 depending on how much the mother smoked, the 
association disappeared (HR=0.88-0.84) when unmeasured confounders within 
the nuclear family (i.e., comparison between siblings) were taken into account 
(Skoglund et al., 2014). 
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The association of preterm birth with ADHD, on the other hand, seems to be 
largely independent of shared familial confounds and, therefore, potentially 
causal (D’Onofrio et al., 2013). A population-based cohort study, combining 
Swedish registries to identify all individuals born in Sweden from 1973 to 2008 
(3,300,708 offspring of 1,736,735 mothers) reported a robust association 
between early gestation (23-27 weeks’ gestation) and ADHD diagnosis (hazard 
ratio, HR=2.3), independent of measured covariates and familial factors shared 
by siblings (D’Onofrio et al., 2013). Preterm birth is a key topic of this thesis and 
is discussed in more detail below (section 1.7; chapters 3 and 4). 
 
1.4.4 Gene-environment interplay 
Previous research has demonstrated that both genetic and environmental 
influences play a part in the aetiology of ADHD. Yet, genes and environment do 
not operate in isolation (Nigg, Nikolas, & Burt, 2010; Purcell, 2002). Instead, a 
certain genotype may make an individual more susceptible to environmental 
risk or protective factors (gene-environment interaction) or may increase the 
likelihood of exposure to certain environmental influences (gene-environment 
correlation) (Purcell, 2002). Although clear evidence for gene-environment 
interplay has been found for other psychiatric disorders, such as depression 
(Caspi et al., 2003; Caspi, Hariri, Holmes, Uher, & Moffitt, 2010; Thapar, 
Collishaw, Pine, & Thapar, 2012), only a small proportion of relevant genes and 
environments have been investigated for gene-environment interplay in ADHD  
and often findings from these studies have not been replicated (Nigg et al., 
2010; Thapar et al., 2013).  
 
Environmental factors may also influence genes more dynamically via 
epigenetic processes (Cortessis et al., 2012; Mill & Petronis, 2008), which 
regulate gene expression independently of the DNA sequence (Henikoff & 
Matzke, 1997). Epigenetic research is still very much in its infancy and very few 
studies have investigated the epigenetic mechanisms underlying ADHD (Nigg, 
2012). Studies that have looked at the epigenetic changes in animal models of 
ADHD have shown that as well as producing ADHD-like behaviours, prenatal 
exposure to toxins can result in an increase of histone acetylation (Luo, 
Haworth, & Plomin, 2010) and methylation (Kim et al., 2014) in the rat brain. 
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Changes in histone acetylation and DNA methylation have also been shown in 
initial epigenetic studies of children with ADHD (van Mil et al., 2014; Xu et al., 
2015). These findings suggest a role for gene-environment interplay in the 
aetiological pathway to ADHD. Yet, future research will have to substantiate 
these early findings.  
 
1.4.5 Summary 
Taken together, these findings suggest that a combination of genetic and 
environmental factors, none of which are individually necessary or sufficient, 
may lead to ADHD. While quantitative genetic research has shown that ADHD 
is highly heritable throughout the lifespan, results from molecular genetic 
studies highlight the aetiological complexity of ADHD. Several potential 
environmental risk factors have been identified. Interplay between genetic and 
environmental risk factors may contribute to susceptibility to ADHD or moderate 
the manifestation of the ADHD phenotype. Advances in analysis techniques 
may help to further unravel the heterogeneous and complex aetiology of ADHD 
in the future.  
 
1.5 Cognitive and neurophysiological impairments in ADHD 
Evidence from quantitative and molecular genetic studies suggests that a large 
number of genes with small effect likely confer risk for ADHD (Smoller et al., 
2013). Therefore, multiple pathways, both shared and unique, are likely to lead 
to the same symptoms or neurophysiological deficits. To advance our 
understanding of complex heterogeneous psychiatric conditions such as ADHD, 
research efforts are being dedicated to gaining insights into the pathways from 
the biological basis of the disease to the full clinical phenotype. Biological 
markers, or biomarkers, which are objectively measured indicators of a 
biological state or condition (Biomarkers Definitions Working Group, 2001), may 
not only help to elucidate the pathways and processes underlying ADHD, but 
may also inform us on the boundaries and overlap between current categorical 
definitions of ADHD and other associated disorders. Consequently, studying 
ADHD using multiple levels of intermediate measurements is likely an 
informative approach. An appreciation of the cognitive and neurophysiological 
 42 
processes underlying ADHD may not only improve diagnosis but also 
intervention, prognosis and prevention of ADHD. The following section offers a 
review of the key cognitive and neurophysiological impairments of ADHD. 
 
1.5.1 Phenotypic studies of cognitive impairments 
Impairments in executive functioning (EF) resulting from dysfunction in the 
fronto-striatal region of the prefrontal cortex have long been conceptualised as 
being a central deficit of ADHD (Willcutt, Doyle, Nigg, Faraone, & Pennington, 
2005). EF is an umbrella term comprising various higher cognitive functions 
such as response inhibition, planning, problem solving and working memory 
(Barkley, 1997; Castellanos & Tannock, 2002). A meta-analysis found moderate 
effect sizes (d=0.46-0.69) for the association between ADHD and impairments 
in various EF domains, namely response inhibition and working memory 
(Willcutt et al., 2005).  
 
Sustained attention, which is the maintenance of focused attention over an 
extended period of time, can be assessed using the continuous performance 
test (CPT, see section 2.3.2 for task description). The CPT requires participants 
to detect target stimuli among a sequence of distractor stimuli. Omission errors 
(OE; the lack of a response to a target) are assumed to represent impairments 
in sustained attention. Other performance measures that can be obtained from 
the CPT are reaction time variability (RTV), which is defined as intra-individual 
fluctuations in reaction times during task performance, and commission errors 
(CE), which are responses to non-target stimuli. CEs are an index of response 
inhibition. Whereas the CPT can indicate response inhibition with the help of 
CEs, it is designed to measure sustained attention. Response inhibition is better 
assessed using a Go/NoGo task. The reason for this is the target-to-non-target 
ratios of these two tasks, which is low for the CPT (few targets and many 
distractors) and high for the Go/NoGo task (many targets and few distractors). 
The CPT is, therefore, more likely to lead to OEs, while the Go/NoGo task is 
more likely to lead to CEs. 
 
A recent meta-analysis examining 47 studies of CPT performance in children 
with ADHD found increased OE, CE and RTV in children with ADHD compared 
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to typically developing controls, with moderate-to-large effect sizes (d=0.62, 
d=0.55 and d=0.56 respectively) (Huang-Pollock, Karalunas, Tam, & Moore, 
2012). Similarly, a meta-analysis of Go/NoGo performance in 30 studies of 
children with ADHD found a moderate-to-large effect for CE, with the standard 
mean difference ranging from 0.37 to 0.57 (Metin, Roeyers, Wiersema, van der 
Meere, & Sonuga-Barke, 2012). In adults with ADHD, similar deficits have been 
reported, including problems in sustained attention (Antshel et al., 2010; 
Gallagher & Blader, 2001; Lijffijt, Kenemans, Verbaten, & Van Engeland, 2005; 
Malloy-Diniz, Fuentes, Leite, Correa, & Bechara, 2007) and response inhibition 
(Bekker et al., 2005; Bekker et al., 2005; Boonstra, Kooij, Oosterlaan, Sergeant, 
& Buitelaar, 2010; Boonstra, Oosterlaan, Sergeant, & Buitelaar, 2005; Lampe et 
al., 2007; Lijffijt et al., 2005). These findings provide support for the notion that 
impairments in sustained attention and response inhibition are important 
features of ADHD across development. 
 
In addition, a recent meta-analysis of 319 studies established a large effect size 
for RTV in children and adolescents with ADHD (Hedges' g=0.76) and a 
moderate effect size for RTV in adults with ADHD (g=0.46) relative to typically 
developing controls (Kofler et al., 2013). The size of the effect suggests that 
RTV is a relatively ubiquitous and stable feature of ADHD. Yet, reaction time 
impairments in ADHD are sensitive to task condition. As such individuals with 
ADHD demonstrate significantly greater improvements in the consistency of 
their responses under relatively stimulating (fast-rewarded) task conditions 
compared to controls (Andreou et al., 2007; Cheung et al., 2015a; Kuntsi et al., 
2013; Uebel et al., 2010). This suggests that, rather than being a stable 
cognitive deficit, increased RTV in ADHD is a malleable and dynamic 
impairment, which could be explained by difficulties in arousal regulation or the 
allocation of sufficient neuronal resources (Sergeant, 2005).  
 
Another cognitive impairment linked to ADHD is lower general cognitive ability. 
Correlations between ADHD symptoms and IQ scores have been reported to 
range from –0.2 to –0.4 in population-based samples (Kuntsi et al., 2004; 
Wood, Asherson, Van Der Meere, & Kuntsi, 2010). Furthermore, a meta-
analysis of 123 studies estimated a 7–11-point difference in full-scale IQ 
between control individuals and individuals diagnosed with ADHD (Frazier et al., 
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2004). Lower IQ scores have been linked to increased severity of ADHD 
symptoms (Grizenko, Qi Zhang, Polotskaia, & Joober, 2012), higher levels of 
externalising and behavioural problems in individuals diagnosed with ADHD 
(Ahuja, Martin, Langley, & Thapar, 2013), as well as worse long-term outcome 
(Cheung et al., 2015b). On the contrary, higher IQ has been shown to positively 
impact the response to pharmaceutical treatment in ADHD (Aman, Buican, & 
Arnold, 2003; Hinshaw, 2007; Owens et al., 2003; van der Oord, Prins, 
Oosterlaan, & Emmelkamp, 2008). The association between ADHD and IQ is a 
focus of this thesis and is discussed in more detail below (chapter 5). 
 
1.5.2 Quantitative genetic studies of cognitive impairments in ADHD 
Impairments in EF, such as response inhibition, and RTV, have been reported 
in unaffected siblings of individuals diagnosed with ADHD (Andreou et al., 2007; 
Bidwell, Willcutt, Defries, & Pennington, 2007; Chen et al., 2008; Crosbie & 
Schachar, 2001; Gau & Shang, 2010; Goos, Crosbie, Payne, & Schachar, 
2009; Lin, Hwang-Gu, & Gau, 2015; Loo et al., 2008; Nikolas & Nigg, 2015; 
Pironti et al., 2014; Slaats-Willemse, Swaab-Barneveld, De Sonneville, & 
Buitelaar, 2007; Uebel et al., 2010). Furthermore, univariate twin analysis has 
revealed moderate genetic influences for reaction time, inhibition and working-
memory performance (Kuntsi et al., 2006).  
 
With regard to IQ, the negative association with ADHD can largely be attributed 
to genetic factors. One twin study reported that 86% of the phenotypic 
correlation between ADHD symptom and IQ scores and 100% of the 
association between ADHD research diagnosis and IQ scores were accounted 
for by genetic factors, with genetic correlations of rA=-0.45 between IQ and 
ADHD symptoms and rA=-0.59 between IQ and ADHD research diagnosis 
(Kuntsi et al., 2004). Significant genetic correlations have also been found in 
other population-based twin samples (Greven, Kovas, Willcutt, Petrill, & Plomin, 
2014; Paloyelis, Rijsdijk, Wood, Asherson, & Kuntsi, 2010; Polderman et al., 
2006; Wood, Asherson, et al., 2010). Multivariate model fitting analyses in both 
family (Rommelse et al., 2008; Wood et al., 2011) and twin studies (Wood, 
Asherson, et al., 2010) have revealed that the aetiological influences shared 
between ADHD and IQ largely separate from the aetiological influences on 
 45 
ADHD and other cognitive impairments. While the shared genetic origins of 
ADHD and IQ are well documented, little is known about the direction of effects 
or the genetic overlap between these variables at different developmental 
stages. Chapter 5, therefore, focuses on the developmental and aetiological 
patterns of the association between ADHD symptoms and IQ in a population-
based sample of twins.  
 
The overall genetic architecture underlying the various cognitive impairments 
associated with ADHD may best be conceptualised using multivariate 
investigations. In a multivariate familial analysis of a large sample of ADHD and 
control sibling pairs (N=1,265), two familial cognitive impairment factors 
emerged (Kuntsi et al., 2010). The larger factor, accounting for 85% of the 
familial variance of ADHD, captured 98-100% of the familial influences on mean 
reaction time and RTV. The second, smaller factor, reflecting 13% of the familial 
variance of ADHD, captured 82% of the familial influences on OE and 62% of 
those on CE on the Go/NoGo task. A similar pattern of results emerged in an 
investigation of 238 ADHD families (350 ADHD-affected and 195 non-affected 
children) and 147 control families (271 children), which also yielded two familial 
cognitive impairment factors (Frazier-Wood et al., 2012). IQ was not related to 
the first familial factor shared with reaction time data, but a portion (33%) of the 
familial influences on IQ were shared with the second factor, capturing working 
memory. Moreover, in a large sample of ADHD and control sibling pairs a 
significant familial association between cognitive performance, including MRT 
and RTV, and both ADHD and IQ emerged (Wood et al., 2011). Again, the 
association between ADHD and cognitive performance was largely independent 
(80-87%) of any contribution from aetiological factors shared with IQ.  
 
Results from a recent twin study further revealed that the association between 
ADHD and RTV reflects largely genetic influences that RTV shares with 
inattention (Kuntsi et al., 2014). In line with aetiological separation of these 
cognitive impairments, no significant shared genetic influences across RTV and 
CE (rA=-0.03) emerged. Taken together these findings suggest aetiological 
separation of cognitive processes in ADHD, with one familial cognitive factor 
capturing executive control (inhibition, working memory) and separating from 
another familial cognitive factor capturing the slow and highly variable 
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responses (Frazier-Wood et al., 2012; Kuntsi et al., 2010). Both of these familial 
factors largely separate from the aetiological influences ADHD symptoms share 
with IQ (Frazier-Wood et al., 2012; Rommelse et al., 2008; Wood, Asherson, et 
al., 2010; Wood et al., 2011). 
 
1.5.3 Phenotypic studies of neurophysiological impairments in ADHD 
Electroencephalography (EEG) provides an index of neural activity by 
measuring electrical activity along the scalp. The resulting electrophysiological 
parameters offer excellent temporal resolution, allowing for precise analysis of 
atypical oscillation patterns as well as neurophysiological processes underlying 
cognitive impairment.  
 
1.5.3.1 Quantitative EEG 
Neural activity shows oscillations at a range of frequencies. Frequency is the 
number of oscillations per unit time and is measured in hertz (Hz), where 1 Hz 
describes one oscillation per second. Electrophysiological recordings are 
traditionally quantified into the frequency bands delta (0.5-3.5 Hz), theta (3.5-7.5 
Hz), alpha (7.5-12.5 Hz), beta (12.5-30 Hz) and gamma (>30 Hz) (Tye, 
McLoughlin, Kuntsi, & Asherson, 2011) (Figure 1.1). These frequency bands 
have demonstrated high test-retest reliability (0.71-0.95), particularly the theta 
and delta bands (>0.85) (Williams et al., 2005). Quantitative EEG (QEEG) 
measures the strength of the electrical activity (EEG power in μV). 
 
QEEG studies in children, adolescents and adults with ADHD have established 
atypical oscillation patterns in individuals with ADHD (Arns, Conners, & 
Kraemer, 2013). Increased power in slow (mainly theta) and decreased power 
in fast (mainly beta) frequency bands, as well as a higher proportion of slow to 
fast frequencies in the brain, as reflected by the theta:beta ratio (TBR), during 
resting-state conditions are the most frequently cited findings in relation to 
ADHD (Bresnahan, Anderson, & Barry, 1999; Bresnahan & Barry, 2002; Clarke 
et al., 2003a, 2006, 2008; Cooper et al., 2014; Koehler et al., 2009; Snyder & 
Hall, 2006). These results were initially reinforced by a meta-analysis that 
claimed an effect size of 3.08 for the TBR in ADHD, which was proposed to 
have sensitivity and specificity of 94% (Snyder & Hall, 2006). A subsequent 
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study by the same research group described 87% sensitivity, 94% specificity, 
and 89% overall accuracy of TBR for ADHD diagnosis, which was relatively 
independent of co-occurring psychiatric disorders, developmental level 
(childhood and adolescence), gender and race (Snyder et al., 2008). However, 
the increased TBR as a marker of ADHD diagnosis is now considered 
controversial (Jeste, Frohlich, & Loo, 2015), as several recent studies have 
failed to replicate high TBRs in ADHD (Buyck & Wiersema, 2014; Liechti et al., 
2013; Loo et al., 2009; Ogrim, Kropotov, & Hestad, 2012; Poil et al., 2014; 
Skirrow et al., 2015). These negative findings were further reinforced in a recent 
meta-analysis, which concluded that excessive TBR could not be considered a 
reliable diagnostic measure of ADHD (Arns et al., 2013). Moreover, the meta-
analysis demonstrated a significant highly negative correlation (r=-0.97, 
p<0.001) between year of publication and TBR effect size, indicating a 
significant decline in support for the TBR in ADHD over time. The authors 
attributed this decline to an increase in the TBR among control participants 
(possibly due to decreased sleep duration), which attenuates the TBR 
difference between individuals with ADHD and typically developing individuals 
(Arns et al., 2013). Other sources of difference may lie in uncontrolled 
developmental factors (i.e. age differences in samples) (Buyck & Wiersema, 
2014; Poil et al., 2014) and the heterogeneity of ADHD (Jeste et al., 2015). 
 
EEG research has indicated elevated resting delta and theta power in younger 
compared to older typically developing children (Benninger, Matthis, & 
Scheffner, 1984; Gasser, Jennen-Steinmetz, Sroka, Verleger, & Möcks, 1988; 
Gasser, Verleger, Bächer, & Sroka, 1988; Michels et al., 2013). Consequently, 
elevation of delta and theta power has been thought to represent immaturity of 
the brain. This has led to the development of a maturational-lag hypothesis of 
ADHD (Kinsbourne, 1973), which holds that that there is a delay in central 
nervous system (CNS) development in individuals with ADHD as fast wave 
activity replaces slow wave activity. Yet, research demonstrating elevated theta 
power in adults with ADHD (Bresnahan et al., 1999; Bresnahan & Barry, 2002; 
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Figure 1.1. EEG frequency bands commonly investigated in ADHD.   
Adapted from “Electrophysiological markers of genetic risk for attention deficit hyperactivity disorder” 
by C. Tye, G.  McLoughlin, J. Kuntsi and P. Asherson, 2011, Expert Reviews in Molecular Medicine, 
13, p.4, Copyright 2011 by Cambridge University Press. Reprinted with permission. 
 
Elevated theta power during resting-state conditions in individuals with ADHD 
has been interpreted as representing cortical underarousal (Lubar, 1991; 
Satterfield & Dawson, 1971), because of its association with drowsiness 
(Makeig & Jung, 1996). Yet, no relationship between resting theta power and 
skin conductance levels (another marker of CNS arousal) has been found in 
children with and without ADHD (Barry et al., 2004; Barry, Clarke, Johnstone, 
McCarthy, & Selikowitz, 2009). Consequently, it is not fully understood what 
increased theta power during resting-state conditions in ADHD represents. 
Nevertheless, increased theta power seems to be a relatively consistent marker 
of ADHD (McLoughlin, Palmer, Rijsdijk, & Makeig, 2014). 
 
QEEG studies of individuals with ADHD conducted during cognitive tasks have 
yielded less consistent results. One study reported elevated theta and 
decreased alpha power (El-Sayed, Larsson, Persson, & Rydelius, 2002) in 
children with ADHD (n=36) compared to controls (n=63) in both resting-state 
and cognitive task condition (CPT). Attenuated alpha power in the ADHD group 
compared to controls during a resting-state and a cognitive task condition (CPT) 
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was also found in a study which investigated the EEG patterns of adults with 
ADHD (n=38) and controls (n=42) (Loo et al., 2009). Yet, other studies have 
reported an increase in alpha power in individuals with ADHD compared to 
controls when shifting from resting-state to cognitive task (CPT) condition 
(Nazari, Wallois, Aarabi, & Berquin, 2011; Swartwood, Swartwood, Lubar, & 
Timmermann, 2003). One study found no differences in cortical activity patterns 
of adults with ADHD (n=41) compared to controls (n=48) during a CPT (Skirrow 
et al., 2015). Instead, individuals with ADHD demonstrated lower theta power 
compared to controls during the Sustained Attention to Response Task (SART). 
These discrepancies may result from diverging sample characteristics, such as 
age and IQ, as well as from methodological differences. A recent study 
investigating QEEG differences between adolescents with ADHD (n=76) and 
controls (n=85) at the beginning and the end of a 1.5 h long testing session 
provided evidence for time-context effects. Whereas at the beginning of the 
testing session delta and theta power were increased in the ADHD group 
compared to controls, at the end of the session ADHD was associated with 
greater activity in the beta band relative to controls (Kitsune et al., 2015). The 
findings may represent short-term fluctuations in arousal during long 
experimental sessions and highlight the importance of recording context on 
resting-state QEEG data.  
 
1.5.3.2 Event-related potentials 
Event-related potentials (ERPs) are small voltage fluctuations in response to a 
cognitive, sensory or affective stimulus (or ‘event’), which are averaged across 
multiple trials and time-locked to the event. Averaging across trials increases 
the signal-to-noise ratio by removing random background EEG signals. 
Moreover, averaging provides a measure of neural activity that is consistently 
linked to event processing in a time-locked fashion. The nomenclature of 
individual ERP components is often dictated by their polarity, where ‘P’ stands 
for positive and ‘N’ stands for negative, as well as their order of occurrence 
within the waveform (P1, N1, P2, N2, etc.) (see Figure 1.2).  
 
The high temporal resolution and time-locked nature of ERPs provide an ideal 
medium to investigate covert neurocognitive processes, such as the 
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neurophysiological impairments underlying poor attention and response 
inhibition in individuals with ADHD (see section 1.5.1). ERP components of 
sustained attention and response inhibition have shown moderate to high long-
term test-retest reliability, ranging from 0.56 to 0.92 (Fallgatter, Aranda, Bartsch, 
& Herrmann, 2002; Weinberg & Hajcak, 2011). CPTs (see section 2.3.2 for task 
description) have been employed frequently to investigate attentional processes 
and response inhibition using ERPs. CPTs yield electrophysiological indices of 
attentional orienting (Cue-P3, Cue-P2), response preparation (contingent 
negative variation; CNV), response execution at targets (Go-P3), conflict 












Figure 1.2. Simulated ERP waveform showing several ERP components 
according to the typical naming conventions. Negative voltages are plotted upwards.  
Adapted from “The Neurocognitive Networks of the Executive Functions” by S. Rusnáková and 
I. Rektor, 2012, In I.M. Ajeena (Ed.) Advances in Clinical Neurophysiology, p.165. The image is 
available under the Creative Commons license. 
 
In line with findings from cognitive studies, which showed that CPT performance 
is typically impaired in individuals with ADHD, children (Albrecht et al., 2013; 
Banaschewski et al., 2003, 2008; Hennighausen, Schulte-Körne, Warnke, & 
Remschmidt, 2000; Perchet, Revol, Fourneret, Mauguière, & Garcia-Larrea, 
2001; Tye, Asherson, et al., 2014; van Leeuwen et al., 1998) and adults with 
ADHD (McLoughlin et al., 2010; McLoughlin, Asherson, et al., 2011; Valko et 
al., 2009; Woltering, Liu, Rokeach, & Tannock, 2013) have shown reduced Cue-
P3 and CNV amplitudes in response to cue stimuli, reflecting impaired 











follow-up study of these ERP components in individuals with ADHD (n=11) and 
controls (n=12) indicated that only the CNV continued to show a reduced 
amplitude in young adults with ADHD (mean age=21.9 years) compared to 
controls (mean age=21.1 years) (Doehnert, Brandeis, Schneider, Drechsler, & 
Steinhausen, 2013), a meta-analysis of the Cue-P3 conducted across six 
studies in adults also revealed reduced Cue-P3 amplitude in adults with ADHD 
(n=154, mean age=27.6) compared to controls (n=140, mean age=26.2) with a 
medium effect size (Cohen’s d=-0.55) (Szuromi, Czobor, Komlósi, & Bitter, 
2011). These inconsistencies may arise due to limited power in the longitudinal 
study, as 8 out of 11 participants with ADHD no longer met full ADHD diagnosis 
at follow-up (Doehnert et al., 2013). Less is known about the association of 
ADHD with ERP latencies. Whereas some studies have found reduced Cue-P3 
latency in ADHD (McLoughlin et al., 2010), others have reported no differences 
between individuals with and without ADHD (Albrecht et al., 2013).  
 
Following a cue, response control is required. Whereas Go-trials entail a 
response, the response on NoGo-trials needs to be suppressed. These task 
demands are reflected in the ERP components Go-P3 and NoGo-P3 
respectively. Few studies have directly investigated the Go-P3, reflecting 
response execution, in individuals with ADHD. Those studies that have 
examined the Go-P3 in individuals with ADHD have reported an attenuated Go-
P3 amplitude (Banaschewski et al., 2004; Lawrence et al., 2005; Overtoom et 
al., 1998; Strandburg et al., 1996). The NoGo-P3, indexing response inhibition, 
on the other hand, represents a persistent neurophysiological deficit in ADHD 
and consistently shows reduced amplitude in children (Albrecht et al., 2013; 
Banaschewski et al., 2003; Brandeis, van Leeuwen, Steger, Imhof, & 
Steinhausen, 2002; Fallgatter et al., 2004, 2005; Tye, Asherson, et al., 2014; 
van Leeuwen et al., 1998) and adults with ADHD (Dhar, Been, Minderaa, & 
Althaus, 2010; McLoughlin et al., 2010; McLoughlin, Asherson, et al., 2011; 
Valko et al., 2009). Taken together, findings from ERP amplitudes elicited by 
the CPT suggest impaired attentional and preparatory brain processes as well 
as deficits in response inhibition in both children and adults with ADHD.  
 
Performance monitoring has also been proposed to be impaired in ADHD 
(Geburek, Rist, Gediga, Stroux, & Pedersen, 2013; Shiels & Hawk, 2010). 
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Go/NoGo and flanker tasks are commonly used to examine performance 
monitoring. The ERP components obtained from these tasks vary with task 
demands and accuracy of response. An N2 component, indexing performance 
monitoring, is obtained following a correct response to a target stimulus, while 
an error-related negativity (ERN or Ne) component is elicited by an erroneous 
response. Conscious processing of an erroneous response is reflected in the 
Pe component. Conversely, the ERN is thought to represent unconscious error 
monitoring. 
 
Inconsistent findings have emerged with regards to conflict and error monitoring 
in individuals with ADHD. Reduced N2 amplitude has been reported in children 
(e.g. Albrecht et al., 2008; Broyd et al., 2005; Johnstone, Barry, Markovska, 
Dimoska, & Clarke, 2009; Wiersema, van der Meere, Roeyers, Van Coster, & 
Baeyens, 2006; Wild-Wall, Oades, Schmidt-Wessels, Christiansen, & 
Falkenstein, 2009), adolescents (Gow et al., 2012) and adults (McLoughlin et 
al., 2009) with ADHD. However, some studies have not found a difference in N2 
amplitude between individuals with ADHD and controls (Fisher, Aharon-Peretz, 
& Pratt, 2011; Johnstone & Galletta, 2013; Jonkman, van Melis, Kemner, & 
Markus, 2007; Wiersema, van der Meere, Antrop, & Roeyers, 2006). 
Furthermore, a review of nine studies found that four studies demonstrated a 
reduction in ERN amplitude in children with ADHD compared to controls, while 
the same number of studies did not, and one study even found an increase in 
ERN amplitude in children with ADHD relative to controls (Shiels & Hawk, 
2010). The review concluded that a reduction in Pe amplitude was a more 
robust finding in children with ADHD, with five studies reporting reduced Pe 
amplitude in children with ADHD and two studies failing to replicate these 
findings. While the results of adolescent and adult studies have also been 
inconsistent, a recent meta-analysis of seven studies reported that Ne/ERN 
amplitude was reduced in adolescents and adults with ADHD (n=166) 
compared to controls (n=161), with a moderate effect size of Cohen’s d=0.50 
(Geburek et al., 2013). A moderate effect size (Cohen’s d=0.42) was also found 
for the attenuation of Pe in the ADHD group compared to controls, but this 
effect only showed trend level significance (p=0.052). In line with these findings, 
two recent studies have reported both ERN and Pe attenuation in children with 
ADHD on both Go/NoGo (Groom et al., 2013) and flanker tasks (Rosch and 
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Hawk, 2013). Further research is needed for clarification and to identify the 
sources of variation in the literature. Inconsistencies may arise due to 
differences in sample size, clinical subtypes, comorbidity, task conditions and 
analysis (Shiels & Hawk, 2010). Overall, however, the results hint at a 
monitoring and response control deficit in individuals with ADHD. 
 
1.5.3.3 Quantitative genetic studies of neurophysiological impairments in 
ADHD 
Quantitative genetic studies have established that EEG parameters have high 
heritability, with heritability for all frequency bands ranging from 70% to 90% 
(Van Baal, De Geus, & Boomsma, 1996; van Beijsterveldt, Molenaar, de Geus, 
& Boomsma, 1996) and heritability for ERP components ranging from 41% to 
60% (Anokhin, Heath, & Myers, 2004; van Beijsterveldt & van Baal, 2002). 
Moderate-to-high sibling correlations for EEG spectral power initially indicated 
familiality of EEG measures in families affected by ADHD (Loo et al., 
2010). Familial effects with ADHD have also been observed for attentional, 
preparatory and inhibitory processes, as indexed by the Cue-P3, CNV and 
NoGo-P3 respectively, and weaker error and conflict monitoring, as indexed by 
reduced ERN and the N2 components respectively, in both child (Albrecht et al., 
2008, 2010, 2013) and adult ADHD samples (McLoughlin et al., 2009; 
McLoughlin, Asherson, et al., 2011).  
 
Few twin studies have investigated the shared aetiological pathway between 
ADHD and neuropsychological impairments. However, substantial genetic 
overlap between ADHD symptoms and elevated theta power (rA=0.35) has 
been established (Tye, Rijsdijk, & McLoughlin, 2014). In addition, a recent 
multivariate twin analysis found shared genetic influences between ADHD 
symptoms, frontal midline theta activity and RTV, with genetic correlations 
ranging from rA=0.39 to -0.61 (where a negative genetic correlation reflects that 
the genetic influences resulting in lower mean theta amplitude lead to increased 
ADHD symptoms) (McLoughlin, Palmer, et al., 2014). A small genetic overlap 
(rA=-0.15− -0.22) between the Go-P3 and externalising problems associated 
with ADHD (e.g. substance abuse, CD and antisocial behaviour) has also been 
demonstrated (Gilmore, Malone, & Iacono, 2010; Hicks et al., 2007). 
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1.5.4 Summary 
Research into the cognitive and neurophysiological impairments associated with 
ADHD is starting to elucidate the neurobiological basis underlying the clinical 
phenotype. The understanding gained from this research may in the future aid 
the development of biologically informed diagnostic criteria to improve 
interventions, prognosis and prevention. ADHD is linked to impairments in EF 
such as response inhibition and sustained attention, as well as to deficits in 
general cognitive ability (i.e. IQ). The phenotypic associations between ADHD 
and cognitive impairments are partly accounted for by genetic factors.  
 
EEG and ERPs have been useful tools in the investigation of the 
neurophysiological impairments of ADHD. Individuals with ADHD show atypical 
oscillatory activity during resting-state and cognitive task conditions. While 
findings are mixed, elevated theta power during resting-state conditions is the 
most consistently reported EEG-abnormality in ADHD. Furthermore, findings 
from ERP studies suggest impaired attentional (P3 components) and 
preparatory (CNV) brain processes, as well as deficits in response inhibition 
(NoGo-P3) and performance monitoring (N2, ERN/Ne and Pe) in both children 
and adults with in ADHD. Familial and genetic overlap of these 
neurophysiological impairments with ADHD has been demonstrated, but more 
research is needed to fully determine the familial and genetic associations of 
these variables with ADHD. 
 
1.6 Bipolar disorder 
According to DSM criteria, bipolar disorder (BD) denotes a psychiatric condition 
that is distinct from ADHD (American Psychiatric Association, 2013). Yet, 
uncertainties regarding diagnostic boundaries between these two disorders 
arise from symptomatic overlap. Direct comparisons across ADHD and BD on 
cognitive-neurophysiological measures are limited, despite their potential utility 
to inform us on impairments that are specific to or shared between the disorders 




1.6.1 Clinical symptoms and epidemiology 
BD denotes episodic and recurrent pathological disturbances in mood, ranging 
from severe depression to extreme elation (mania), including periods of normal 
mood (euthymia), although not necessarily a return to full function (Müller-
Oerlinghausen, Berghöfer, & Bauer, 2002). A depressive episode is a period of 
pervasive and persistent low mood and/or a profound loss of interest and 
pleasure (American Psychiatric Association, 2000). A manic episode is defined 
as a distinct period during which patients experience abnormally and 
persistently raised, expansive, or irritable mood along with decreased need for 
sleep, grandiose ideas, impulsive behaviour, increased talkativeness, 
heightened activity and distractibility. Fifty per cent of episodes last between two 
and seven months (Angst & Sellaro, 2000). The mood disturbances are often 
accompanied by disturbances in thinking and behaviour as well as psychotic 
features such as delusions and hallucinations in more severe cases (American 
Psychiatric Association, 2000).  
 
BD is a heterogeneous disorder presenting with varying degrees and 
expressions of mania and depression (American Psychiatric Association, 2000; 
Merikangas et al., 2011) and is, therefore, best conceptualised as ‘bipolar 
spectrum’ (Ghaemi, 2013). BD is categorised into bipolar I disorder (BD-I), 
bipolar II disorder (BD-II) and cyclothymia. The DSM-IV defines BD-I as one or 
more manic episodes, or mixed episodes of mania and depression, lasting a 
week or more. A diagnosis of BD-II requires one or more hypomanic episodes 
(similar to mania but not severe enough to cause marked social or occupational 
impairment) lasting at least four days and one or more major depressive 
episode. Cyclothymia is characterised by hypomanic episodes, alternating with 
episodes of mild or moderate depression (American Psychiatric Association, 
2000). Although diagnostic criteria for BD remain largely unchanged in the 
DSM-5, the diagnosis of mania or hypomania now requires an individual to 
present with “persistently increased goal-directed activity or energy” (American 
Psychiatric Association, 2013).  
 
BD is thought of as an adult disorder, with approximately half the cases 
retrospectively reporting disorder onset before age 25 years (Kessler et al., 
2005; Merikangas et al., 2011; Post et al., 2008). In a survey of 61,392 adults 
 56 
from the general populations of 11 countries in the Americas, Europe, and Asia, 
worldwide lifetime prevalence was estimated at 0.6% for BD-I, at 0.4% for BD-II 
and at 2.4% for bipolar spectrum (Merikangas et al., 2011). While in this study 
BD prevalence differed widely by country (with the highest lifetime prevalence of 
4.4% in the USA and the lowest lifetime prevalence of 0.1% in India) 
(Merikangas et al., 2011), a review by the World Health Organisation of several 
other population surveys suggested that BD had comparable prevalence, 
ranging from 0.2% to 2.1%, across different regions of the world, including 
Europe, North America, Oceania, Africa, and South Asia (Ayuso-Mateos, 2006).  
 
Comorbidities are common in BD, with over three-quarters of affected 
individuals also meeting criteria for another lifetime disorder (Merikangas et al., 
2007, 2011). Anxiety disorders are the most common co-occurring conditions in 
individuals with BD, with comorbidity rates of around 60%. Externalising 
disorders, such as ADHD (a20%) and CD (a20%), as well as substance use 
disorders (a40%) also frequently co-occur in individuals with BD (Merikangas et 
al., 2011).  
 
1.6.1.1 Gender differences 
Aggregated results from 12 population surveys from around the world 
suggested that equal proportions of men and women are affected by BD 
(Ayuso-Mateos, 2006). More recently, a study of 61,392 adults from 11 
countries reported greater lifetime prevalence rates of BD-I and sub-threshold 
BD in males than females, and higher rates of BD-II in females than males 
(Merikangas et al., 2011). A multisite seven-year follow-up study (n=711) by the 
Stanley Foundation Bipolar Treatment Outcome Network found that likelihood of 
having depressive symptoms was significantly greater for women than for men 
with BD (Altshuler et al., 2010), explaining the higher prevalence of BD-II in 
females. In addition, rapid cycling forms of BD-I and II may be more common in 
women (Schneck et al., 2004). In men, higher rates of co-occurring disorders 
have been reported (Hendrick, Altshuler, Gitlin, Delrahim, & Hammen, 2000; 
Kawa et al., 2005; Kessing, 2004). 
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1.6.1.2 Overlap with ADHD 
The comorbidity between BD and ADHD is well documented in the literature 
(Bernardi et al., 2012; Faraone et al., 1997; Hensch, Himmerich, & Hegerl, 
2011; Klassen, Katzman, & Chokka, 2010; Lus & Mukaddes, 2009; Masi et al., 
2006; Merikangas et al., 2011). Family and twin studies have provided evidence 
for the importance of genetic influences on susceptibility to BD (as well as 
ADHD, see section 1.4.1.3) and for its genetic and phenotypic complexity 
(Craddock & Sklar, 2009). A meta-analysis of family studies has also shown a 
significantly higher prevalence of ADHD among relatives (n=4,301) of 
individuals with BD (relative risk; RR=2.6) and a significantly higher prevalence 
of BD among relatives (n=1,877) of individuals with ADHD (RR=1.8) (Faraone, 
Biederman, & Wozniak, 2012). These findings suggest that ADHD and BD 
aggregate in families at higher-than-expected rates. The largest genome-wide 
analysis of psychiatric illness to date provided support for this assumption by 
demonstrating that common genetic variants confer risk of a range of 
psychiatric disorders, including ADHD and BD (Smoller et al., 2013). As 
molecular genetic research of ADHD and BD is not a central part of this thesis, 
it is not reviewed in more detail here. Importantly, common genetic risk factors 
influence susceptibility to both ADHD and BD (Smoller et al., 2013).  
 
Current diagnostic criteria aim to discriminate between disorders such as ADHD 
and BD based on distinct clusters of signs and symptoms, which are predictive 
of clinical parameters including course, outcome and treatment 
response (Farmer, McGuffin, & Williams, 2002). Yet, differentiation between 
ADHD and BD may be complicated by their symptom overlap. A diagnosis of 
mania, based on DSM-IV criteria, requires the presence of elevated, expansive 
or irritable mood for a week or more, as well as several secondary features 
including decreased need for sleep, distractibility, psychomotor agitation and 
increased talkativeness. Several of these symptoms, particularly distractibility 
(or inattention), motor restlessness (or hyperactivity) and talkativeness, are also 
central to the diagnosis of ADHD in the DSM-IV (American Psychiatric 
Association, 2000; Asherson et al., 2014; Kent & Craddock, 2003; Klassen et 
al., 2010). Beyond core diagnostic features of DSM-IV, ADHD and BD also 
overlap on symptoms of mood dysregulation such as irritability and emotional 
lability in ADHD, which match the symptoms of mood fluctuation in BD 
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(Asherson et al., 2014; Chan, Stringaris, & Ford, 2011; Skirrow & Asherson, 
2013; Skirrow, Hosang, Farmer, & Asherson, 2012). The introduction of the 
DSM-5 has further complicated the picture, as mood dysregulation is now 
acknowledged as an associated feature of ADHD, and “persistently increased 
goal-directed activity or energy” is recognised as a symptom of BD (American 
Psychiatric Association, 2013). 
 
Clinical challenges, for example in establishing the most appropriate treatment, 
may arise from problems in delineating the two disorders and recognising 
comorbidities, owing to the symptom overlap (Asherson et al., 2014). Whereas 
psychostimulants or atomoxetine are employed in the treatment of ADHD, mood 
stabilisers or antipsychotics are used to treat mania. Research suggests that 
incorrect treatment may result in non-response or aggravation of symptoms, 
particularly in BD (Asherson et al., 2014; DelBello et al., 2001; Klassen et al., 
2010; Scheffer, 2007). Consequently, for optimal outcome and treatment 
response, the presentation of symptoms requires careful deliberation, but key 
differences in symptomatology may help to delineate ADHD and BD. 
 
1.6.1.3 Delineation from ADHD 
One crucial distinction between ADHD and BD is the time-course of symptom 
presentations. While BD presents with distinct and recurrent episodes of mood 
disturbances, ADHD symptoms show persistent trait-like qualities (American 
Psychiatric Association, 2000, 2013; Asherson et al., 2014; Skirrow et al., 2012; 
van Schalkwyk & Schronen, 2010; Wilens et al., 2003).  Importantly, the 
persistent trait-like ADHD symptoms reflect deviations from developmental 
norms, whereas the episodic BD symptoms are thought of as changes from an 
individual's idiosyncratic premorbid state (Skirrow et al., 2012). Yet, DSM-IV 
criteria for BD allow for considerable heterogeneity in the time-course of 
symptom presentations. While BD-I and BD-II are characterised by a strict 
episodic nature with clear euthymic periods, cyclothymia represents a more 
chronic form of BD (Skirrow et al., 2012). 
 
In addition, several symptoms that are commonly observed during manic (i.e. 
elation, decreased need for sleep and grandiosity) and depressive episodes 
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(i.e. psychomotor retardation, fatigue or loss of energy, hypersomnia, loss of 
interest in pleasure and thoughts of death and suicidality) in individuals with BD 
are not part of the ADHD diagnosis (Asherson et al., 2014). Subtle differences 
further exist in the overlapping symptoms. The low mood exhibited by some 
individuals with ADHD, for example, may stem from low self-esteem and low 
self-confidence due to frustration with poor achievement in academic, 
vocational or social relationships, rather than reflecting a comorbid depressive 
disorder (Scheffer, 2007). Moreover, while individuals with ADHD frequently 
experience incessant mind wandering (everyday and task-unrelated thoughts 
flitting from one topic to another), individuals with BD may perceive their 
thoughts as ‘racing’ and as being particularly sharp (Asherson, 2005). 
 
Delineating between ADHD and BD, thus, requires careful clinical 
consideration. Few studies have directly investigated the suitability of standard 
clinical measures to differentiate between ADHD and BD. One study that 
compared individuals with ADHD (n=16) to individuals with BD (n=15) on a 
depression scale found that both clinical groups had elevated scores compared 
to controls (Torralva et al., 2011). Another study demonstrated that while ADHD 
measures successfully distinguished ADHD from BD, the ADHD group (n=12) 
showed higher depression and manic symptoms than euthymic BD participants 
(n=13) (Ibanez et al., 2012). However, no firm conclusions can be drawn from 
these studies due to small sample sizes and the use of self-report measures. 
Consequently, the degree of overlap and separation between ADHD and BD 
remain to be elucidated directly in cross-disorder comparison studies. 
 
1.6.2 Cognitive-neurophysiological impairments 
Individuals with BD experience cognitive impairments across multiple domains 
such as working memory, sustained attention and processing speed (Bora, 
Yücel, & Pantelis, 2010; Bourne et al., 2013; Daban et al., 2012; Kurtz & 
Gerraty, 2009; Latalova, Prasko, Diveky, & Velartova, 2011; Lee et al., 2014; 
Quraishi & Frangou, 2002; Robinson et al., 2006). A meta-analysis, which 
reviewed 42 studies of 1,197 euthymic individuals, 13 studies of 314 individuals 
in a manic/mixed phase of BD and 5 studies of 96 individuals in a depressed 
state, reported impairments in sustained attention, working memory and other 
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EFs of moderate-to-large effect in euthymic (Cohen’s d=0.61-0.83), 
manic/mixed (d=0.64-1.43), as well as depressive episodes (d=0.55-1.31) 
(Kurtz & Gerraty, 2009). These findings suggest that the cognitive impairments 
associated with BD are state-independent. Indeed, deficits in EF have been 
reported in individuals prior to the onset of BD in two prospective longitudinal 
studies (Meyer et al., 2004; Ratheesh et al., 2013). Premorbid IQ, however, has 
been found to be comparable to that of healthy controls (Martino, Samamé, 
Ibañez, & Strejilevich, 2015; Reichenberg et al., 2002; Sørensen, Sæbye, Urfer-
Parnas, Mortensen, & Parnas, 2012; Zammit et al., 2004).  
 
Several cognitive impairments, particularly impairments in EF, have also been 
found in first-degree relatives of individuals with BD such as parents, sibling and 
children (Adleman et al., 2014; Arslan, Tiryaki, & Ozkorumak, 2014; Arts, 
Jabben, Krabbendam, & van Os, 2008; Bora, Yucel, & Pantelis, 2009; Brotman, 
Rooney, Skup, Pine, & Leibenluft, 2009; Erol, Kosger, Putgul, & Ersoy, 2013; 
Ethridge et al., 2014; Ferrier, Chowdhury, Thompson, Watson, & Young, 2004; 
Kulkarni, Jain, Janardhan Reddy, Kumar, & Kandavel, 2010; Pattanayak, 
Sagar, & Mehta, 2012; Robinson et al., 2006; Schulze et al., 2011), indicating 
familial influences on these neurocognitive deficits.  
 
Neurophysiological deficits associated with BD have been investigated using 
QEEG and ERPs. Three reviews of QEEG studies in BD concluded that 
individuals with BD show atypical oscillation patterns during resting-state 
conditions, reflected by elevated theta and delta activity, as well decreased 
alpha power (Başar & Güntekin, 2013; Degabriele & Lagopoulos, 2009; 
Outhred, Kemp, & Malhi, 2014). ERP studies of individuals with BD have 
frequently reported abnormalities in P3 components (Bersani et al., 2015; 
Bestelmeyer, 2012; Bestelmeyer, Phillips, Crombie, Philip Benson, & St.Clair, 
2009; Degabriele & Lagopoulos, 2009), adding to existing evidence of attention 
deficits in BD (Bora et al., 2010; Bourne et al., 2013; Daban et al., 2012; Kurtz & 
Gerraty, 2009; Latalova et al., 2011; Lee et al., 2014; Quraishi & Frangou, 2002; 
Robinson et al., 2006). A lower P3 amplitude and a longer P3 latency has also 
been found in relatives of individuals with BD (Hall et al., 2007; Pierson, 
Jouvent, Quintin, Perez-Diaz, & Leboyer, 2000), suggesting familial influences 
on this ERP component. Few studies of individuals with BD have investigated 
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the ERP components ERN and N2, which are thought to reflect conflict 
monitoring. One study showed a significantly reduced N2 amplitude in 
participants with BD, reflecting reduced conflict monitoring, compared to control 
groups in response to NoGo stimuli during a cued CPT (Michelini et al., 2015).  
 
1.6.2.1 Comparison with ADHD 
Similar cognitive impairments have been described in ADHD and BD. Both 
individuals with ADHD and individuals with BD show deficits in EF, such as 
attentional and inhibitory processes (Arts et al., 2008; McLoughlin et al., 2010; 
Robinson & Ferrier, 2006; Torralva et al., 2011). In addition, increased RTV, 
reflecting short-term fluctuations in attentional performance, has been reported 
for individuals with ADHD, individuals with BD as well as their first-degree 
relatives (Adleman et al., 2014; Brotman et al., 2009; Kuntsi & Klein, 2012; 
Kuntsi et al., 2010).  
 
Despite these similarities, few studies have directly compared ADHD and BD 
samples on cognitive and neurophysiological measures to examine the 
mechanisms underlying these impairments (Skirrow et al., 2012). One direct 
comparison study, and one review of cognitive deficits in ADHD and BD 
separately, concluded that subtle differences in the EF deficits associated with 
ADHD and BD may aid in the differentiation between the disorders (Torralva et 
al., 2011; Walshaw, Alloy, & Sabb, 2010).  
 
Direct comparisons of neurophysiological impairments associated with ADHD 
and BD are scarce and limited by small sample sizes. One study examining 
decision-making and reward-related processes of the brain in adults with ADHD 
(n=12), BD (n=13) and controls (n=25) using a gambling task demonstrated 
impairments in the feedback-related negativity (FRN) in both the BD and ADHD 
groups compared to controls (Ibanez et al., 2012). Like controls, individuals with 
BD displayed an increasing P3 component relative to increasing reward 
magnitude. Individuals with ADHD, instead, demonstrated no modulation of P3 
response in response to reward magnitude changes. Another study investigated 
early cortical processing of emotional stimuli in adults with ADHD (n=16), BD 
(n=14) and schizophrenia (n=15), as well as in the unaffected relatives of 
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schizophrenia participants (n=14) and controls (n=41), using a face-word 
valence task (Ibanez et al., 2014). A shared impairment in the N170 
components, indicating emotional face processing, was found in the clinical 
groups. While individuals with BD demonstrated additional abnormal emotional 
processing of semantic information, individuals with ADHD showed a specific 
impairment in the processing of simultaneous emotional stimuli. A direct 
comparison of women with ADHD (n=20), euthymic BD (n=20) and controls 
(n=20) on a cued CPT found an attenuation of NoGo-P3 amplitude (inhibitory 
control) in the clinical groups compared to controls. In addition, the BD group 
demonstrated reduced NoGo-N2 amplitude (conflict monitoring) compared to 
both ADHD and control groups. According to the authors, these findings may 
suggest disorder-specific (conflict monitoring) and overlapping (inhibitory 
control) neurophysiological impairments in women with ADHD and women with 
BD (Michelini et al., 2015).  
 
Furthermore, to assess brain functional connectivity and variability in adults with 
ADHD (n=9) and euthymic BD (n=11) relative to healthy controls (n=15), 
another study employed a graph theory approach (Barttfeld et al., 2014). 
Increased functional connectivity was observed in the ADHD and BD groups. 
Yet, individuals with ADHD showed enhanced variability compared to controls, 
while in individuals with BD variability was reduced. Lastly, one study assessed 
mathematical approaches intended to classify groups of patients with ADHD 
and BD on the basis of EEG using data from adults with ADHD (n=21) or BD 
(n=22) (Sadatnezhad, Boostani, & Ghanizadeh, 2011). EEG data from eyes-
open and eyes-closed resting-state conditions allowed a high classification rate 
between individuals with ADHD and BD with 78–86% specificity, depending on 
the exact method used. As the purpose of the paper was the examination of 
mathematical approaches to improve classification and diagnosis, no EEG 
parameter differences between the groups are reported. While limited in 
number, direct comparisons of ADHD and BD have furthered our understanding 
of the neurophysiology underlying these disorders, indicating both disorder-
specific and shared neurophysiological impairments in individuals with ADHD 
and BD. Yet, more research is needed to gain greater insight into cross-disorder 
differences and similarities. 
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1.6.3 Summary 
BD is a chronic affective disorder characterised by recurrent episodes of mania 
(or hypomania) and depression. Both males and females are equally affected 
by BD, although differences in its expression (e.g. comorbidities and BD type) 
may exist. Because of its heterogeneous nature, BD is best conceptualised as a 
spectrum. Cognitive and neurophysiological impairments in BD can be severe 
and commonly persist during periods of euthymia. Research into these 
impairments has mainly focused on a few deficits, such as EF and the P3 ERP 
component. The diagnostic criteria for BD include symptoms that overlap with 
ADHD, which may result in clinical challenges regarding treatment and 
management plans when the disorder is severe and presents with mental health 
symptoms such as restlessness, emotional instability, low self-esteem, and 
sleep problems (Asherson et al., 2014). As careful clinical consideration is 
required to delineate between ADHD and BD, some direct comparisons have 
tried to elucidate the biological mechanisms underlying these disorders. Overall, 
research of cognitive and neurophysiological impairments suggests both shared 
and unique deficits in ADHD and BD. However, for firm conclusions on the 
nature of the neurophysiological deficits in ADHD and BD and the extent to 
which they overlap or dissociate more research is needed.  
 
1.7 Preterm birth 
Preterm birth has been associated with an increased risk for ADHD-like 
symptoms and cognitive impairments. Whether these reflect identical 
behavioural symptoms and cognitive–neurophysiological impairments in term-
born individuals with ADHD is unclear. Direct comparisons of individuals born 
preterm and individuals with ADHD on cognitive-neurophysiological measures 




Preterm birth denotes all births before 37 completed weeks of gestation (World 
Health Organization, 1977). Based on data from 184 countries, the worldwide 
prevalence of preterm birth is estimated at 11.1%, ranging from 8.6% in 
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developed countries and Latin America to 13.3% in Southeastern Asia 
(Blencowe et al., 2012). Approximately 5% of preterm births are extremely 
preterm (<28 weeks), about 15% are very preterm (28 to <32 weeks), roughly 
20% moderately preterm (32 to <34), and 60–70% are late preterm births (34 to 
<37 completed weeks of gestation) (Goldenberg, Culhane, Iams, & Romero, 
2008).  
 
Preterm birth may result from an induction of labour (or elective caesarean 
birth) for medical reasons or from spontaneous labour onset owing to a range of 
risk factors. Risk factors include genetic influences, extreme maternal 
reproductive ages (<18 or >40), lifestyle factors (obesity, tobacco, alcohol and 
drug use), infections or allergic reactions, and psychosocial stresses 
(Goldenberg et al., 2008; Muglia & Katz, 2010; Plunkett & Muglia, 2008; Wu et 
al., 2015). Many of these risk factors result in DNA methylation changes (e.g. 
Maccani, Koestler, Houseman, Marsit, & Kelsey, 2013; McKay, Waltham, 
Williams, & Mathers, 2011; Oberlander et al., 2008). As studies have reported 
an association of DNA methylation and other epigenetic differences with 
gestational age (GA) and growth patterns (Novakovic et al., 2011; Schroeder et 
al., 2011; Tobi et al., 2011), epigenetic processes have been proposed as a 
potential mechanism contributing to preterm birth and its long-term effects 
(Parets, Bedient, Menon, & Smith, 2014).  
 
Preterm birth is linked to numerous adverse long-term effects, such as 
increased risk of mortality during infancy (D’Onofrio et al., 2013; Fellman et al., 
2009; Moster, Lie, & Markestad, 2008; Patel et al., 2015) and young adulthood 
(Crump, Sundquist, Sundquist, & Winkleby, 2011), as well as morbidity across 
the lifespan (Doyle & Anderson, 2010; McCormick, Litt, Smith, & Zupancic, 
2011). Morbidity associated with preterm birth includes psychiatric disorders 
(D’Onofrio et al., 2013; Samantha Johnson & Marlow, 2014; Moster et al., 2008; 
Treyvaud et al., 2013), academic problems (Bhutta, Cleves, Casey, Cradock, & 
Anand, 2002; D’Onofrio et al., 2013; Lindström, Lindblad, & Hjern, 2011; 
McGowan, Alderdice, Holmes, & Johnston, 2011; Moster et al., 2008), and 
social challenges, such as higher levels of unemployment and criminal activity, 
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as well as lower income (D’Onofrio et al., 2013; Lindström, Winbladh, Haglund, 
& Hjern, 2007; Männistö et al., 2015; Moster et al., 2008; Saigal et al., 2009).  
 
A recent large-scale population-based cohort study of all individuals born in 
Sweden between 1973 and 2008 (n=3,300,708 offspring of 1,736,735 mothers) 
investigated the relationship of preterm birth with offspring mortality and 
morbidity using a quasi-experimental design (D’Onofrio et al., 2013). The study 
found strong associations between GA and risk of infant mortality in preterm-
born compared to term-born individuals, with hazard ratios (HRs) ranging from 
288.1 for individuals born 23–27 weeks of gestation to 6.9 in individuals born 
34–36 weeks of gestation. In line with a causal effect, GA significantly predicted 
infant mortality within discordant sibling pairs across the entire range of GA 
while controlling for familiality. Extremely preterm GA (<28 weeks) was also 
linked to increased risk of psychiatric disorders, such as psychotic or bipolar 
disorders (HR=3.2), autism (HR=3.2), and ADHD (HR=2.3), as well as lower 
educational attainment (HR=1.7). While the magnitude of the association 
between psychiatric disorders and GA was only slightly attenuated within sibling 
pairs, suggesting that familial confounder account for a very small proportion of 
the increased risk of psychiatric conditions with shorter GA, the magnitude of 
the association between educational attainment and GA was greatly attenuated 
within sibling pairs, suggesting that confounding factors shared by siblings 
account for a large proportion of the association. These findings are in line with 
a causal explanation for the association between preterm birth and the 
increased risk of psychiatric disorders.  
 
Preterm birth can have adverse effects on cognitive and neurophysiological 
development. A systematic review of long-term outcomes of intrauterine and 
neonatal insults concluded that, worldwide, the most common impairments in 
preterm-born individuals were learning difficulties, cognitive deficits and 
developmental delay, impacting 60% of those born preterm (Mwaniki, Atieno, 
Lawn, & Newton, 2012). The cognitive and neurophysiological impairments 
associated with preterm birth are reviewed below (see section 1.7.2). 
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1.7.1.1 Gender differences 
Compared to females, males are at somewhat greater risk of preterm birth, with 
about 55% of preterm births being males (Blencowe et al., 2013; Ingemarsson, 
2003; Kent, Wright, & Abdel-Latif, 2012; Vatten & Skjaerven, 2004; Zeitlin, 
2002; Zeitlin, Ancel, Larroque, & Kaminski, 2004). More postnatal 
complications, higher overall perinatal mortality rates and poorer long-term 
outcome are also seen in preterm males compared to females born at similar 
gestation (Brothwood, Wolke, Gamsu, Benson, & Cooper, 1986; Costeloe, 
Hennessy, Gibson, Marlow, & Wilkinson, 2000; Hack & Fanaroff, 2000; 
Ingemarsson, 2003; Kent et al., 2012; Peacock, Marston, Marlow, Calvert, & 
Greenough, 2012; Roy, Kumar, Kaur, & Faridi, 2014; Smith, 2000; Stevenson et 
al., 2000; Verloove-Vanhorick et al., 1994). Moreover, a male disadvantage has 
been reported for long-term neurodevelopmental outcome (Hintz, Kendrick, 
Vohr, Kenneth Poole, & Higgins, 2006; Månsson, Fellman, & Stjernqvist, 2015; 
Peacock et al., 2012). 
 
Yet, the underlying mechanisms for these gender differences remain unclear. 
The mechanisms proposed to underlie the higher prevalence of preterm-born 
males include heavier average body weight, which may increase the probability 
of preterm labour (Hall & Carr-Hill, 1982; McGregor, Leff, Orleans, & Baron, 
1992), a greater susceptibility to particular medical complications linked to 
preterm birth, such as pregnancy-induced hypertension or infection (Campbell, 
MacGillivray, Carr-Hill, & Samphier, 1983; MacGillivray & Davey, 1985), and 
sex-linked biochemical processes (Cooperstock & Campbell, 1996). Worse 
long-term outcomes may be explained by the relative immaturity of preterm-
born males compared to females born at similar gestation (Peacock et al., 
2012). 
 
1.7.1.2  ADHD and preterm birth 
One frequently reported psychiatric outcome of preterm birth is ADHD. A meta-
analysis of studies conducted between 1980 and 2001 demonstrated that 
school-aged children (≥5 years) born preterm (n=1,556) were at heightened risk 
(RR=2.64) of developing ADHD relative to controls (n=1,720) (Bhutta et al., 
2002). In a population-based sample of children born extremely preterm (<26 
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weeks), the risk of ADHD was further increased by over four-fold (odds ratio; 
OR=4.2) (Johnson et al., 2010). In line with these findings, a Swedish register 
study of 1,180,616 children born between 1987 and 2000 reported a stepwise 
increase in ORs for ADHD medication with increasing degree of immaturity at 
birth, ranging from 2.1 for extremely preterm (23 to 28 weeks) to 1.3 for late 
preterm (35 to 36 weeks) (Lindström et al., 2011). In term-born children, being 
small for GA also increased the risk of ADHD medication by 1.4. However, 
being small for GA did not modify the effect of GA on ADHD medication, 
suggesting that different mechanisms may underlie the associations. 
Furthermore, familial factors were unlikely to account for the effect, as ORs for 
risk of ADHD were highly similar across GA in a within-mother-between-
pregnancy analysis (Lindström et al., 2011). The finding that risk of ADHD 
increases independently of shared familial confounders was confirmed in a 
population-based cohort study of all individuals born in Sweden between 1973 
and 2008 (n=3,300,708 offspring of 1,736,735 mothers) (D’Onofrio et al., 2013).  
 
The long-term effects of preterm birth, including heightened risk of ADHD, have 
also been found to persist into adulthood. A population-based study of 
Norwegian adults reported a 1.3 and 5-fold increased risk for ADHD in adults 
born preterm (<37 weeks) and extremely preterm (<28 weeks), respectively, 
persisting at least 40 years after birth (Halmøy, Klungsøyr, Skjærven, & Haavik, 
2012). Preterm research investigating ADHD symptoms as a continuum (for a 
discussion see section 1.1.1) demonstrates a similar pattern of findings. A 
meta-analysis reported significantly more attention problems among children 
born very preterm (<32 weeks) and/or with a very low birth weight (<1,500g) 
(Aarnoudse-Moens, Weisglas-Kuperus, van Goudoever, & Oosterlaan, 2009). 
Teacher- and parent-ratings of attention problems were found to be 0.43 to 0.59 
standard deviations (SD) higher in very preterm and/or very low birth weight 
children (n=4,125) compared to controls (n=3,197).  
 
In addition, a longitudinal study of more than 14,000 twins registered in the 
Netherlands Twin Register found that birth weight was negatively associated 
with attention problems (Pettersson et al., 2015). Children in the lowest birth 
weight category of 1,500 to 2,000 g scored 0.18 to 0.37 SD higher on ratings of 
attention problems than children in the reference category of 3,000 to 3,500 g. 
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These findings were supported by a longitudinal cohort study of all twins born in 
Sweden between 1992 and 2000 (n=21,775) which demonstrated that a 
reduction of one kilogram of birth weight corresponded to parents rating their 
child nearly one unit higher on the total ADHD scale (β=-0.42), even after 
controlling for all environmental and genetic confounds shared within twin pairs 
(Pettersson et al., 2015). In support of these findings and in line with a causal 
effect of birth weight on attention problems, one study reported that in 
discordant twins the lighter-born twin scored higher on attention problems 
(Groen-Blokhuis, Middeldorp, van Beijsterveldt, & Boomsma, 2011). More 
support for a causal effect of birth weight on attention problems comes from a 
population-based sibling sample (n=1,266), which was followed up over 14 
years: the effect of birth weight and being small for GA on ADHD symptoms 
was shown in term-born and preterm-born individuals (Groen-Blokhuis et al., 
2011; Lindström et al., 2011). One longitudinal cohort study of individuals born 
between 1985 and 1986 (n=828) in Finland even found that instead of GA, 
lower birth weight and being small for GA only were associated with higher 
ADHD symptom scores (Heinonen et al., 2010). However, overall, the relative 
importance of birth weight versus GA in the association with ADHD diagnosis 
and symptoms remains unclear. While research has provided strong support for 
the link between preterm birth (and/or low birth weight) and ADHD, little is 
known about the underlying risk pathways. Neurophysiological assessments 
have the potential to elucidate these pathways further. 
 
1.7.2 Cognitive-neurophysiological impairments 
Preterm-born individuals are at increased risk of cognitive impairments in areas 
such as memory performance, academic achievement and attention across the 
lifespan. Impairments in all memory domains have been reported in children 
born preterm (Anderson, 2014; Omizzolo et al., 2014). Yet, most studies have 
focused on working memory (Anderson, 2014). Preterm samples have 
demonstrated deficits in both verbal (Aarnoudse-Moens et al., 2009; Anderson 
& Doyle, 2004; Hutchinson, De Luca, Doyle, Roberts, & Anderson, 2013) and 
visual working memory tasks (Baron, Erickson, Ahronovich, Litman, & Brandt, 
2010; Luciana, Lindeke, Georgieff, Mills, & Nelson, 1999; Rose, Feldman, 
Jankowski, & Van Rossem, 2011), compared to term-born controls. Both cross-
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sectional and follow-up studies suggest that working memory impairments in 
children born preterm decrease with age (Curtis, Lindeke, Georgieff, & Nelson, 
2002; Rushe et al., 2001; Saavalainen et al., 2007).  
 
Poor academic achievement has also been associated with preterm birth 
(Anderson & Doyle, 2003; Hutchinson et al., 2013; Johnson et al., 2009; Litt et 
al., 2012), with shorter GA predicting greater academic underachievement 
(Aarnoudse-Moens et al., 2009; Johnson et al., 2009; Taylor, Espy, & 
Anderson, 2009). A meta-analysis of 14 studies on academic achievement 
found that very preterm (≤33 weeks) or very low birth weight (≤1500g) children 
scored 0.60 SD lower on mathematics tests, 0.48 SD lower on reading tests, 
and 0.76 SD lower on spelling tests than term-born controls (Aarnoudse-Moens 
et al., 2009). An association between preterm birth and lower mean IQ scores 
has also consistently been reported. A recent meta-analysis of all studies 
(N=27) conducted between 1980 and 2009 found that individuals born preterm 
(n=3,504) scored an average of 11.94 IQ points lower than term-born 
individuals (n=3,540). In addition, there was a strong negative association 
between GA and IQ (r=-0.88, p=0.001) (Kerr-Wilson, Mackay, Smith, & Pell, 
2012). Yet, it is unclear how these general cognitive impairments relate to the 
other cognitive deficits (Lee, Yeatman, Luna, & Feldman, 2011; Loe, Lee, Luna, 
& Feldman, 2012). 
 
Numerous studies have examined attention problems in individuals born 
preterm (van de Weijer-Bergsma, Wijnroks, & Jongmans, 2008). A meta-
analysis of selective and sustained attention in preterm-born children 
demonstrated poorer performance in preterm-born children (n=1,196) compared 
to term-born controls (n=1,008) on selective attention tasks, with a moderate 
effect size of Cohen’s d=0.38. A systematic review also reported poorer 
sustained attention in preterm-born children (n=885) compared to term-born 
controls (n=802), with a moderate effect size of Cohen’s d=0.45 (Mulder, 
Pitchford, Hagger, & Marlow, 2009). These findings were confirmed by two 
cohort studies investigating attention in 189 children and 228 adolescents born 
extremely preterm (<28 weeks) or extremely low birth weight (<1,000g), 
compared to 173 term-born children and 166 term-born 
adolescents respectively (Anderson et al., 2011; Wilson-Ching et al., 2013). 
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Compared to term-born controls, children born preterm were 2.4 times more 
likely to show deficits in selective and sustained attention, and more than three 
times more likely to show deficits in shifting and divided attention (Anderson et 
al., 2011). Adolescents born preterm were 2.5 more likely to display deficits in 
selective, shifting and divided attention, but performed similar to term-born 
controls on sustained attention tasks (Wilson-Ching et al., 2013).  
 
In addition, two meta-analyses have investigated EF in children born preterm 
(Aarnoudse-Moens et al., 2009; Mulder et al., 2009). The first meta-analysis 
focussed on response inhibition in Go/NoGo tasks, verbal fluency, planning 
ability, and set shifting in studies of preterm-born children published between 
1990 and 2008. Eight studies of response inhibition, pooling the results of 830 
preterm-born and 740 term-born children, were included in the meta-analysis. 
These studies yielded a small-to-moderate effect size (Cohen’s d=0.25) and a 
significant positive correlation between GA and response inhibition (R2=0.74), 
suggesting that response inhibition is impaired in children born preterm. Verbal 
fluency, planning ability and set shifting were also found to be impaired in 
individuals born preterm, with effect sizes ranging from 0.38 to 0.50 (Mulder et 
al., 2009). The second meta-analysis included studies published between 1998 
and 2008 and investigating verbal fluency, working memory and cognitive 
flexibility in very preterm (≤33 weeks) and very low birth weight 
(≤1500g) children. Preterm-born children scored 0.57 SD lower for verbal 
fluency, 0.36 SD lower for working memory, and 0.49 SD lower for cognitive 
flexibility compared to term-born controls (Aarnoudse-Moens et al., 2009). 
Taken together, these meta-analyses suggest preterm-born children are at 
increased risk of poorer EF. Impairments in EF have also been found in 
adolescents (Burnett et al., 2015; Taylor, Minich, Bangert, Filipek, & Hack, 
2004) and adults born preterm (Nosarti et al., 2007; Stålnacke, Lundequist, 
Böhm, Forssberg, & Smedler, 2014), indicating that these impairments may 
persist across the lifespan. 
 
Atypical brain maturation, which has been reported in very preterm children 
(Miller & Ferriero, 2009), may be related to the cognitive impairments seen in 
individuals born preterm. Most studies investigating the neurophysiology of 
individuals born preterm have used functional magnetic resonance imaging 
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(fMRI) or magnetoencephalography (MEG). Studies employing fMRI have 
demonstrated reduced activation (as measured by the Blood Oxygen Level 
Dependent (BOLD) contrast) in preterm-born children, compared to term-born 
controls during cognitive task performance (Damaraju et al., 2010; Griffiths et 
al., 2013; Silja Torvik Griffiths et al., 2013, 2014; Lawrence et al., 2009; Ment et 
al., 2006; Nosarti et al., 2006; Peterson et al., 2002; Schafer et al., 2009). In 
addition, MEG studies have revealed altered cortical responses in preterm-born 
neonates (Nevalainen et al., 2008), altered cortical activation and inter-regional 
connectivity in preterm-born children and adolescents (Boersma et al., 2013; 
Doesburg et al., 2011; Frye et al., 2009, 2010; Moiseev, Doesburg, Herdman, 
Ribary, & Grunau, 2014). Moreover, MEG research demonstrated atypical 
oscillatory patterns in children born very preterm (Doesburg et al., 2011), which 
were linked to worse neonatal experience and childhood outcome (Doesburg et 
al., 2013). 
 
While several EEG studies have examined the neurophysiology of preterm-born 
infants in neonatal intensive care units (Meijer et al., 2014; Victor, Appleton, 
Beirne, Marson, & Weindling, 2005) or in the postnatal period (Beckwith & 
Parmelee, 1986; Duffy, Als, & McAnulty, 1990; González et al., 2011; 
Hayakawa et al., 2001; Vecchierini, André, & D’Allest, 2007), less EEG 
research has been conducted in children, adolescents or adults born preterm. 
One study that investigated EEG spectral power in individuals born preterm 
during an eyes-closed resting condition reported increased theta (3.6– 5 Hz), 
beta (20.1–30 Hz) and gamma (30.1– 40.2 Hz) power in preterm-born school-
aged children with educational problems (n=38), compared to term-born 
controls with educational problems (n=22) (Rozhkova, 2008). Furthermore, non-
impaired (defined as being free of neurosensory impairments and psychiatric 
disorders) young adults born at extremely low birth weight (n=71) showed 
increased power in the slow (delta and theta) and decreased power in the fast 
(alpha and beta) frequency bands (Miskovic, Schmidt, Boyle, & Saigal, 2009), 
as well as greater relative right frontal EEG activity at rest (Schmidt, Miskovic, 
Boyle, & Saigal, 2010), compared to controls born at healthy birth weight 
(n=83). The discrepancies between the studies may be explained by differences 
in sample characteristics, such as sample size, age, GA and birth weight.  
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Attenuated P1, potentially reflecting impaired primary auditory processing, and 
larger N2 amplitudes, possibly indicating impaired attention orienting, have 
been found in 5-year-old children born very preterm (<32 weeks) performing on 
an auditory oddball task (Hövel et al., 2014; Mikkola et al., 2007). These 
findings of increased N2 amplitude are comparable to ERP abnormalities 
reported in studies of children with neurodevelopmental disorders such as 
dyslexia, autism and ADHD (Albrecht et al., 2008; Gow et al., 2012; Johnstone, 
Barry, Markovska, Dimoska, & Clarke, 2009; McLoughlin et al., 2009). 
 
1.7.2.1 Comparison with ADHD 
While the cognitive and neurophysiological processes impaired in individuals 
born preterm appear similar to those implicated in ADHD, including attention 
and inhibitory control difficulties (Aarnoudse-Moens et al., 2009; Geva & 
Feldman, 2008; Lawrence et al., 2009; Miskovic et al., 2009; Mulder et al., 
2009; Nosarti et al., 2006), only one ERP study to date has directly compared 
these two populations. The ERP study included very low birth weight children 
born preterm (<1501g and <34 weeks) with (n=9) and without ADHD (n=10), as 
well as term-born controls (n=12) and term-born individuals with ADHD (n=10) 
(Potgieter, Vervisch, & Lagae, 2003). The study found that children with ADHD, 
independent of whether they were born preterm or full term, displayed 
abnormalities in certain ERP markers that are sensitive to deficits in ADHD, 
most notably the NoGo-N2 indexing response inhibition. However, the sample 
size was very small and the test battery restricted to a visual oddball task. 
Consequently, these findings require replication. For more effective, targeted 
interventions, the study of preterm birth should include direct comparisons with 
individuals with ADHD to establish whether the deficits seen in individuals born 
preterm are identical to those associated with ADHD or part of more wide-
ranging impairments.   
 
1.7.3 Summary 
Preterm birth, which is defined as birth before 37 completed weeks of gestation, 
is highly prevalent worldwide, with males at greater risk of being born preterm 
than females. The survival rates for individuals born preterm have increased 
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greatly over the last decade (Goldenberg et al., 2008). While most organs are 
immature following preterm birth, the brain is particularly susceptible to the 
consequences of preterm birth (Rees & Inder, 2005). As a result, preterm-born 
individuals are at increased risk of adverse long-term outcomes compared to 
their term-born counterparts, especially with regards to psychiatric morbidity 
and cognitive-neurophysiological impairments. One of the most consistently 
reported psychiatric outcomes of preterm birth is ADHD, whether ADHD is 
considered as a continuum or a categorical diagnosis. Furthermore, the 
cognitive and neurophysiological domains commonly impaired in individuals 
born preterm including IQ, attention, EF and increased theta power are those 
also implicated in ADHD. Yet, few studies have directly compared individuals 
born preterm to individuals with ADHD. More research is needed to understand 
whether the ADHD-like symptoms reported among individuals born preterm 
reflect ADHD in term-born individuals, with identical cognitive–
neurophysiological impairments. A better understanding of the differences and 
commonalities in the impairments of individuals born preterm and individuals 
with ADHD will enable more effective, targeted interventions. 
 
1.8 Aims and objectives 
In this thesis, ADHD is investigated in the context of associated conditions, as 
well as risk and protective factors. Using a combination of cognitive-
neurophysiological and genetically-sensitive longitudinal designs, this thesis 
aims to elucidate neurophysiological processes underlying ADHD and related 
conditions, and the mechanisms that contribute to the risk of and protection 
from ADHD. 
 
1.8.1 Chapters 2, 3 and 4 
The first three data-based chapters examine the association of ADHD with 
bipolar disorder (BD) and preterm birth. The aim of chapter 2 is to examine 
quantitative EEG differences and similarities between women with ADHD, 
women with BD and healthy controls during a resting-state (EO) and a cognitive 
task (CPT-OX) condition and to explore how cortical activity patterns change in 
relation to recording condition (rest vs. cognitive task condition) in the three 
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groups. This chapter, therefore, aims to further our understanding of potentially 
overlapping and distinct neurophysiological impairments that bring about the 
symptomatic overlap in ADHD and BD. The ultimate aim of this analysis is to 
identify biomarkers, which may aid clinical differentiation of these disorders, and 
may improve disorder management. 
  
Chapter 3 aims to investigate the commonalities and differences in brain 
function between ADHD and preterm birth using quantitative EEG in 
adolescents born preterm, term-born adolescents with ADHD and term-born 
controls during a resting-state condition (eyes open, EO) and a cognitive task 
condition (a cued CPT with flankers, CPT-OX). Similar to chapter 2, this 
analysis investigates the change in cortical activation patterns arising from the 
transition from resting-state to cognitive task condition. Chapter 4 intends to 
elucidate whether the ADHD-like symptoms and cognitive impairments in 
individuals born preterm reflect identical cognitive–neurophysiological 
impairments in term-born individuals with ADHD by directly comparing preterm 
born adolescents, term-born adolescents with ADHD and term-born controls on 
cognitive-performance and ERP measures obtained from a CPT-OX. In 
addition, chapters 3 and 4 aim to examine the relationship of age with EEG 
spectral power and ERP components respectively in adolescents born preterm, 
term-born adolescents with ADHD and term-born controls. Ultimately, the 
purpose of these two studies is to guide future interventions aimed at individuals 
born preterm by informing us on neurophysiological impairments that are 
shared between preterm-born individuals and individuals with ADHD and that, 
therefore, may underlie cognitive and symptomatic similarities.  
 
1.8.2 Chapters 5 and 6 
The remaining two data-based chapters employ genetically-sensitive designs to 
examine risk and protective factors associated with ADHD. The first aim of 
chapter 5 is to establish the developmental pattern of the association of ADHD 
symptoms with verbal IQ (VIQ) and performance IQ (PIQ) in a population-based 
twin sample. While ADHD symptoms typically diminish in severity over the 
course of puberty (~ages 12–16 years (Willcutt, 2012)), individuals with high 
levels of ADHD symptoms are at increased risk of continuing problems related 
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to ADHD during adolescence (Biederman, Petty, Clarke, Lomedico, & Faraone, 
2011; Rasmussen & Gillberg, 2000). We are, therefore, interested in the 
developmental pattern of the association of ADHD symptoms with VIQ and PIQ 
at ages 12, 14 and 16 years; a period of rapid developmental change for which 
both ADHD and IQ data are available in our large twin sample. The second aim 
of this study is to examine the genetic and environmental aetiologies of the 
association of ADHD symptoms with VIQ and PIQ within time point, and their 
stability across time. Making use of the inherently time-ordered nature and 
genetic sensitivity of the data, we use a cross-lagged model to address these 
two objectives: namely, we establish the direction of effects, while modelling the 
genetic and environmental variance and covariance structure of the data 
separately for VIQ and PIQ. 
  
The final chapter (chapter 6) aims to examine the effect of physical activity (PA) 
during late adolescence on ADHD symptoms in early adulthood. Both the 
symptoms and functional impairments associated with ADHD often persist 
across the lifespan (Faraone et al., 2006). The effect of PA on ADHD symptoms 
is investigated together and separately for the two sub-components of ADHD, 
inattention and hyperactivity-impulsivity. Investigating the effect in 232 MZ twin 
pairs enables us to control for unmeasured genetic and shared environmental 
confounding factors that may influence the relationship between PA and ADHD 
symptoms, allowing us to draw tentative causal inferences about this 
relationship. This study, ultimately, aims to provide support for a novel non-
pharmacological treatment or management strategy for ADHD on the basis of 
our growing understanding of the potential protective factor PA. 
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Chapter 2. Commonalities in EEG spectral power 
abnormalities between ADHD and bipolar disorder 
during rest and cognitive performance 
2.1 Abstract 
Background: While attention-deficit/hyperactivity disorder (ADHD) and bipolar 
disorder (BD) denote distinct psychiatric conditions, diagnostic delineation is 
impeded by considerable symptomatic overlap. Direct comparisons across 
ADHD and BD on neurophysiological measures are limited, but could inform us 
on impairments that are specific to or shared between the disorders and, 
therefore, potential biomarkers that may aid clinical differentiation of these 
disorders. The aim of this study was to test whether quantitative EEG (QEEG) 
identifies differences or similarities between women with ADHD and women 
with BD during resting-state and task conditions. Methods: QEEG activity was 
directly compared between 20 ADHD, 20 BD and 20 control women during an 
eyes-open resting-state condition (EO) and a cued continuous performance 
task (CPT-OX). Results: Both ADHD (t=2.50, df=38, p=0.017) and BD (t=2.54, 
df=38, p=0.018) participants showed higher theta power during EO than 
controls. No significant differences emerged between the two clinical groups. 
While control participants showed a task-related increase in theta power from 
EO to CPT-OX (t=-3.77, df=19, p=0.001), no such change in theta power was 
observed in the ADHD (t=-0.61, df=19, p=0.553) or BD (t=1.82, df=19, p=0.084) 
groups. Conclusion: Our results provide evidence for commonalities in brain 
dysfunction between ADHD and BD. Theta power may play a role as a marker 




Attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BD) are 
common psychiatric disorders, respectively affecting around 2-4% and 1-2% of 
the adult population worldwide (Merikangas et al., 2011; Willcutt, 2012). While 
ADHD and BD denote distinct psychiatric conditions, diagnostic delineation is 
impeded by considerable symptomatic overlap. Both ADHD and the manic 
phase of BD are associated with distractibility, restlessness, talkativeness, lack 
of social inhibition and impulsivity (Galanter & Leibenluft, 2008; Kent & 
Craddock, 2003). Both disorders further present with features of mood 
dysregulation, such as irritability and emotional lability (Kitsune et al., under 
review; Skirrow et al., 2014, 2012). However, ADHD symptoms are chronic and 
trait-like, while BD symptoms tend to occur for distinct periods of time (Asherson 
et al., 2014). Nevertheless, symptoms of distractibility and mood dysregulation 
(Najt et al., 2007; Newman & Meyer, 2014; Peluso et al., 2007), as well as 
residual cognitive and functional impairments (Henry et al., 2013; Torres, 
Boudreau, & Yatham, 2007), persist as milder stable traits in euthymic BD. 
Such overlap can lead to challenges in distinguishing the two disorders in 
clinical practice and may, consequently, result in inappropriate treatment 
decisions (Asherson et al., 2014). 
 
Similar cognitive impairments have been described for individuals with ADHD 
and BD. Both ADHD and euthymic BD are associated with poor accuracy in 
attentional and inhibitory processing tasks (Arts et al., 2008; McLoughlin et al., 
2010; Robinson & Ferrier, 2006; Torralva et al., 2011), as well as with increased 
reaction time variability (RTV) (Adleman et al., 2014; Brotman et al., 2009; 
Kuntsi & Klein, 2012; Kuntsi et al., 2010). Yet, similar cognitive performance 
could stem from differing underlying mechanisms (Banaschewski & Brandeis, 
2007). Consequently, our recent cognitive-neurophysiological investigations of 
attentional and inhibitory processing in women with ADHD and women with BD 
revealed evidence for disorder-specific impairments, despite indistinguishable 
cognitive performance (Michelini et al., 2015). Event-related potential (ERP) 
analysis showed significantly reduced N2 amplitude in participants with BD, 
compared to the ADHD and control groups, in response to NoGo stimuli during 
a cued continuous performance task (CPT-OX) (Michelini et al., 2015). As the 
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N2 in response to NoGo stimuli, or in incongruent trials, is considered to reflect 
conflict-monitoring processing (Yeung & Cohen, 2006), the results suggest 
impaired conflict monitoring in women with BD, compared to women with ADHD 
and control women. Yet, women with ADHD and women with BD also showed 
overlapping neurophysiological impairments compared to controls on the NoGo-
P3, suggesting shared inhibitory control deficits (Michelini et al., 2015).  
 
Another method to investigate covert processing and other underlying 
mechanisms in the absence of overt performance differences is employing 
quantitative electroencephalography (QEEG). QEEG allows the direct 
examination of subtle changes in cortical activity, which may reflect state 
regulation and arousal (Banaschewski & Brandeis, 2007). This is of particular 
relevance in conditions such as ADHD and BD, which show abnormalities in 
state regulation and arousal (Cortese et al., 2012; Degabriele & Lagopoulos, 
2009; Nigg, 2013; Ongür et al., 2010). In QEEG, electrophysiological recordings 
are quantified in the frequency ranges delta (0.5-3.5 Hz), theta (3.5-7.5 Hz), 
alpha (7.5-12.5 Hz), beta (12.5-30 Hz) and gamma (>30 Hz). The most 
frequently reported findings of QEEG studies in children and adults with ADHD 
during resting-state conditions are elevated power in slow frequency bands 
(delta and theta), reduced power in fast wave cortical activity (mainly beta) and 
an elevated proportion of slower to faster frequencies in the brain, as reflected 
by the theta:beta ratio (TBR) (Bresnahan et al., 1999; Bresnahan & Barry, 2002; 
Clarke et al., 2003a, 2006, 2008; Cooper et al., 2014; Koehler et al., 2009; 
Snyder & Hall, 2006). Yet, several recent studies have failed to replicate these 
findings (Buyck & Wiersema, 2014; Kitsune et al., 2015; Liechti et al., 2013; Loo 
et al., 2009; Ogrim et al., 2012; Poil et al., 2014; Skirrow et al., 2015) and the 
increased TBR as a marker of ADHD diagnosis is being contested (Arns et al., 
2013; Jeste et al., 2015; Lenartowicz & Loo, 2014). EEG spectral power in 
ADHD further seems to depend on the context: one study found elevated delta 
and theta activity in individuals with ADHD compared to controls during the 
resting-state condition at the start of recording sessions, and increased beta 
power in the ADHD group compared to controls at the end of the recording 
session (Kitsune et al., 2015). In BD, elevated delta and theta power, as well as 
decreased alpha power, have been reported during resting-state conditions 
(Başar et al., 2012; Clementz, Sponheim, Iacono, & Beiser, 1994; Degabriele & 
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Lagopoulos, 2009). However, direct QEEG comparison studies between ADHD 
and BD have not yet been conducted.  
 
Few studies on ADHD have examined cortical activity patterns during cognitive 
task conditions and findings are inconsistent. While some studies have shown 
no differences in cortical activation between controls and individuals with ADHD 
during a CPT (Loo et al., 2009; Skirrow et al., 2015), others have reported 
elevated alpha (Nazari et al., 2011; Swartwood et al., 2003) and theta power 
(El-Sayed et al., 2002) in individuals with ADHD compared to controls. In 
addition, lower theta power in adults with ADHD has been demonstrated in the 
Sustained Attention to Response Task (SART), owing to task-related increases 
in frontal theta activity in control participants that were absent in participants 
with ADHD (Skirrow et al., 2015). Treatment with methylphenidate resulted in 
normalisation of the resting-state to task activation pattern. These findings may 
indicate a lack of modulation of cortical activity from resting-state to cognitive 
task in the ADHD group compared to controls. QEEG profiles of individuals with 
BD during cognitive tasks have not yet been studied. Investigating the 
oscillatory patterns of individuals with ADHD and BD across condition, from rest 
to cognitive task condition, may allow us to investigate cortical activation and 
arousal patterns that could inform us on impairments that are specific to or 
shared between the disorders. 
 
The aim of the present study was to test whether QEEG identifies differences or 
similarities between women with ADHD, women with BD and controls during a 
resting-state condition (eyes open, EO) and an active task condition (a CPT 
with flankers), which could inform us on the potentially overlapping and distinct 
electrophysiological impairments in both disorders that may underlie 
symptomatic and cognitive similarities. In addition, we aim to investigate how 






The sample consisted of 20 women with ADHD, 20 women with euthymic BD 
and 20 control women. Participants with ADHD were recruited from the Adult 
ADHD Clinic at the Maudsley Hospital, London, UK. Participants with BD were 
recruited from the Maudsley Psychosis Clinic, London, UK, or had previously 
participated in another research study (Hosang, Uher, Maughan, McGuffin, & 
Farmer, 2012). Control participants were recruited from the Mindsearch 
volunteer database maintained by the Institute of Psychiatry, Psychology and 
Neuroscience, King’s College London, UK, which comprises several thousand 
potential participants. Participants for this study were randomly selected from all 
those meeting inclusion criteria. 
 
In the clinical groups, diagnosis was confirmed from medical records, following 
Diagnostic and Statistical Manual (DSM-IV) criteria (American Psychiatric 
Association, 2000). The ADHD participants met current criteria for combined-
type ADHD or inattentive-type ADHD with sufficient symptoms of hyperactivity-
impulsivity in the past to meet a childhood combined-type diagnosis. 
Participants in the BD group had a diagnosis of bipolar I disorder (BD-I), with 
evidence of a past manic episode lasting one week or more. BD-I patients were 
selected if they were currently euthymic. Exclusion criteria for all groups were 
drug or alcohol dependency in the last six months, autism, epilepsy, 
neurological disorders, brain injury, past electroconvulsive therapy (ECT), 
current involvement in another research trial likely to alter symptom severity, 
pregnancy or limited proficiency in the English language. Those with a reported 
comorbidity of ADHD and BD, or who were currently experiencing a manic 
episode, were also excluded. In addition, control participants, who reported a 
history of psychiatric disorders, or who were taking psychiatric medication, were 
excluded from the study.  
 
Participants’ IQs were assessed with the Wechsler Abbreviated Scale of 
Intelligence - Fourth Edition (WASI-IV; Wechsler 1999). IQ (F2,59=1.37, p=0.26) 
and age (F2,59=1.63, p=0.21), which ranged from 20 to 52 years, did not differ 
between groups (Table 2.1). Participants with ADHD were asked to come off 
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stimulant medication 48 h before the assessment. For ethical reasons, 
participants were not asked to stop taking mood stabilisers (70% of the BD 
group), anti-psychotic medication (40% of the BD group) or anti-depressants 
(7% of the ADHD group and 25% of the BD group), which they had been 
prescribed. Ethical approval for the study was granted by the Camberwell St 
Giles Research Ethics Committee (11/LO/0438) and all participants provided 
informed consent.  
 
 
Table 2.1. Descriptive statistics.  






Age in years (SD) 37.4 (7.6) 40.3 (7.7) 36.7 (4.3) 0.21 
IQ (SD) 104.5 (17.9) 108.0 (12.5) 112.4 (14.2) 0.26 
 
 
2.3.2 Procedure and cognitive-performance measures 
Participants attended a single 4.5 h research session, which included an EEG 
assessment, an IQ test and clinical interviews. As part of the EEG assessment, 
participants completed a 3-minute eyes-open resting-state condition (EO), as 
well as a 3-minute eyes-closed resting-state condition, prior to performing on a 
CPT with flankers (CPT-OX) (Doehnert, Brandeis, Imhof, Drechsler, & 
Steinhausen, 2010; McLoughlin et al., 2010; McLoughlin, Asherson, et al., 
2011). In line with recent research (Nazari et al., 2011; Skirrow et al., 2015), 
QEEG differences between EO and CPT-OX are analysed here. 
 
The CPT-OX is a cued Go/NoGo task that probes attention, preparation and 
response inhibition. The task consisted of 400 black letter arrays, made up of a 
centre letter and incompatible flankers on each side to increase. The presented 
arrays included the cue letter ‘O’, the target letter ‘X’ as well as the distractors 
‘H’, ‘B’, ‘C’, ‘D’, ‘E’, ‘F’, ‘G’, ‘J’ and ‘L’. Letters were presented centrally on the 
computer monitor, subtending approximately 5°. Cue and target letters (‘O’ and 
‘X’ respectively) were flanked by incompatible letters (‘XOX’ and ‘OXO’ 
respectively). Participants were instructed to ignore the flanking letters and 
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respond as quickly as possible to cue-target sequences (‘O’-‘X’). 80 cues 
(‘XOX’) were followed by the target (‘OXO’) in 40 trials (Go condition), and by 
neutral distractors in the remainder of trials (NoGo condition). On 40 trials, the 
target letter ‘X’ was not preceded by a cue ‘O’ and had to be ignored. Letters 
were presented every 1.65 s for 150 ms in a pseudo-randomised order. Ten 
practice trials preceded the main task and were repeated, if required, to ensure 
participant comprehension. Participants were instructed to respond only to Cue-
Go sequences by pressing a button as quickly as possible with the index finger 
of their preferred hand. Participants were further asked to withhold the response 
in the presence of a NoGo stimulus, in the presence of a Go stimulus not 
preceded by a cue, or in the presence of any other irrelevant letters. Task 
duration was 11 min. 
 
2.3.3 Electrophysiological recording and analysis 
The EEG was recorded from a 62 channel direct-current-coupled recording 
system (extended 10–20 montage), using a 500 Hz sampling-rate, impedances 
under 10 kΩ and FCz as the recording reference. The electro-oculograms were 
recorded from electrodes above and below the left eye and at the outer canthi. 
Participants were seated on a height-adjustable chair in a dimly-lit video-
monitored testing cubicle. Stimuli were presented on a computer monitor at a 
distance of approximately 120 cm, using the Presentation software package 
(www.neurobs.com). EEG data were analysed using Brain Vision Analyzer 2.0 
(Brain Products, Germany). Researchers were blind to group status during EEG 
pre-processing and analysis. Raw EEG recordings were down-sampled to 256 
Hz, re-referenced to the average of all electrodes, and digitally filtered using 
Butterworth band-pass filters (0.1-30 Hz, 24 dB/oct). All trials were also visually 
inspected for electrical artefacts (due to electrical noise in the EEG recording) or 
obvious movement, and sections of data containing artefacts were removed 
manually. Ocular artefacts, corresponding to blink-related and vertical and 
horizontal eye movements, were identified using the infomax independent 
component analysis (ICA) algorithm (Jung et al., 2000), which allows for 
removal of activity associated with ocular artefacts by back-projection of all but 
this activity. Sections of data with remaining artefacts exceeding ± 100 μV in 
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any channel or with a voltage step greater than 50 μV were automatically 
rejected.  
 
Quantitative EEG was investigated for EO and CPT-OX. Data were segmented 
into 2-second epochs and power spectra were computed using a Fast Fourier 
Transform (FFT) with a 10% Hanning window. Analyses focused on delta (0.5-
3.5 Hz), theta (3.5-7.5 Hz), alpha (7.5-12.5 Hz) and beta (12.5-30 Hz) frequency 
band differences between ADHD, BD and control groups. All data were log 
transformed (lg) to normalise the data. To reduce the number of statistical 
comparisons, EEG power (μV2) within each frequency band was averaged 
across frontal (Fz, F1, F2, F3, F4, F5, F6, F7, F8), central (Cz, C1, C2, C3, C4, 
C5, C6) and parietal (Pz, P3, P4, P7, P8) regions from individual scalp 
electrodes.  
 
2.3.4 Statistical analysis 
A repeated-measures analysis of variance (ANOVA), applying a Greenhouse-
Geisser correction when appropriate, was carried out to investigate diagnostic 
status-related differences between ADHD, BD and controls in EEG power. 
Recording condition (EO, CPT-OX) and recording site (frontal, central, parietal) 
were used as within-subject variables and diagnostic status (ADHD, BD, 
control) as between-subjects variable. Delta, theta, alpha and beta power were 
each investigated with a 2 x 3 x 3 repeated-measures ANOVA. Bonferroni 
correction was implemented to correct for multiple testing in the different 
frequency bands: Bonferroni-adjusted p-value=0.0125. Post-hoc analyses were 
carried out using independent samples t-tests for between-subjects contrasts, 
and paired samples t-tests for within-individual task related differences in EEG 
power. Effect size (Cohen’s d), which was calculated using the difference in the 
means divided by the pooled standard deviation, is also reported (Cohen, 
1988). According to Cohen (1988), d=0.20 constitutes a small effect, d=0.50 a 




2.4.1 EEG power 
Repeated-measures ANOVAs indicated no significant mean effects of group for 
delta (F1,57=1.29, p=0.28), theta (F1,57=1.70, p=0.19), alpha (F1,57=1.20, p=0.31) 
or beta (F1,57=0.44, p=0.65) power. 
 
A significant main effect of recording site was identified for theta (F1,57=43.90, 
p<0.001), with significantly lower theta power in frontal than central (t=-24.28, 
df=59, p<0.001) and parietal locations (t=-29.32, df=59, p<0.001). Central theta 
power was also significantly lower than parietal theta power (t=12.50, df=59, 
p<0.001). No significant condition-by-site-by-group interaction emerged 
(F1,57=1.39, p=0.241). 
 
Significant main effects of testing condition emerged for delta (F1,57=85.43, 
p<0.01), alpha (F1,57=16.53, p<0.01) and beta power (F1,57=14.73, p<0.01), 
but not for theta power (F1,57=0.29, p=0.600). 
 
No significant group-by-condition interaction emerged for delta (F1,57=2.20, 
p=0.073), alpha (F1,57=1.29, p=0.278) or beta power (F1,57=2.04, p=0.093). 
Consequently, the results for these frequency bands are not reported further.  
 
A significant group-by-condition interaction emerged for theta power (F1,57=6.15, 
p=0.004). Post-hoc tests revealed significantly higher theta power in the ADHD 
group compared to controls during EO (t=2.50, df=38, p=0.017), with medium-
to-large effect size (d=0.72), but the ADHD and control groups did not differ in 
theta power during CPT-OX (t=0.61, df=38, p=0.548). Post-hoc tests further 
demonstrated significantly higher theta power in the BD group compared to 
controls during EO (t=2.54, df=38, p=0.016), with medium-to-large effect size 
(d=0.74), but the BD and control groups did not differ in theta power during 
CPT-OX (t=1.40, df=38, p=0.169). Moreover, no significant differences in theta 
power emerged between the ADHD and BD groups during EO (t=0.32, df=38, 
p=0.748) or CPT-OX (t=0.64, df=38, p=0.524). While control participants 
showed a task-related increase in theta power (t=3.34, df=19, p=0.003), with 
medium effect size (d=0.59), no significant changes in theta power from EO to 
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CPT-OX were observed in the ADHD (t=-1.23, df=19, p=0.235) or BD groups 
(t=-1.50, df=19, p=0.150) (Figure 2.1). These group differences in rest-to-task 





Figure 2.1. Mean theta power across resting-state (EO) and task (CPT-OX) 
condition in women with adult ADHD, women with bipolar disorder (BD) and 
control women. Error bars represent 95% confidence intervals. 
 
2.5 Discussion 
In this study investigating the relationship of EEG indices of cortical activity in 
women with ADHD, women with BD and control women, both ADHD and BD 
participants showed higher theta power than controls during the resting-state 
condition. No significant differences emerged between the two clinical groups. 
While control participants showed a task-related increase in theta activity from 
resting-state to cognitive task, no significant changes in theta power were 

























commonalities in brain dysfunction between ADHD and BD. Theta power may 
act as a marker of neurobiological processes in both disorders.  
 
Both the ADHD and BD groups showed an elevation of theta power during the 
resting-state condition, compared to controls. To date, no study has directly 
compared the cortical activity patterns of individuals with ADHD and BD. This 
finding suggests commonalities in oscillation patterns between women with 
ADHD and BD. The lack of significant differences between the clinical groups 
adds to previous research, which has shown an elevation of theta power during 
resting-state conditions independently in individuals with ADHD (Bresnahan et 
al., 1999; Bresnahan & Barry, 2002; Clarke et al., 2003a, 2006, 2008; Koehler 
et al., 2009; Snyder & Hall, 2006) and in individuals with BD (Degabriele & 
Lagopoulos, 2009), compared to controls. It is not fully understood what 
increased theta power in individuals with ADHD and BD during resting-state 
conditions represents. The findings of elevated resting theta power in younger 
compared to older neurotypical children (Benninger et al., 1984; Gasser, 
Jennen-Steinmetz, et al., 1988; Gasser, Verleger, et al., 1988) led to the 
development of a maturational-lag hypothesis (Kinsbourne, 1973). This 
hypothesis holds that that there is a delay in central nervous system (CNS) 
development in individuals with ADHD because during neurotypical CNS 
maturation, slow wave activity is replaced with fast wave activity. Yet, this study 
and other research demonstrating elevated theta power in adolescents and 
adults with ADHD (Bresnahan et al., 1999; Bresnahan & Barry, 2002; Clarke et 
al., 2008; Kitsune et al., 2015; Koehler et al., 2009; Skirrow et al., 2015) and BD 
(Degabriele & Lagopoulos, 2009) do not support this hypothesis. Increased 
theta power in individuals with ADHD during resting-state conditions has also 
been interpreted as representing hypo-arousal (Lubar, 1991; Satterfield & 
Dawson, 1971). Yet, two studies investigating the relationship between resting 
EEG power and skin conductance level (another marker of CNS arousal) in 
children with and without ADHD linked increased alpha rather than theta to 
under-arousal as indexed by skin conductance levels (Barry et al., 2004, 2009). 
While the significance of increased theta power during resting-state conditions 
remains to be fully elucidated, our findings may suggest a role for theta power 
as a common marker of neurobiological processes in both ADHD and BD. This 
is in line with findings from quantitative genetics studies, which have found 
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strong phenotypic and genetic links between ADHD and abnormal theta activity, 
suggesting it may be a biological marker or intermediate phenotype 
(endophenotype) for ADHD (McLoughlin, Palmer, et al., 2014; Tye, Rijsdijk, et 
al., 2014). 
 
In addition, no differences in EEG power were observed between the three 
groups during the cognitive task condition and no change in theta from resting-
state to task condition in the clinical groups was found. Our study is the first to 
investigate the QEEG profile of individuals with BD during a cognitive task and 
to directly compare it to an ADHD group. The findings, therefore, suggest 
commonalities in brain dysfunction between ADHD and BD during this cognitive 
task. Furthermore, the current study is the first to investigate the EEG patterns 
during both rest and task condition in women with adult ADHD. The results 
support previous work in an all-male sample, which showed no differences in 
cortical activation between controls and individuals with ADHD during the CPT 
and no change in spectral power from rest to cognitive task (Skirrow et al., 
2015). Yet, previous QEEG studies have yielded inconsistent results, such as 
elevated alpha (Nazari et al., 2011; Swartwood et al., 2003) and theta power 
(El-Sayed et al., 2002) on switching from resting-state to CPT in individuals with 
ADHD compared to controls. The seeming lack of task-dependent modulation of 
theta power in ADHD and BD participants may be explained by abnormalities in 
the default mode network (DMN), which is typically activated during resting-
state conditions and deactivated during task performance (Broyd et al., 2009; 
Raichle, 2010). Abnormalities in the DMN during rest have been demonstrated 
in both ADHD and BD (Cortese et al., 2012; Ongür et al., 2010). Yet, while task-
related modulation remains to be examined in BD, the DMN has been found to 
be inadequately attenuated when individuals with ADHD perform a task 
(Cortese et al., 2012; Fassbender et al., 2009; Sonuga-Barke & Castellanos, 
2007). The absence of task-related changes in theta power in our sample of 
women with ADHD and BD, as well as in previous research on ADHD (Skirrow 
et al., 2015), might therefore indicate inadequate attenuation of the DMN. A 
recent review, summarising findings from studies employing functional magnetic 
resonance imaging (fMRI) and EEG simultaneously, provides support for this 
idea (Nishida et al., 2015), by concluding that increased frontal theta power 
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indexes decreased DMN activity. Consequently, theta power may be vital to the 
attenuating processes required for cognitive functioning. 
 
Unlike previous research, this study did not find decreased beta activity in 
individuals with ADHD (Bresnahan et al., 1999; Bresnahan & Barry, 2002; 
Clarke et al., 2008; Koehler et al., 2009) or elevated delta power in individuals 
with BD (Degabriele & Lagopoulos, 2009). These discrepancies may be due to 
age and gender effects. Our all-female sample had a mean age of 38 years and 
an age range of 20 to 52 years. As EEG power tends to decline with age 
(Lüchinger, Michels, Martin, & Brandeis, 2011; Michels et al., 2013; Poil et al., 
2014), this wide age range may have reduced power to detect differences of 
smaller effect between the groups. Yet, some recent studies have also failed to 
replicate previous findings of decreased beta power in ADHD (Buyck & 
Wiersema, 2014; Liechti et al., 2013; Loo et al., 2009; Ogrim et al., 2012; Poil et 
al., 2014; Skirrow et al., 2015). A recent meta-analysis demonstrated that the 
reported effect size for TBR abnormalities in ADHD showed a strong 
relationship with year of publication, declining over time (Arns et al., 2013). The 
paper proposes the trend for reduced sleep duration in children across time, as 
well as sample and testing context differences between studies, as possible 
explanations. Support for context effects comes from a study of resting-state 
EEG power differences between recordings made at the beginning and the end 
of a 1.5 h testing session in 76 adolescents and young adults with ADHD and 
85 controls, which showed elevated delta and theta power in the ADHD group in 
the beginning and elevated beta power in the ADHD group at the end of the 
testing session (Kitsune et al., 2015). 
 
Several limitations should be considered alongside these results. First, 
medication status differed between the groups. While participants with ADHD 
were asked to come off their stimulant medication 48 hours before the 
assessment, participants were not asked to stop taking their mood-stabilising, 
anti-psychotic or anti-depressant medication for ethical reasons. We were 
further not able to directly test the effect of medication on EEG power, given the 
small number of individuals in the various medication sub-groups. Although the 
understanding of the effects of medications on QEEG is still limited, no 
significant differences between medicated and unmedicated individuals with 
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euthymic BD on QEEG have been found (Degabriele & Lagopoulos, 2009; El-
Badri, Ashton, Moore, Marsh, & Ferrier, 2001). It is, therefore, unlikely that 
medication effects produced the results in this study. However, medication 
cannot be excluded as potential confounder and studies of non-medicated 
individuals are needed to elucidate the effects of medication on EEG power. 
Second, we examined cortical activation for the frequency bands alpha, beta, 
delta and theta. While some researchers have advocated abandoning fixed 
frequency bands (Klimesch, 1999), the grouping of these frequencies into the 
particular bands has occurred historically and makes comparison between 
studies easier. For finer resolution and increased signal to noise ratio, future 
studies may conduct source based analyses such as independent component 
analysis (ICA). Finally, this investigation was conducted in a homogenous all-
female sample. Future studies will need to replicate these findings in larger 
samples of both genders, in order to generalise these findings to more typical 
clinical populations.  
 
Our results provide evidence for commonalities in brain dysfunction between 
ADHD and BD, with theta power potentially playing a role as a marker of shared 
neurobiological processes in both disorders. In light of shared cognitive 
impairments and the overlapping symptomatology of ADHD and BD, these 
findings represent a move towards uncovering biological markers underlying the 
pathophysiology shared between the disorders. Currently, diagnostic manuals 
such as the DSM (American Psychiatric Association, 2000, 2013) outline clinical 
diagnoses in a categorical system based on the description of behavioural 
symptoms. Yet, research has revealed substantial evidence for 
pathophysiological heterogeneity within disorders (Burdick, Ketter, Goldberg, & 
Calabrese, 2015; Jeste et al., 2015; Sjöwall, Roth, Lindqvist, & Thorell, 2013), 
as well as pathogenic overlap between disorders (Lee et al., 2013; Michelini et 
al., 2015). Consequently, diagnostic boundaries based on behavioural 
symptoms do not seem to correspond seamlessly to findings from 
neuropsychological and genetic studies, and have been only moderately 
successful at predicting treatment outcome (Insel et al., 2010; Ostacher et al., 
2015; Retz & Retz-Junginger, 2014). Future studies should build on the results 
from this and similar studies to understand the relationship between behaviour, 
neurophysiology and the genome to identify syndromes based on 
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pathophysiology. This could lead to more objective and precise approaches to 
diagnosis and prognosis and may eventually result in improved interventions 





Chapter 3. Altered EEG spectral power in adolescents 
with ADHD and preterm born adolescents during rest 
and cognitive performance  
3.1 Abstract 
Background: Preterm birth has been associated with an increased risk for 
ADHD-like symptoms and cognitive impairments similar to those seen in ADHD. 
However, direct comparisons across ADHD and preterm birth on 
neurophysiological measures are limited. The aim of this analysis was to test 
whether quantitative EEG (QEEG) measures identify differences or similarities 
between term-born adolescents with ADHD and adolescents born preterm 
during resting-state and cognitive task conditions. In addition, we aimed to 
investigate age effects on EEG spectral power. Methods: First, we directly 
compared QEEG activity between 75 term-born adolescents with ADHD, 145 
adolescents born preterm and 153 term-born control adolescents during an 
eyes-open resting-state condition (EO) and a cued continuous performance 
task (CPT-OX). Although age was statistically controlled in the analysis, we 
reran all analyses on a carefully age-matched subsample, due to significant 
group mean differences in age and the possibility of strong age effects on 
QEEG activity. This sub-sample comprised 36 term-born adolescents with 
ADHD, 94 preterm-born adolescents and 63 control adolescents. We also 
examined the relationship between age and EEG spectral power in the full 
sample using correlation analyses. Results: Age had a strong effect on delta 
power in the full sample, as demonstrated by correlations of r=-0.50– -0.64, as 
well as by differences in results between the full sample and the age-matched 
subsample. We, therefore, interpret the group comparisons from the carefully 
age-matched analyses only. Delta power was the only frequency range to 
demonstrate a significant group-by-condition interaction. The ADHD group did 
not differ significantly from the preterm and control groups during EO with 
regard to delta power, but during CPT-OX the ADHD group showed significantly 
increased delta power compared to both the preterm and control groups. The 
preterm group did not differ significantly from the control group on delta power 
during EO or CPT-OX. Rest-to-task transition effects in the delta band differed 
between the groups: while the ADHD and control groups demonstrated a 
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significant increase in delta power from EO to CPT-OX, no change in delta 
power from EO to CPT-OX was found in the preterm group. Conclusion: Our 
results provide evidence for differences in delta power between term-born 
adolescents with ADHD and adolescents born preterm, as well as for 
maturational effects on EEG spectral power. Future large-scale studies are 
needed to elucidate how the cortical activation patterns and rest-to-task 
transition effects observed in adolescents born preterm mediate cognitive 
impairments and clinical symptoms.  
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3.2 Introduction 
Preterm births, denoting births before 37 completed weeks of gestation (World 
Health Organization, 1977), are highly prevalent. In the developed world, 8.6% 
of individuals are born preterm (Blencowe et al., 2012). Although the survival 
rates for individuals born preterm have increased greatly over the last decades 
(Goldenberg et al. 2008), preterm birth is a type of pre- and peri-natal trauma 
that increases the risk of adverse long-term outcomes (Bhutta et al., 2002; 
D’Onofrio et al., 2013), possibly because the late third trimester (32–40 weeks’ 
gestation) serves as a critical period to lay the foundation of brain networks (Ball 
et al., 2014; van den Heuvel et al., 2014). A cognitive profile that resembles 
those of individuals with ADHD, including deficits in attention and inhibitory 
control (Aarnoudse-Moens et al., 2009; Geva & Feldman, 2008; Lawrence et 
al., 2009; Miskovic et al., 2009; Mulder et al., 2009; Nosarti et al., 2006), as well 
as ADHD diagnosis, are frequently associated with preterm birth (Bhutta et al., 
2002; D’Onofrio et al., 2013; Halmøy et al., 2012; Lindström et al., 2007). Yet, it 
is unclear whether the symptoms and deficits seen in individuals born preterm 
are identical to those associated with ADHD or whether they are part of more 
wide-ranging impairments.   
 
Quantitative electroencephalography (QEEG), which measures the strength of 
electrical activity along the scalp, allows investigation of covert processes due 
to its sensitivity to subtle changes in the power of oscillatory activity and its high 
temporal resolution (Banaschewski & Brandeis, 2007). QEEG is, therefore, a 
useful tool to examine and compare the neurocognitive profiles of individuals 
with ADHD and preterm-born individuals. Electrophysiological recordings are 
quantified and conventionally described in the following frequency bands: delta 
(0.5-3.5 Hz), theta (3.5-7.5Hz), alpha (7.5-12.5 Hz), beta (12.5-30 Hz) and 
gamma (>30 Hz). Traditionally, elevated power in slow (delta and theta) and 
reduced power in fast (mainly beta) frequency bands have been reported for 
children (Bresnahan et al., 1999; Clarke et al., 2003a, 2006; Snyder & Hall, 
2006) and adults (Bresnahan et al., 1999; Bresnahan & Barry, 2002; Clarke et 
al., 2008; Koehler et al., 2009) with ADHD during resting-state conditions. 
However, a number of recent studies have not replicated these findings (Buyck 
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& Wiersema, 2014; Kitsune et al., 2015; Liechti et al., 2013; Loo et al., 2009; 
Ogrim et al., 2012; Poil et al., 2014; Skirrow et al., 2015).  
 
Although several EEG studies have examined the neurophysiology of preterm-
born infants in neonatal intensive care units (Meijer et al., 2014; Victor et al., 
2005) and in the postnatal period (Beckwith & Parmelee, 1986; Duffy et al., 
1990; González et al., 2011; Hayakawa et al., 2001; Vecchierini et al., 2007), 
few EEG studies have been conducted in children, adolescents and adults born 
preterm. One study that investigated spectral EEG power in children with 
educational problems during an eyes-closed resting condition reported 
increased theta (3.6-5 Hz), beta (20.1-30 Hz) and gamma (30.1-40.2 Hz) power 
in preterm born children (n=38) compared to term-born controls with education 
problems (n=22) (Rozhkova, 2008). A second study investigated QEEG in 
young adults who were born preterm and at extremely low birth weight (n=71; 
mean birth weight=874 g, mean gestational age=27.5 weeks), and who were 
not impaired in adulthood (defined as being free of neurosensory impairments 
and psychiatric disorders). This study found increased power in the slow (delta 
and theta) and decreased power in the fast (alpha and beta) frequency bands in 
preterm-born individuals compared to term-born controls with healthy birth 
weight (n=83) during a resting-state condition (Miskovic et al., 2009). While it is 
now possible to study survivors of preterm birth due to major advances in 
neonatal care over the last few decades (Goldenberg et al. 2008), the cortical 
activation patterns of adolescents born preterm remain to be assessed. In 
addition, no study to date has directly compared cortical activation between 
individuals born preterm and individuals with ADHD. 
 
Relative power in slow (delta and theta) and fast (alpha and beta) frequency 
bands have been indicated as reliable markers of typical development, 
respectively decreasing and increasing across the lifespan (Clarke, Barry, 
McCarthy, & Selikowitz, 2001; Gasser, Verleger, et al., 1988; John et al., 1980; 
Matoušek & Petersén, 1973; Somsen, van’t Klooster, van der Molen, van 
Leeuwen, & Licht, 1997). Consequently, the findings of elevated power in slow 
and reduced power in fast frequency bands reported in ADHD have been 
interpreted as maturational delay (Clarke et al., 2001; Kinsbourne, 1973). 
QEEG studies of ADHD have shown maturational effects similar to those in 
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typically developing individuals (i.e. increased power in slow and decreased 
power in fast frequency bands in children compared to adolescents and adults) 
(Buyck & Wiersema, 2014; Liechti et al., 2013; Monastra, Lubar, & Linden, 
2001). Yet, research on the development of EEG spectral power in individuals 
with ADHD compared to age-matched controls has yielded inconsistent results. 
One study found elevated theta power in ADHD throughout the lifespan 
(Bresnahan et al., 1999), whereas other studies showed atypical developmental 
trajectories in individuals with ADHD during late childhood (Liechti et al., 2013) 
or adulthood (Poil et al., 2014). While cognitive impairments in individuals born 
preterm persist into adolescence (Burnett et al., 2015; Taylor et al., 2004) and 
adulthood (Nosarti et al., 2007; Stålnacke et al., 2014), little is known about 
EEG maturation effects in individuals born preterm. In the first weeks and 
months after birth, marked developmental changes in background EEG activity 
occur in preterm born infants (Biagioni et al., 1994; Hayakawa et al., 2001; 
Myers et al., 2012; Nunes, Khan, Gomes Filho, Booij, & da Costa, 2014; 
Okumura et al., 2003; Vecchierini et al., 2007). However, no conclusion on EEG 
maturation across the lifespan can be drawn from these findings.  
 
Research examining oscillatory patterns during cognitive task performance in 
ADHD has yielded inconsistent results. While some studies have reported no 
differences in EEG power between controls and individuals with ADHD during a 
continuous performance test (CPT) (Loo et al., 2009; Skirrow et al., 2015, 
chapter 2), others have reported elevated alpha (Nazari et al., 2011; Swartwood 
et al., 2003) and theta power (El-Sayed et al., 2002) in individuals with ADHD 
compared to controls. The lack of significant differences in EEG spectral power 
between controls and individuals with ADHD during the CPT was likely driven 
by the absence of rest-to-task transition effects in the ADHD group (i.e. no 
changes in spectral power from resting-state to cognitive task) in two of the 
studies reviewed above (Skirrow et al., 2015, chapter 2). To date, no studies 
have examined the QEEG profile of preterm born individuals during cognitive 
task performance. 
 
The aim of the present study is to test whether QEEG measures identify 
differences or similarities between adolescents with ADHD, adolescents born 
preterm and control adolescents during a resting-state condition (eyes open, 
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EO) and a cognitive task condition (a CPT with flankers, CPT-OX (van Leeuwen 
et al., 1998)) to elucidate whether potential impairments observed among 
individuals born preterm are identical to those seen in term-born individuals with 
ADHD. As part of this investigation, we examine how EEG patterns change in 
relation to recording condition (resting vs. cognitive task) to examine task-
related modulation of EEG spectral power in adolescents with ADHD and 
adolescents born preterm. Although the full sample consists entirely of 
adolescents, significant differences in age emerge between the groups (Table 
3.1). To address this issue, age is controlled for statistically in the analysis of 
the full sample. In addition, all analyses are rerun using a carefully age-matched 
subsample. We further aim to explore the effect of age on QEEG within these 
three groups of the full sample using correlation analyses. If diverging results in 
the age-matched subsample and significant correlations between age and EEG 
spectral power emerge, the findings from the age-matched subsample, rather 





ADHD and control sibling pairs who had taken part in previous research (Chen 
et al., 2008; Kuntsi et al., 2010; Wood, Asherson, Rijsdijk, & Kuntsi, 2009), were 
invited to take part in a follow-up study (Cheung et al., 2015a, 2015b). All 
participants were of European Caucasian decent and had one or more full 
siblings available for ascertainment. Initially, participants with ADHD were 
included if they had a clinical diagnosis of DSM-IV combined-type ADHD during 
childhood. At follow-up, participants in the ADHD group were included if, as well 
as having an ADHD diagnosis in childhood, they met DSM-IV criteria for any 
ADHD subtype at follow-up. The control group was initially recruited from 
primary (ages 6–11 years) and secondary (ages 12–18 years) schools in the 
UK, aiming for an age- and sex-match with the ADHD sample. Control 
individuals were included in the study if they did not meet DSM-IV criteria for 
any ADHD subtype either in childhood or at follow-up. Exclusion criteria for both 
groups included IQ<70, autism, epilepsy, general learning difficulties, brain 
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disorders and any genetic or medical disorder associated with externalising 
behaviours that might mimic ADHD.     
 
We followed up the sample on average 5.8 years (SD=1.1) after initial 
assessments. Siblings of individuals with ADHD were included in the ADHD 
group if they met DSM-IV criteria for any ADHD subtype at follow-up. Siblings of 
control individuals were included in the control group if they did not meet DSM-
IV criteria for any ADHD subtype at follow-up. The ADHD and control groups 
were previously included in a study investigating ADHD case-control differences 
on cognitive and neurophysiological markers of ADHD persistence and 
remission (Cheung et al., 2015a). While ADHD-control differences for this 
sample have been reported previously, here, a subsample of the ADHD and 
control groups is compared to a group of preterm-born adolescents. 
 
At follow-up, six participants from the ADHD-sibling pair sample were excluded 
from the group analyses, as they had missing parent ratings of clinical 
impairment and their current ADHD status could not be determined. Two 
additional participants from the ADHD-sibling pair sample were excluded 
because they became very drowsy during the cognitive task and fell asleep. In 
two cases there was EEG equipment failure, resulting in exclusion. Seven 
participants from the ADHD-sibling pair sample, who were born preterm, as well 
as 38 individuals from the ADHD-sibling pair sample, who provided no 
information about gestational age (GA), were also excluded. Two participants 
with childhood ADHD who did not meet ADHD symptom criteria but met clinical 
levels of impairment at follow-up were further excluded to minimize 
heterogeneity in the ADHD sample.  
 
Since age has a large effect on QEEG measures (Clarke et al., 2001; Gasser, 
Verleger, et al., 1988; John et al., 1980; Matoušek & Petersén, 1973; Somsen 
et al., 1997), we chose to also analyse a homogeneous group of participants 
with regard to age. For this subsample, we excluded an additional 37 individuals 
from the ADHD-sibling pair sample who fell outside the investigated age range 
(14-19 years).  On average, the ADHD group was older than the preterm group.  
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Forty-five participants from the control-sibling pair sample were excluded 
because no GA information was available. Six control participants were 
removed from the analyses for meeting DSM-IV ADHD criteria based on the 
parent-rated Barkley Informant Rating Scale (Barkley & Murphy, 2006). For the 
subsample analysis, an additional 66 participants from the control-sibling pair 
sample were excluded because they fell outside the investigated age range (14-
19 years). On average, the control group was older than the preterm group. 
 
The preterm group was recruited from secondary schools in Southeast England. 
All preterm participants had one or more full siblings available for 
ascertainment, and were born before 37 weeks’ gestation. Siblings of 
individuals born preterm were included in the preterm group if they were born 
before 37 weeks’ gestation. Exclusion criteria for the preterm group included 
IQ<70, general learning difficulties, cerebral palsy and any other medical 
conditions that affects motor co-ordination including epilepsy. Three individuals 
born preterm were excluded because they showed insufficient 
understanding/engagement with the CPT-OX, as suggested by the testing notes 
and further indicated by extreme omission errors=17, 31 and 41 respectively, 
which were more than 3.5 SD from the mean (Tye et al., 2011; Tye, Asherson, 
et al., 2014). Seven individuals from the preterm-sibling pair sample were 
excluded because their GA was equal to or above 37 weeks; one individual was 
excluded because of an IQ<70 and 26 participants had to be excluded due to 
EEG equipment failure. For the subsample analysis, an additional 71 individuals 
from the preterm-sibling pair sample were excluded because they fell outside 
the investigated age range (14-19 years). On average, the preterm group was 
younger than the ADHD and control groups. Seven preterm-born individuals in 
the full sample and three preterm-born individuals in the age-matched 
subsample met diagnostic criteria for a research diagnosis of ADHD. Since, in 
this thesis, preterm birth is investigated as a potential risk factor for ADHD, 
individuals who were born preterm and also demonstrate high levels of ADHD 
symptoms are not excluded from this analysis. 
 
The final full sample consisted of 75 ADHD participants (six sibling pairs and 63 
singletons), 145 preterm-born participants (25 sibling pairs and 95 singletons) 
and 153 controls (69 sibling pairs and 15 singletons). The groups differed 
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significantly in terms of age, IQ, gender distribution, GA and ADHD symptom 
scores (Table 3.1). The ADHD group showed significantly higher ADHD 
symptom scores than both the preterm (t=19.57, df=175, p<0.001) and control 
groups (t=-46.19, df=139, p<0.001). The preterm group further demonstrated 
significantly higher ADHD symptom scores than the control group (t=-8.85, 
df=178, p<0.001). Age was included as a covariate in all analyses. All analyses 
were rerun with IQ as an additional covariate. Gender was not included as a 
covariate in the group analyses to avoid controlling for ADHD status (Cheung et 
al., 2015a). Written informed consent was obtained and the studies were 
approved by the London-Surrey Borders Research Ethics Committee 




Table 3.1. Descriptive statistics.  
 ADHD Preterm Control Statistic p-value 
Full sample n=75 n=145 n=153 - - 
GA in weeks (SD) 39.9 (1.4) 33.2 (2.8) 40.0 (1.2) z=-19.9    <0.001 
IQ (SD) 97.1(13.7) 104.2 (12.5) 110.3 (12.5) z=-2.4      0.015 
Age (SD) 18.5 (2.9) 15.3 (1.9) 17.8 (2.1) z=-8.1 <0.001 
Age range 12.7-25.9 11.0-20.0 11.9-21.6 - - 
Males % 86.7 51.0 75.6 F2=34.4 <0.001 
ADHD symptom 
score 
14.0 (3.0) 3.6 (4.0) 0.0 (0. 0) t=  6.3  <0.001 
Age-matched 
subsample 
n=36 n=94 n=63 - - 
GA in weeks (SD) 39.72 (1.3) 33.5 (2.4) 40.0 (1.10) z=-18.0    <0.001 
IQ (SD) 96.4 (14.0) 103.6 (13.2) 108.0 (12.4) z=-1.6      0.112 
Age (SD) 16.6 (1.5) 16.4 (1.1) 16.7 (1.0) z=-1.7      0.082 
Age range 14.1-18.9 14.8-18.8 14.4-18.1 - - 
Males % 88.9 44.7 47.5 F2=24.1 <0.001 
ADHD symptom 
score 
14.2 (3.0) 3.5 (3.8) 0.0 (0.0) t=  3.4 <0.001 
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The final age-matched subsample consisted of 36 ADHD participants (five 
sibling pairs and 26 singletons), 94 preterm-born participants (13 sibling pairs 
and 68 singletons) and 63 controls (eight sibling pairs and 47 singletons). The 
groups did not differ in terms of age or IQ (Table 3.1). Significant differences in 
gender distribution, GA and ADHD symptom scores were observed. The ADHD 
group showed significantly higher ADHD symptom scores than both the preterm 
(t=14.62, df=113, p<0.001) and the control groups (t=-35.25, df=84, p<0.001). 
The preterm group further demonstrated significantly higher ADHD symptom 
scores than the control group (t=-6.72, df=133, p<0.001). Gender was not 
included as a covariate in the group analyses to avoid controlling for ADHD 
status (Cheung et al., 2015a). 
 
3.3.2 Procedure  
Participants attended a single 4.5 h research session, which included an EEG 
assessment, an IQ test and clinical interviews. As part of the EEG assessment, 
participants completed a 3-minute eyes-open resting-state condition (EO), as 
well as a 3-minute eyes-closed resting-state condition, prior to performing on a 
CPT with flankers (CPT-OX) (Doehnert et al., 2010; McLoughlin et al., 2010; 
McLoughlin, Asherson, et al., 2011). Participants were requested to remain as 
still as possible, and keep their eyes on a fixed point in front of them for the 
duration of the recording. A 48 h ADHD medication-free period was required 
before the research session. 
 
3.3.3 Measures 
3.3.3.1 ADHD diagnosis 
In the ADHD group, ADHD was assessed using parental ADHD symptom 
ratings on the Diagnostic Interview for ADHD in adults (DIVA) (Kooij & 
Francken, 2007) and the Barkley’s functional impairment scale (BFIS) (Barkley 
& Murphy, 2006). The DIVA is a semi-structured interview designed to evaluate 
the DSM-IV criteria for both adult and childhood ADHD symptoms and 
impairment. It consists of 18 items used to define the DSM-IV symptom criteria 
for ADHD. Each item is scored affirmatively if the behavioural symptom was 
present often within the past six months. Based on DSM-IV criteria, a research 
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diagnosis of ADHD was made if participants scored six or more on either the 
inattention or hyperactivity-impulsivity subscales of the DIVA and if they 
received two or more positive scores on two or more areas of impairment on the 
BFIS. In the preterm group, ADHD was assessed using parental ADHD 
symptom ratings on the DIVA (Kooij & Francken, 2007). A research diagnosis of 
ADHD was made if participants scored six or more on the inattention or 
hyperactivity-impulsivity subscales of the DIVA.  
 
3.3.3.2 IQ 
The vocabulary and block design subtests of the Wechsler Abbreviated Scale of 
Intelligence Fourth Edition (WASI-IV) (Wechsler, 1999) were administered to all 
participants to derive an estimate of IQ. 
 
3.3.3.3 Cued continuous performance task with flankers 
The CPT-OX is a cued Go/NoGo task that probes attention, preparation and 
response inhibition. The task consisted of 400 black letter arrays, made up of a 
centre letter and incompatible flankers on each side to increase difficulty. The 
presented arrays included the cue letter ‘O’, the target letter ‘X’ as well as the 
distractors ‘H’, ‘B’, ‘C’, ‘D’, ‘E’, ‘F’, ‘G’, ‘J’ and ‘L’. Letters were presented 
centrally on the computer monitor, subtending approximately 5°. Cue and target 
letters (‘O’ and ‘X’ respectively) were flanked by incompatible letters (‘XOX’ and 
‘OXO’ respectively). Participants were instructed to ignore the flanking letters 
and respond as quickly as possible to cue-target sequences (‘O’-‘X’). 80 cues 
(‘XOX’) were followed by the target (‘OXO’) in 40 trials (Go condition), and by 
neutral distractors in the remainder of trials (NoGo condition). On 40 trials, the 
target letter ‘X’ was not preceded by a cue ‘O’ and had to be ignored. Letters 
were presented every 1.65 s for 150 ms in a pseudo-randomised order. Ten 
practice trials preceded the main task and were repeated, if required, to ensure 
participant comprehension. Participants were instructed to respond only to Cue-
Go sequences by pressing a button as quickly as possible with the index finger 
of their preferred hand. Participants were further asked to withhold the response 
in the presence of a NoGo stimulus, in the presence of a Go stimulus not 
preceded by a cue, or in the presence of any other irrelevant letters. Task 
duration was 11 min. 
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3.3.3.4 EEG recording and analysis 
The EEG was recorded from a 62 channel direct-current-coupled recording 
system (extended 10–20 montage), using a 500Hz sampling-rate, impedances 
under 10kΩ and FCz as the recording reference. The electro-oculograms were 
recorded from additional electrodes above and below the left eye and at the 
outer canthi. Participants were seated on a height-adjustable chair in a dimly-lit 
video-monitored testing cubicle. Stimuli were presented on a computer monitor 
at a distance of approximately 120 cm, using the Presentation software 
package (www.neurobs.com). The EEG data were analysed using Brain Vision 
Analyzer 2.0 (Brain Products, Germany).  
 
Researchers were blind to group status during EEG pre-processing and 
analysis. Raw EEG recordings were down-sampled to 256 Hz, re-referenced to 
the average of all electrodes, and digitally filtered using Butterworth band-pass 
filters (0.1-30 Hz, 24 dB/oct). All trials were also visually inspected for electrical 
artefacts (due to electrical noise in the EEG recording) or obvious movement, 
and sections of data containing artefacts were removed manually. Ocular 
artefacts, corresponding to blink-related and vertical and horizontal eye 
movements, were identified using the infomax independent component analysis 
(ICA) algorithm (Jung et al. 2000), which allows for removal of activity 
associated with ocular artefacts by back-projection of all but this activity. 
Sections of data with remaining artefacts exceeding ± 100 μV in any channel or 
with a voltage step greater than 50 μV were automatically rejected.  
 
Prior to performing a CPT-OX (Doehnert et al., 2010; McLoughlin et al., 2010; 
McLoughlin, Asherson, et al., 2011), participants carried out a 3-minute eyes-
open resting-state condition (EO), as well as a 3-minutes eyes-closed resting-
state condition. Here, we focus on the EO and CPT-OX condition in order to be 
able to compare the findings to recent studies (Nazari et al., 2011; Skirrow et 
al., 2015) and to findings from chapter 2. Quantitative EEG was investigated for 
these two conditions (EO and CPT-OX). Data were segmented into 2-second 
epochs and power spectra were computed using a Fast Fourier Transform 
(FFT) with a 10% Hanning window. Analyses focus on delta (0.5-3.5 Hz), theta 
(3.5-7.5 Hz), alpha (7.5-12.5 Hz) and beta (12.5-30 Hz) frequency band 
differences between ADHD, preterm and control groups. To normalise the data, 
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all data were log 10 transformed. To reduce the number of statistical 
comparisons, EEG power (μV2) within each frequency band was averaged 
across frontal (Fz, F1, F2, F3, F4, F5, F6, F7, F8), central (Cz, C1, C2, C3, C4, 
C5, C6) and parietal (Pz, P3, P4, P7, P8) regions from individual scalp 
electrodes.  
 
3.3.4 Statistical analysis 
Data were analysed using random intercept models in Stata, to control for non-
independence of the data, i.e. data coming from siblings of one family, in a 
repeated-measures design, using a ‘robust cluster’ command to estimate 
standard errors (Tye et al., 2012; Wood et al., 2009). This command was not 
available for correlational analyses, which were conducted to investigate the 
effect of age on EEG spectral power in the full sample. For these analyses 
siblings were removed from the ADHD (n=6), preterm (n=25) and control group 
(n=69) of the full sample. Post-hoc analyses were carried out using the 
independent samples t-tests for between-subjects contrasts, and paired 
samples t-tests for within-individual task-related differences in condition (EO 
and CPT-OX) and electrode site by employing the ‘cltest’ command (Herrin, 
2012) to control for the non-independence of the data. Bonferroni correction 
was implemented to correct for multiple testing in the different frequency bands: 
Bonferroni adjusted p-value=0.0125. Effect size (Cohen’s d), which was 
calculated using the difference in the means divided by the pooled standard 
deviation, is also reported (Cohen, 1988). According to Cohen (1988), d=0.20 
constitutes a small effect, d=0.50 a medium effect and d=0.80 a large effect. 
 
In full sample analyses, age was routinely included as a covariate since the 
groups differed significantly on age. In the full sample, groups further differed in 
terms of IQ. Therefore, all analyses in the full sample were subsequently re-ran 
with IQ as a covariate, but results and significant levels did not change.  In the 
age-matched subsample age was not included as a covariate since all three 
groups were matched on age. Although the groups in both the full sample and 
the age-matched subsample differed significantly on gender, gender was not 
included as a covariate in the group analyses to avoid controlling for ADHD 
status (Cheung et al., 2015a).  
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3.4 Results 
3.4.1 Full sample 
3.4.1.1 QEEG results 
The random intercept model indicated no significant main effects of group in the 
delta (z=0.08, p=0.938), theta (z=0.05, p=0.959), alpha (z=-0.10, p=0.920) or 
beta frequency ranges (z=-0.48, p=0.632). 
 
Significant main effects of condition emerged for both delta (z=6.84, p<0.001) 
and theta power (z=10.63, p<0.001). No significant main effects of condition 
were found for alpha (z=0.59, p=0.556) and beta power (z=1.77, p=0.077). 
Post-hoc paired sample t-tests revealed that, overall, both delta (t=-6.71, 
df=372, p<0.001) and theta power (t=-12.07, df=372, p<0.001) were 
significantly reduced during EO compared to CPT-OX.  
 
The random intercept model yielded a significant group-by-condition interaction 
for delta power (z=-3.86, p<0.001) (Figure 3.1A). No significant group-by-
condition interactions were found for theta (z=-1.25, p=0.213), alpha (z=-1.19, 
p=0.234) and beta power (z=-2.25, p=0.024). Post-hoc independent sample t-
tests revealed that delta power in individuals with ADHD was not significantly 
different from controls during EO (t=0.27, df=139, p=0.788) or CPT-OX (t=-1.73, 
df=139, p=0.086). While the ADHD group showed significantly reduced delta 
power compared to the preterm group during EO (t=-5.83, df=175, p<0.001), 
with large effect size (d=0.92), during CPT-OX the ADHD and preterm groups 
did not differ significantly with regard to delta power (t=-1.91, df=178, p=0.058). 
The preterm group showed significantly increased delta power compared to the 
control group during EO (t=-6.85, df=178, p<0.001) and CPT-OX (t=-4.28, 
df=178, p<0.001), with large (d=0.95) and moderate (d=0.60) effect sizes 
respectively. Paired sample t-tests demonstrated an increase in delta power 
from EO to CPT-OX in the ADHD (t=-7.46, df=74, p<0.001) and control groups 
(t=-5.35, df=153, p<0.001). No significant change from EO to CPT-OX was 
found in the preterm group (t=0.343, df=144, p=0.732) (Figure 3.1A).  
 
Significant main effects of recording site (frontal, central and parietal) emerged 
for theta (z=4.51, p<0.001) and alpha power (z=19.68, p<0.001) but not for 
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delta (z=-0.69, p=0.490) and beta power (z=0.37, p=0.713). Since no significant 
main effect of recording site was found for delta power, post-hoc results are not 
presented here. 
 
3.4.1.2 Correlation results 
Correlational analyses were conducted to investigate the effect of age on delta 
power. Results for the other frequency bands are not presented here, since 
delta was the only frequency range to demonstrate a significant group-by-
condition interaction. Significant negative correlations emerged between age 
and delta power during EO (r=-0.62, p<0.001; r=-0.50, p<0.001; r=-0.57, 
p<0.001) and CPT-OX (r=-0.64, p<0.001; r=-0.60, p<0.001; r=-0.53, p<0.001) in 
the ADHD, preterm and control groups respectively, highlighting the importance 
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Figure 3.1. Mean delta power across resting-state (EO) and task (CPT-OX) condition in (A) the full sample and (B) the age-
matched adolescent subsample. Error bars represent 95% confidence intervals. 
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3.4.2 Age-matched subsample 
3.4.2.1 QEEG results 
The random intercept model indicated no significant main effects of group in the 
delta (z=-0.79, p=0.427), theta (z=-0.37, p=0.708), alpha (z=-0.26, p=0.793) or 
beta frequency ranges (z=-0.15, p=0.881). 
 
Significant main effects of condition emerged for both delta (z=3.65, p<0.001) 
and theta power (z=8.08, p<0.001). No significant main effects of condition were 
found for alpha (z=-0.76, p=0.445) and beta power (z=-0.04, p=0.966). Post-hoc 
paired sample t-tests revealed that, overall, both delta (t=-3.56, df=192, 
p<0.001) and theta power (t=-8.61, df=192, p<0.001) were significantly reduced 
during EO compared to CPT-OX.  
 
A significant group-by-condition interaction emerged for delta power (z=-3.37, 
p<0.001) (Figure 3.1B). No significant group-by-condition interactions were 
found for theta (z=-1.43, p=0.152), alpha (z=-2.34, p=0.020) and beta power 
(z=-2.54, p=0.016). Post-hoc independent sample t-tests revealed that delta 
power during EO was not significantly different in individuals with ADHD 
compared to control (t=-1.27, df=84, p=0.26; Cohen’s d=0.26) or preterm-born 
individuals (t=0.15, df=113, p=0.881; Cohen’s d=0.03). However, during CPT-
OX the ADHD group showed significantly greater delta power than both the 
control (t=-2.86, df=84, p=0.005) and preterm groups (t=3.41, df=113, p<0.001), 
with moderate (d=0.61) and moderate-to-large (d=0.71) effect sizes 
respectively. The preterm group did not differ significantly from the control group 
with regard to delta power during EO (t=-1.58, df=133, p=0.117) or CPT-OX 
(t=0.80, df=133, p=0.423). Paired sample t-tests demonstrated an increase in 
delta power from EO to CPT-OX in the ADHD (t=-4.33, df=35, p<0.001) and 
control groups (t=-3.26, df=62, p=0.002). No significant change from EO to 
CPT-OX was found in the preterm group (t=0.240, df=93, p=0.811) (Figure 
3.1B). 
 
Moreover, significant main effects of recording site (frontal, central and parietal) 
were found for theta (z=3.92, p<0.001) and alpha power (z=16.90, p<0.001), but 






significant main effect of recording site emerged for delta power, post-hoc 
results are not presented here. 
 
3.5 Discussion 
In this study examining the relationship of EEG spectral power in adolescents 
with ADHD, adolescents born preterm and control adolescents across resting-
state and cognitive task conditions, different cortical activation patterns in the 
delta band emerged for the three groups. Since we demonstrated considerable 
age effects on delta power, the following discussion of results on group 
differences is based on the age-matched subsample. While the ADHD group 
did not differ significantly from the preterm and control groups during EO with 
regard to delta power, during CPT-OX the ADHD group showed significantly 
increased delta power compared to both the preterm and control groups. The 
preterm group did not differ significantly from the control group with regard to 
delta power during EO or CPT-OX.  
 
Rest-to-task transition effects differed between the ADHD and the preterm 
group in the delta band. While the preterm group showed no changes in EEG 
spectral power from resting-state to task condition, the ADHD group exhibited a 
task-related increase in delta power. As a result, the ADHD and preterm groups 
did not differ with regard to delta power during the resting-state condition, but 
participants with ADHD demonstrated significantly increased delta power 
compared to the preterm group during the cognitive task condition. To date, no 
study has directly compared the cortical activity patterns of individuals with 
ADHD and preterm-born individuals. These findings provide evidence for 
differences in oscillation patterns in the delta range, especially with regard to 
rest-to-task transition effects, between adolescents with ADHD and adolescents 
born preterm.  
 
Both the ADHD and control groups showed a task-related increase in delta 
power from resting-state to task condition. Whereas delta power did not differ 
significantly between these two groups during the resting-state condition, power 
in the delta band was significantly increased in the ADHD group compared to 
controls during the cognitive task condition. This result of rest-to-task transition 
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effects in the ADHD and control groups does not replicate previous research in 
men (Skirrow et al., 2015) and women (chapter 2) with adult ADHD, which 
found no theta power differences in cortical activation between controls and 
individuals with ADHD during the CPT-OX and no change in EEG spectral 
power from resting-state to cognitive task in the ADHD group. In addition, the 
findings of a lack of significant differences between these two groups during the 
resting-state condition fail to replicate the previously reported elevation of slow 
oscillatory power during rest in individuals with ADHD (Bresnahan et al., 1999; 
Bresnahan & Barry, 2002; Clarke et al., 2003a, 2006, 2008; Koehler et al., 
2009; Snyder & Hall, 2006). However, they are in agreement with more recent 
studies failing to replicate slow oscillatory power abnormalities in children, 
adolescents and adults with ADHD compared to controls during resting-state 
(Buyck & Wiersema, 2014; Kitsune et al., 2015; Liechti et al., 2013; Loo et al., 
2009; Ogrim et al., 2012; Poil et al., 2014). 
 
While it is conceivable that heterogeneity in the ADHD samples with regard to 
ADHD subtype (Buyck & Wiersema, 2014; Clarke et al., 2001; Loo et al., 2013), 
medication status (Clarke, Barry, Bond, McCarthy, & Selikowitz, 2002; Clarke et 
al., 2003b; Loo, Hopfer, Teale, & Reite, 2004) and comorbidities (Clarke, Barry, 
McCarthy, & Selikowitz, 2002; Loo et al., 2013) have resulted in inconsistencies 
between studies, it seems more likely that differences in sample ages may have 
contributed to the discrepancies between the current findings in adolescents 
and previous findings in adults with ADHD (chapter 2; Skirrow et al., 2015). This 
idea is supported by our findings of a negative moderate-to-large relationship 
between delta power and age across all three groups in the full sample, which 
suggest substantial maturational effects on delta power. Differences in results 
between the full sample and the age-matched subsample further suggest 
maturational effects on delta power. Compared to the preterm group of the age-
matched subsample, the preterm group in the full sample showed increased 
delta power during both EO and CPT-OX. These findings point to age effects 
because the preterm group in the full sample is younger, on average, than the 
preterm group of the age-matched subsample, and power in slow (delta and 
theta) frequency bands decreases across the lifespan (Clarke et al., 2001; 
Gasser, Verleger, et al., 1988; John et al., 1980; Matoušek & Petersén, 1973; 
Somsen et al., 1997).  
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That EEG spectral power in all frequency bands is affected by age has also 
been shown in other studies of individuals with ADHD (Buyck & Wiersema, 
2014; Liechti et al., 2013; Monastra et al., 2001). Research further indicates the 
possibility that developmental trajectories of EEG spectral power in individuals 
with ADHD may not be linear throughout the lifespan but may deviate in late 
childhood (Liechti et al., 2013) or adulthood (Poil et al., 2014). Consequently, 
discrepancies between our current and previous findings may arise from 
differences in sample ages. Yet, longitudinal studies are needed to fully 
elucidate the trajectory of EEG spectral power development in ADHD and to 
examine these discrepancies in rest-to-task transition effects in ADHD.  
 
The increase in delta power from rest to cognitive task condition in adolescents 
with ADHD and control adolescents may be linked to the increased task 
demand (Harmony, 2013; Lal & Craig, 2001) and enhanced task performance 
(Knyazev, 2012). It is plausible that elevated delta power during the cognitive 
task condition in adolescents with ADHD compared to controls indicates a 
compensatory mechanism (Lenartowicz et al., 2014). Yet, this possibility 
remains to be elucidated in future studies employing tools such as independent 
component analysis (ICA) and time-frequency analysis to tease apart the 
various cognitive processes involved in task performance. 
 
The preterm group showed no differences in delta power during resting-state 
and cognitive task conditions compared to controls. While delta power 
significantly increased in control individuals from the rest condition to the task 
condition, no change in delta power from EO to CPT-OX was seen in the 
preterm group. This seeming lack of task-dependent modulation of delta power 
in preterm participants may result from lack of task engagement. This cannot be 
ruled out, as causal models (or the direction of effect) were not tested directly. 
Yet, the participants overtly displaying a lack of task engagement, as 
highlighted by excessive error counts, were excluded from the analysis. Covert 
task disengagement, where individuals born preterm seem to be on task but 
experience a drift of attention, could, nevertheless, result in decreased cortical 
activity. Future research is needed to replicate and elucidate the lack of rest-to-
task transition effects in adolescents born preterm. 
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A few limitations should be considered along with the present results. Our 
sample of individuals born preterm was drawn from the general population and 
may differ from samples ascertained through clinics or support groups. Yet, a 
general population sample reduces the risk of referral and selection biases 
associated with clinical samples. As reflected in its above-average IQ, our 
control sample may not be fully representative of other typically developing 
adolescents. Another limitation of this study is that we examined cortical 
activation for the frequency bands alpha, beta, delta and theta. While some 
researchers have advocated abandoning fixed frequency bands (Klimesch, 
1999), the grouping of these frequencies into the particular bands has occurred 
historically and makes comparison between studies easier. Moreover, QEEG 
provides averaged measures of cortical activation across the resting-state and 
the cognitive task condition. To explore the various cognitive processes 
underlying cortical activation, future research may employ time-frequency 
analysis. For finer resolution and increased signal to noise ratio, future studies 
may further conduct source based analyses such as ICA. 
 
In conclusion, our results provide some of the first QEEG evidence for 
differences in oscillation patterns in the delta range, especially with regard to 
rest-to-task transition effects between term-born adolescents with ADHD and 
adolescents born preterm. Furthermore, our data indicate an important effect of 
age on EEG spectral power. Future large-scale studies are needed to elucidate 
how the cortical activation patterns observed in adolescents born preterm 
mediate cognitive impairments and clinical symptoms. To fully elucidate the 
discrepancies in rest-to-task transition effects between this and previous studies 
longitudinal studies of the trajectory of EEG spectral power development in 






Chapter 4. Neurophysiological impairments of attention 
and inhibition: a comparison of adolescents with ADHD 
and adolescents born preterm 
4.1 Abstract 
Background. Preterm birth has been associated with an increased risk for 
ADHD-like symptoms and cognitive impairments similar to those seen in ADHD, 
including attention and inhibitory control difficulties. Yet, data on direct 
comparisons across ADHD and preterm birth on cognitive-neurophysiological 
measures are limited. Methods. First, we directly compared 75 term-born 
adolescents with ADHD, 145 adolescents born preterm and 153 term-born 
control adolescents on cognitive-performance and event-related potential (ERP) 
measures associated with attentional and inhibitory processing from a cued 
continuous performance test (CPT-OX) to elucidate whether the ADHD-like 
symptoms and cognitive impairments in individuals born preterm reflect identical 
cognitive–neurophysiological impairments in term-born individuals with ADHD. 
Although age was statistically controlled in the analysis, we reran all analyses 
on a carefully age-matched subsample due to significant group mean 
differences in age and the possibility of strong age effects on ERP measures. 
This sub-sample comprised 36 term-born adolescents with ADHD, 94 preterm-
born and 63 control adolescents. Results. As demonstrated by differences in 
results between the full sample and the age-matched subsample, age had an 
effect on ERP measures. We, therefore, interpreted the group comparisons 
from the carefully age-matched analyses only. Go-P3 amplitude was reduced, 
reflecting impaired response execution, in preterm-born adolescents compared 
to both control adolescents and adolescents with ADHD. Moreover, in 
adolescents born preterm CNV amplitude was attenuated, reflecting 
impairments in response preparation, compared to controls but not compared to 
adolescents with ADHD. The preterm group demonstrated significantly reduced 
NoGo-P3 amplitude, reflecting impaired response inhibition, compared to the 
control group at Cz but the two groups did not differ significantly at FCz. The 
preterm group further showed significantly increased NoGo-P3 amplitude 
compared to the ADHD group at FCz but not at Cz. Compared to the control 
group, NoGo-P3 amplitude was attenuated in the ADHD group at Cz but not at 
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FCz. Conclusion. These findings indicate impairments in response preparation, 
response execution and response inhibition in adolescents born preterm. While 
the response inhibition impairments found in adolescents born preterm overlap 
with those found in term-born adolescents with ADHD, the preterm group also 
shows unique deficits, suggesting more wide-ranging deficits in the preterm 




Preterm birth has been associated with an increased risk for ADHD-like 
symptoms and cognitive impairments similar to those seen in ADHD, including 
attention and inhibitory control difficulties (Aarnoudse-Moens et al., 2009; 
Anderson et al., 2011; Geva & Feldman, 2008; Lawrence et al., 2009; Miskovic 
et al., 2009; Mulder et al., 2009; Nosarti et al., 2006; Wilson-Ching et al., 2013). 
Direct comparisons across ADHD and preterm birth, using identical measures, 
may elucidate whether the ADHD-like symptoms and cognitive impairments in 
preterm-born individuals reflect identical cognitive–neurophysiological 
impairments in term-born individuals with ADHD. 
 
Cognitive performance data alone provides only indirect insight into covert 
processing as various covert mechanisms may result in indistinguishable overt 
performance on cognitive tasks, and abnormal covert processing may underlie 
overt performance deficits or normal performance (Banaschewski & Brandeis, 
2007). The study of event-related potentials (ERPs), however, allows direct 
investigation of these covert brain processes with millisecond temporal 
resolution (see section 1.5.3.2. for discussion). Consequently, ERP measures 
may permit a sensitive comparison of the cognitive-neurophysiological profiles 
associated with ADHD and preterm birth (McLoughlin, Makeig, & Tsuang, 
2014). 
 
Impairments in attentional processing and response inhibition in ADHD have 
frequently been examined using ERP components obtained from the cued 
continuous performance test (CPT-OX). The CPT-OX comprises the 
presentation of cue (‘XOX’), target (Go; target ‘OXO’ preceded by a cue ‘XOX’) 
and non-target stimuli (NoGo; letters other than ‘OXO’ following a cue ‘XOX’) 
and entails a response to a target stimulus preceded by a cue (van Leeuwen et 
al., 1998). The CPT-OX yields electrophysiological indices of attentional 
orienting (Cue-P3) and response preparation (contingent negative variation; 
CNV) during the presentation of cue stimuli, electrophysiological indices of 
response execution (Go-P3) during Go trials, as well as electrophysiological 
indices of conflict monitoring (NoGo-N2) and response inhibition (NoGo-P3) 
during NoGo trials (Tye et al., 2011).  
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The fronto-central NoGo-P3, the third positive waveform following NoGo trials, 
has consistently shown reduced amplitude in children, adolescents and adults 
with ADHD (Albrecht et al., 2013; Banaschewski et al., 2003; Brandeis, 
Banaschewski, et al., 2002; Dhar et al., 2010; Doehnert et al., 2010; Fallgatter 
et al., 2004, 2005; McLoughlin et al., 2010; McLoughlin, Asherson, et al., 2011; 
Tye, Asherson, et al., 2014; Valko et al., 2009; van Leeuwen et al., 1998). 
Reduced amplitude of the parietal Cue-P3, as well as attenuated CNV 
amplitude, which is a late negative potential before the presentation of the next 
stimulus, have also been demonstrated in children, adolescents and adults with 
ADHD (Albrecht et al., 2013; Doehnert et al., 2010; McLoughlin et al., 2010; 
McLoughlin, Asherson, et al., 2011; Tye, Asherson, et al., 2014). However, not 
all studies have replicated these findings (Dhar et al., 2010). Few studies have 
directly investigated Go-P3 amplitude in individuals with ADHD and findings are 
inconsistent. Some studies report attenuated Go-P3 amplitude (Strandburg et 
al. 1996; Overtoom et al. 1998; Banaschewski et al. 2004; Lawrence et al. 
2005), while others show no case-control differences (Albrecht et al., 2013; 
Banaschewski et al., 2003; McLoughlin et al., 2010; van Leeuwen et al., 1998). 
Lastly, although conflict-monitoring deficits, indexed by attenuated amplitude of 
the frontally distributed N2, have been found in ADHD during high-conflict tasks, 
such as the flanker task (Albrecht et al., 2008; Gow et al., 2012; Johnstone et 
al., 2009; McLoughlin et al., 2009), case-control differences in N2 amplitude to 
non-target stimuli (NoGo-N2) are typically not found in the CPT-OX (McLoughlin 
et al., 2010; Yeung & Cohen, 2006). One study investigating ADHD case-
control differences on data partially overlapping with the current analysis 
reported attenuated amplitude of the CNV, Cue-P3 and NoGo-P3 in 
adolescents with ADHD compared to control adolescents (Cheung et al., 
2015a).  
 
While the neurophysiology of preterm-born infants in neonatal intensive care 
units (Meijer et al., 2014; Victor et al., 2005) and in the postnatal period 
(Beckwith & Parmelee, 1986; Duffy et al., 1990; González et al., 2011; 
Hayakawa et al., 2001; Vecchierini et al., 2007) are well researched, few ERP 
studies have been conducted in children, adolescents or adults born preterm. In 
auditory ERP studies, preterm-born children have demonstrated abnormalities 
in early sensory and attentional ERP components (mismatch negativity (MMN), 
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P1 and P3a) (Hövel et al., 2014; Mikkola et al., 2007, 2010). Larger N2 
amplitudes have also been found in 5-year-old children born very preterm (<32 
weeks) (Hövel et al., 2014; Mikkola et al., 2007). Despite initial evidence for 
impairments in ERP measures of attentional processing in preterm-born 
individuals, the research overall is limited. Moreover, no ERP study to date has 
investigated impairments in attentional processing and response inhibition in 
preterm-born individuals using the CPT-OX. Yet, the CPT-OX is a sensitive 
measure of the cognitive impairments seen in ADHD and preterm-born 
individuals are at increased risk for cognitive impairments similar to those linked 
to ADHD, including attention and inhibitory control difficulties (Aarnoudse-
Moens et al., 2009; Anderson et al., 2011; Geva & Feldman, 2008; Lawrence et 
al., 2009; Miskovic et al., 2009; Mulder et al., 2009; Nosarti et al., 2006; Wilson-
Ching et al., 2013).  
 
Direct comparisons on ERP measures in ADHD and preterm birth are scarce. 
One ERP study investigated attentional processing in very low birth weight 
children born preterm (<1501g and <34 weeks) with and without ADHD, as well 
as in term-born controls and term-born individuals with ADHD (Potgieter et al., 
2003). Term- and preterm-born children with ADHD, who showed increased 
mean reaction time (MRT) and reaction time variability (RTV), and who made 
more commission and omission errors on a visual oddball paradigm, also 
demonstrated an increased NoGo-N2 amplitude compared to term-born 
controls and preterm-born participants without ADHD. However, the sample 
size was small (N=41) and the test battery was restricted to a visual oddball 
task. No study to date has compared ERP components associated with 
attentional and inhibitory processing in both ADHD and preterm birth using the 
CPT-OX. In addition, despite major advances in neonatal care over the last few 
decades (Goldenberg et al. 2008), and the resulting possibility to study 
survivors of preterm birth, cognitive-performance and ERP measures remain to 
be assessed in adolescents born preterm.  
 
In the current study, we aim to directly compare cognitive-performance and 
ERP measures associated with attentional and inhibitory processing in 
adolescents with ADHD and adolescents born preterm, to establish whether the 
cognitive impairments associated with preterm birth, including attention and 
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inhibitory control difficulties, reflect identical neurophysiological impairments to 
those observed in term-born individuals with ADHD. Although the full sample 
consists entirely of adolescents, significant differences in age emerge between 
the groups (Table 4.1). To address this issue, age is controlled statistically in 
the analysis of the full sample. In addition, all analyses are rerun using a 
carefully age-matched subsample. If diverging results in the age-matched 
subsample emerge, the findings from the age-matched subsample, rather than 
from the full sample, are discussed and interpreted because of apparent age 
effects. We further aim to explore the effect of age on ERP measures within 
these three groups of the full sample using correlation analyses. 
 
4.3 Method  
4.3.1 Sample 
ADHD and control sibling pairs who had taken part in previous research (Chen 
et al., 2008; Kuntsi et al., 2010; Wood, Asherson, Rijsdijk, & Kuntsi, 2009), were 
invited to take part in a follow-up study (Cheung et al., 2015a, 2015b). All 
participants were of European Caucasian decent and had one or more full 
siblings available for ascertainment. Initially, participants with ADHD were 
included if they had a clinical diagnosis of DSM-IV combined-type ADHD during 
childhood. At follow-up, participants in the ADHD group were included if, as well 
as having an ADHD diagnosis in childhood, they met DSM-IV criteria for any 
ADHD subtype at follow-up. The control group was initially recruited from 
primary (ages 6–11 years) and secondary (ages 12–18 years) schools in the 
UK, aiming for an age- and sex-match with the ADHD sample. Control 
individuals were included in the study if they did not meet DSM-IV criteria for 
any ADHD subtype either in childhood or at follow-up. Exclusion criteria for both 
groups included IQ<70, autism, epilepsy, general learning difficulties, brain 
disorders and any genetic or medical disorder associated with externalising 
behaviours that might mimic ADHD.   
 
We followed up the sample on average 5.8 years (SD=1.1) after initial 
assessments. Siblings of individuals with ADHD were included in the ADHD 
group if they met DSM-IV criteria for any ADHD subtype at follow-up. Siblings of 
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control individuals were included in the control group if they did not meet DSM-
IV criteria for any ADHD subtype at follow-up. The ADHD and control groups 
were previously included in a study investigating ADHD case-control differences 
on cognitive and neurophysiological markers of ADHD persistence and 
remission (Cheung et al., 2015a). While ADHD-control differences for this 
sample have been reported previously, here, a subsample of the ADHD and 
control groups is compared to a group of preterm-born adolescents. 
 
At follow-up, six participants from the ADHD-sibling pair sample were excluded 
from the group analyses, as they had missing parent ratings of clinical 
impairment and their current ADHD status could not be determined. Two 
additional participants from the ADHD-sibling pair sample were excluded 
because they became very drowsy during the cognitive task and fell asleep. In 
two cases there was EEG equipment failure, resulting in the exclusion. Seven 
participants from the ADHD-sibling pair sample, who were born preterm, as well 
as 38 individuals from the ADHD-sibling pair sample, who provided no 
information about gestational age (GA), were also excluded. Two participants 
with childhood ADHD, who did not meet ADHD symptom criteria but met clinical 
levels of impairment at follow-up, were further excluded to minimize 
heterogeneity in the ADHD sample.  
 
Since age has an effect on ERP measures (Doehnert et al., 2010, 2013; 
Fallgatter, Mueller, & Strik, 1999; Zurrón, Lindín, Galdo-Alvarez, & Díaz, 2014)., 
we chose to also analyse a homogeneous group of participants with regard to 
age. For this subsample, we excluded an additional 37 individuals from the 
ADHD-sibling pair sample who fell outside the investigated age range (14-19 
years).  On average, the ADHD group was older than the preterm group.  
 
Forty-five participants from the control-sibling pair sample were excluded 
because no GA information was available. Six control participants were 
removed from the analyses for meeting DSM-IV ADHD criteria based on the 
parent-rated Barkley Informant Rating Scale (Barkley & Murphy, 2006). For the 
subsample analysis, an additional 66 participants from the control-sibling pair 
sample were excluded because they fell outside the investigated age range (14-
19 years). On average, the control group was older than the preterm group. 
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The preterm group was recruited from secondary schools in Southeast England. 
All preterm participants had one or more full siblings available for 
ascertainment, and were born before 37 weeks’ gestation. Siblings of 
individuals born preterm were included in the preterm group if they were born 
before 37 weeks’ gestation. Exclusion criteria for the preterm group included 
IQ<70, general learning difficulties, cerebral palsy and any other medical 
conditions that affects motor co-ordination including epilepsy. Three individuals 
born preterm were excluded because they showed insufficient 
understanding/engagement with the CPT-OX, as suggested by the testing notes 
and further indicated by extreme omission errors=17, 31 and 41 respectively, 
which were more than 3.5 SD from the mean (Tye et al., 2011; Tye, Asherson, 
et al., 2014). Seven individuals from the preterm-sibling pair sample were 
excluded because their GA was equal to or above 37 weeks; one individual was 
excluded because of an IQ<70 and 26 participants had to be excluded due to 
EEG equipment failure. For the subsample analysis, an additional 71 individuals 
from the preterm-sibling pair sample were excluded because they fell outside 
the investigated age range (14-19 years). On average, the preterm group was 
younger than the ADHD and control groups. Seven preterm-born individuals in 
the full sample and three preterm-born individuals in the age-matched 
subsample met diagnostic criteria for a research diagnosis of ADHD. Since, in 
this thesis, preterm birth is investigated as a potential risk factor for ADHD, 
individuals who were born preterm and also demonstrate high levels of ADHD 
symptoms are not excluded from this analysis. 
 
The final full sample consisted of 75 ADHD participants (six sibling pairs and 63 
singletons), 145 preterm-born participants (25 sibling pairs and 95 singletons) 
and 153 controls (69 sibling pairs and 15 singletons). The groups differed 
significantly in terms of age, IQ, gender distribution, GA and ADHD symptom 
scores (Table 4.1). As reported in chapter 3, the ADHD group showed 
significantly higher ADHD symptom scores than both the preterm (t=19.57, 
df=175, p<0.001) and control groups (t=-46.19, df=139, p<0.001). The preterm 
group further demonstrated significantly higher ADHD symptom scores than the 
control group (t=-8.85, df=178, p<0.001). Age was included as a covariate in all 
analyses. All analyses were rerun with IQ as an additional covariate. Gender 
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was not included as a covariate in the group analyses to avoid controlling for 
ADHD status (Cheung et al., 2015a). Written informed consent was obtained 
and the studies were approved by the London-Surrey Borders Research Ethics 
Committee (09/H0806/58) and the National Research Ethics Service Committee 
London – Bromley (13/LO/0068). 
 
Table 4.1. Descriptive statistics. 
 
The final age-matched subsample consisted of 36 ADHD participants (five 
sibling pairs and 26 singletons), 94 preterm-born participants (13 sibling pairs 
and 68 singletons) and 63 controls (eight sibling pairs and 47 singletons). The 
groups did not differ in terms of age or IQ (Table 4.1). Significant differences in 
gender distribution, GA and ADHD symptom scores were observed. As reported 
in chapter 3, the ADHD group showed significantly higher ADHD symptom 
 ADHD Preterm Control Statistic p-value 
Full sample n=75 n=145 n=153 - - 
GA in weeks 
(SD) 39.9 (1.4) 33.2 (2.8) 40.0 (1.2) z=-19.9    <0.001 
IQ (SD) 97.1(13.7) 104.2 (12.5) 110.3 (12.5) z=-2.4      0.015 
Age (SD) 18.5 (2.9) 15.3 (1.9) 17.8 (2.1) z=-8.1 <0.001 
Age range 12.7-25.9 11.0-20.0 11.9-21.6 - - 
Males % 86.7 51.0 75.6 F2=34.4 <0.001 
ADHD symptom 
score 14.0 (3.0) 3.6 (4.0) 0.0 (0. 0) t=   6.3  <0.001 
Age-matched 
subsample n=36 n=94 n=63 - - 
GA in weeks 
(SD) 39.72 (1.3) 33.5 (2.4) 40.0 (1.10) z=-18.0    <0.001 
IQ (SD) 96.4 (14.0) 103.6 (13.2) 108.0 (12.4) z=-1.6      0.112 
Age (SD) 16.6 (1.5) 16.4 (1.1) 16.7 (1.0) z=-1.7      0.082 
Age range 14.1-18.9 14.8-18.8 14.4-18.1 - - 
Males % 88.9 44.7 47.5 F2=24.1 <0.001 
ADHD symptom 
score 14.2 (3.0) 3.5 (3.8) 0.0 (0.0) t=   3.4 <0.001 
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scores than both the preterm (t=14.62, df=113, p<0.001) and the control groups 
(t=-35.25, df=84, p<0.001). The preterm group further demonstrated 
significantly higher ADHD symptom scores than the control group (t=-6.72, 
df=133, p<0.001). Gender was not included as a covariate in the group 
analyses to avoid controlling for ADHD status (Cheung et al., 2015a). 
 
4.3.2 Procedure  
Participants attended a single 4.5 h research session, which included an EEG 
assessment, an IQ test and clinical interviews. As part of the EEG assessment, 
participants completed a CPT with flankers (CPT-OX) (Doehnert et al., 2010; 
McLoughlin et al., 2010; McLoughlin, Asherson, et al., 2011). The task was 
preceded by two 3-minute resting-state recordings and was the first of three 
cognitive-EEG tasks to be conducted during the testing session. Participants 
were requested to remain as still as possible, and keep their eyes on a fixed 
point in front of them for the duration of the recording. A 48 h ADHD medication-
free period was required before the research session. 
 
4.3.3 Measures 
4.3.3.1 ADHD diagnosis 
In the ADHD group, ADHD was assessed using parental ADHD symptom 
ratings on the Diagnostic Interview for ADHD in adults (DIVA) (Kooij & 
Francken, 2007) and the Barkley’s functional impairment scale (BFIS) (Barkley 
& Murphy, 2006). The DIVA is a semi-structured interview designed to evaluate 
the DSM-IV criteria for both adult and childhood ADHD symptoms and 
impairment. It consists of 18 items used to define the DSM-IV symptom criteria 
for ADHD. Each item is scored affirmatively if the behavioural symptom was 
present often within the past six months. Based on DSM-IV criteria, a research 
diagnosis of ADHD was made if participants scored six or more on either the 
inattention or hyperactivity-impulsivity subscales of the DIVA and if they 
received two or more positive scores on two or more areas of impairment on the 
BFIS. In the preterm group, ADHD was assessed using parental ADHD 
symptom ratings on the DIVA (Kooij & Francken, 2007). A research diagnosis of 
 122 
ADHD was made if participants scored six or more on the inattention or 
hyperactivity-impulsivity subscales of the DIVA.  
 
4.3.3.2 IQ 
The vocabulary and block design subtests of the Wechsler Abbreviated Scale of 
Intelligence Fourth Edition (WASI-IV) (Wechsler, 1999) were administered to all 
participants to derive an estimate of IQ. 
 
4.3.3.3 Cued continuous performance task with flankers 
The CPT-OX is a cued Go/NoGo task that probes attention, preparation and 
response inhibition. The task consisted of 400 black letter arrays, made up of a 
centre letter and incompatible flankers on each side to increase difficulty. The 
presented arrays included the cue letter ‘O’, the target letter ‘X’ as well as the 
distractors ‘H’, ‘B’, ‘C’, ‘D’, ‘E’, ‘F’, ‘G’, ‘J’ and ‘L’. Letters were presented 
centrally on the computer monitor, subtending approximately 5°. Cue and target 
letters (‘O’ and ‘X’ respectively) were flanked by incompatible letters (‘XOX’ and 
‘OXO’ respectively). Participants were instructed to ignore the flanking letters 
and respond as quickly as possible to cue-target sequences (‘O’-‘X’). 80 cues 
(‘XOX’) were followed by the target (‘OXO’) in 40 trials (Go condition), and by 
neutral distractors in the remainder of trials (NoGo condition). On 40 trials, the 
target letter ‘X’ was not preceded by a cue ‘O’ and had to be ignored. Letters 
were presented every 1.65 s for 150 ms in a pseudo-randomised order. Ten 
practice trials preceded the main task and were repeated, if required, to ensure 
participant comprehension. Participants were instructed to respond only to Cue-
Go sequences by pressing a button as quickly as possible with the index finger 
of their preferred hand. Participants were further asked to withhold the response 
in the presence of a NoGo stimulus, in the presence of a Go stimulus not 
preceded by a cue, or in the presence of any other irrelevant letters. Task 
duration was 11 min. 
 
Cognitive-performance measures obtained from the CPT-OX included target 
MRT (i.e. mean latency of responding in milliseconds after target onset), RTV 
(measured as standard deviation of target reaction time) and number of errors. 
MRT and RTV were obtained from correct Go trials. Errors included total 
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omission errors (non-responses to Go trials) and total commission errors 
(responses to Cue, NoGo or distractor stimuli).  
 
4.3.4 Electrophysiological recording and analysis 
The EEG was recorded from a 62 channel direct-current-coupled recording 
system (extended 10–20 montage), using a 500 Hz sampling-rate, impedances 
under 10 kΩ, and FCz as the recording reference. The electro-oculograms were 
recorded from electrodes above and below the left eye and at the outer canthi. 
The EEG data were analysed using Brain Vision Analyzer 2.0 (Brain Products, 
Germany). Researchers were blind to group status during EEG pre-processing 
and analysis. Raw EEG recordings were down-sampled to 256 Hz, re-
referenced to the average of all electrodes, and digitally filtered using 
Butterworth band-pass filters (0.1-30 Hz, 24 dB/oct). All trials were also visually 
inspected for electrical artefacts (due to electrical noise in the EEG recording) or 
obvious movement, and sections of data containing artefacts were removed 
manually. Ocular artefacts, corresponding to blink-related and vertical and 
horizontal eye movements, were identified using the infomax Independent 
Component Analysis (ICA) algorithm (Jung et al., 2000), which allows for 
removal of the components associated with ocular artefacts by back-projection 
of all but those components. Sections of data with remaining artefacts 
exceeding ± 100 μV in any channel or with a voltage step greater than 50 μV 
were automatically rejected.  
 
For the CPT, stimulus-locked epochs (stimulus window from −200 to 1650 ms) 
were averaged based on three different response conditions: Cue, Go and 
NoGo. Averages were calculated for trials with correct responses (Go) or 
correctly rejected trials (NoGo and Cue), which included at least 20 clean 
segments. Based on previous research (Albrecht et al., 2013; Doehnert et al., 
2013; McLoughlin et al., 2010), ERP measures were identified within selected 
electrodes and latency windows for which effects were expected to be largest. 
These measures were then confirmed separately for the three groups using 
topographic maps.  
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ERPs were measured as the mean amplitude in a given latency window. In Cue 
trials, the P3 was measured at Pz between 300-650 ms, and the CNV was 
measured at Cz between 1300-1650 ms. In Go trials, the P3 was measured at 
Pz between 250-500 ms. No clear N2 was observed in Go trials, consistent with 
other studies employing tasks with low conflict-monitoring demands (Bokura, 
Yamaguchi, & Kobayashi, 2001; Gajewski & Falkenstein, 2013) and was, 
therefore, not included in the analysis. In NoGo trials, the P3 was measured at 
Cz and FCz between 250-550 ms and the N2 was measured at Fz between 
175-325 ms.  
 
Whereas ERP components with baseline correction are thought to represent the 
absolute change in neural activity elicited by the stimulus, ERP components 
without baseline correction are thought to reflect the absolute state of neural 
activity measured at a given time (Brandeis & Lehmann, 1986). Here, results 
are presented and interpreted without baseline correction since most previous 
ERP analyses on CPT-OX did not apply a baseline correction (Albrecht et al., 
2013; Banaschewski et al., 2004; Doehnert et al., 2013; McLoughlin et al., 
2010; McLoughlin, Asherson, et al., 2011), including the study partially 
overlapping with the current analysis (Cheung et al., 2015a). Moreover, there is 
evidence to suggest that this approach may distort post-stimulus topographies 
(Brandeis & Lehmann, 1986; Koenig & Gianotti, 2009). However, to enable 
comparison to analyses where such corrections have been applied, and to 
explore whether our results change, analyses were rerun with baseline 
correction in the age-matched sample (see Appendix 2).  
 
4.3.5 Statistical analysis 
Five participants with ADHD were excluded from the ERP analysis of the Go 
and NoGo condition and two participants with ADHD were excluded from the 
ERP analysis of the Cue condition due to having fewer than 20 artefact-free 
segments available for analysis. Four preterm-born participants were excluded 
from the ERP analysis of the NoGo and Cue condition and twelve preterm-born 
participants were excluded from the ERP analysis of the Go condition due to 
having fewer than 20 artefact-free segments available for analysis. Two control 
participants were excluded from the ERP analysis of the NoGo condition and 
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three control participants were excluded from the ERP analysis of the Go 
condition due to having fewer than 20 artefact-free segments available for 
analysis. 
 
Data were analysed using random intercept models in Stata, to control for non-
independence of the data, i.e. data coming from siblings of one family, using a 
‘robust cluster’ command to estimate standard errors (Tye et al., 2012; Wood et 
al., 2009). This command was not available for correlational analyses, which 
were conducted to investigate the effect of age on ERP measures in the full 
sample. For these analyses siblings were removed from the ADHD (n=6), 
preterm (n=25) and control group (n=69) of the full sample. Post-hoc t-tests 
were conducted using the ‘cltest’ command (Herrin, 2012) to control for the non-
independence of the data. Bonferroni correction was implemented to correct for 
multiple testing with a Bonferroni adjusted p-value=0.01. Effect sizes (Cohen’s 
d), which were calculated using the difference in the means divided by the 
pooled standard deviation (Cohen, 1988), are also reported. According to 
Cohen (1988), d=0.20 constitutes a small effect, d=0.50 a medium effect and 
d=0.80 a large effect.  
 
As groups differed with regard to age in the full sample, age was included as a 
covariate in the analysis in the full sample. Groups in the full sample further 
differed in terms of IQ. Therefore, all analyses in the full sample were 
subsequently re-ran with IQ as a covariate, but results and significant levels did 
not change. In the age-matched subsample age was not included as a covariate 
since all three groups were matched on age. Although the groups in both the full 
sample and the age-matched subsample differed significantly on gender, 
gender was not included as a covariate in the group analyses to avoid 




4.4.1 Full sample 
4.4.1.1 Cognitive-performance measures 
A trend-level significant effect of group emerged for RTV (t=2.73, df=254, 
p=0.007). Post-hoc analyses revealed no significant difference between the 
ADHD and preterm groups (t=1.94, df=160, p=0.055). However, the ADHD (t=-
7.09, df=160, p<0.001) and preterm groups (t=-5.83, df=184, p<0.001) showed 
significantly increased RTV compared to the control group, with large effect 
sizes (d=1.07 and d=0.79 respectively) (Table 4.2). Groups did not differ on 
MRT (t=1.57, df=254, p=0.119).  
 
A significant effect of group emerged for the number of total omission errors 
(t=2.54, df=254, p=0.012). Post-hoc analyses revealed no significant difference 
between the ADHD and preterm groups with regard to total omission errors 
(t=1.14, d=160, p=0.257). However, the ADHD (t=-4.65, d=160, p<0.001) and 
preterm groups (t=-2.19, d=184, p=0.030) made significantly more omission 
errors than the control group, with moderate-to-large (d=0.69) and small-to-
moderate (d=0.30) effect sizes respectively (Table 4.2). No significant effect of 
group emerged for the number of total commission errors (t=-0.27, df=254, 
p=0.787).  
 
4.4.1.2 ERP results 
4.4.1.2.1 Cue condition 
No significant main effect of group emerged for Cue-P3 amplitude (z=-1.66, 
p=0.096). The random intercept model yielded a significant main effect of group 
for CNV amplitude (z=4.62, p<0.001). Post-hoc tests revealed that the preterm 
group in the full sample demonstrated significantly attenuated CNV amplitude 
compared to the control group (t=-4.25, df=203, p<0.001), with moderate effect 
size (d=0.51) (Table 4.2), but not compared to the ADHD group (t=0.25, df=177, 
p=0.804). The ADHD group showed significantly attenuated CNV amplitude 
compared to the control group (t=-4.24, df=158, p<0.001), with a moderate-to-
large effect size (d=0.61) (Table 4.2). 
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4.4.1.2.2 Go condition 
No significant main effect of group emerged for Go-P3 amplitude (z=-2.28, 
p=0.02).  
 
4.4.1.2.3 NoGo condition 
The random intercept model yielded no significant main effect of group for 
NoGo-N2 amplitude (z=-1.50, p=0.133). For NoGo-P3 amplitude, no significant 
main effect of group (z=-2.34, p=0.015) or recording site (FCz and Cz) (z=0.45, 
p=0.652) emerged. However, a significant group-by-recording site interaction 
emerged for NoGo-P3 amplitude (z=5.70, p<0.001). Post-hoc tests revealed 
that the preterm group showed significantly increased NoGo-P3 amplitude 
compared to the ADHD group at FCz (t=-2.87, df=162, p=0.024), with small-to-
moderate effect size (d=0.45) (Table 4.2), but not at Cz (t=-0.30, df=199, 
p=0.769). In addition, the preterm group demonstrated significantly reduced 
NoGo-P3 amplitude compared to the control group at Cz (t=4.08, df=200, 
p<0.001), with moderate effect size (d=0.55) (Table 4.2), but the two groups did 
not differ significantly at FCz (t=-1.14, df=160, p=0.255). The ADHD group 
demonstrated significantly reduced NoGo-P3 amplitude compared to the control 
group at Cz (t=3.90, df=155, p<0.001), with moderate-to-large effect size 





 Table 4.2. Cognitive and ERP measures from the CPT-OX: means (SDs) and effect sizes (Cohen’s d) for the ADHD, preterm and control groups. 
Note: Large effect sizes in bold; *p<0.05; ADHD=attention-deficit/hyperactivity disorder; MRT=mean reaction time in ms; RTV=reaction time variability in ms; 
OE=omission errors; CE=commission errors; CNV=contingent negative variation. 





ADHD vs. Preterm 
effect size (d) 
ADHD vs. Control 
effect size (d) 
Preterm vs. Control  
effect size (d) 
MRT - 417.23 (69.0) 400.93 (72.2) 386.84 (48.1) 0.23* 0.55* 0.24* 
RTV - 111.52  (58.3) 95.95 (49.6) 59.69 (43.8) 0.29* 1.07* 0.79* 
OE - 2.48 (3.9) 1.69 (4.4) 0.77 (1.5) 0.19* 0.69* 0.30* 
CE - 1.70 (2.3) 1.33 (2.8) 0.91 (1.4) 0.14* 0.46* 0.20* 
Cue-P3 Pz 5.24 6.91 6.35 0.47* 0.43* 0.18* 
CNV Cz -2.71 -2.81 -3.81 0.05* 0.61* 0.51* 
Go-P3 Pz 8.59 8.72 9.64 0.03* 0.27* 0.21* 
NoGo-P3 FCz 6.26 8.36 7.55 0.45** 0.29* 0.17* 
 Cz 6.35 6.84 9.06 0.12* 0.68* 0.55* 
NoGo-N2 Fz -5.45 -5.66 -5.67 0.06* 0.07* 0.03* 
Age-matched 







ADHD vs. Preterm  
effect size (d) 
ADHD vs. Control  
effect size (d) 
Preterm vs. Control  
effect size (d) 
MRT - 412.50 (51.5) 391.44 (70.7) 386.44 (43.9) 0.32* 0.56* 0.08* 
RTV - 110.53 (54.3) 86.51 (47.2) 84.40 (38.8) 0.48* 0.58* 0.05* 
OE - 2.58 (4.2) 0.80 (1.5) 0.81 (1.9) 0.66* 0.60* 0.00* 
CE - 1.50 (2.0) 0.84 (1.7) 0.98 (1.4) 0.36* 0.31* 0.09* 
Cue-P3 Pz 5.50 (3.7) 5.88 (3.0) 6.55 (2.5) 0.12* 0.36* 0.24* 
CNV Cz -3.29 (1.5) -2.82 (2.0) -3.77 (1.9) 0.25* 0.28* 0.49* 
Go-P3 Pz 9.90 (3.6) 7.63 (5.0) 10.36 (3.8) 0.46* 0.12* 0.57* 
NoGo-P3 FCz 6.26 (4.1) 8.87 (5.9) 7.55 (5.3) 0.59* 0.29* 0.28* 
 Cz 7.49 (4.9) 7.05 (5.3) 9.44 (4.1) 0.10* 0.44* 0.59* 
NoGo-N2 Fz -5.44 (3.3) -5.04 (3.6) -4.78 (3.2) 0.11* 0.24* 0.11* 
 129 
4.4.1.3 Correlation results 
Correlational analyses were conducted to investigate the effect of age on ERP 
measures. In the ADHD group, significant negative correlations emerged 
between age and Cue-P3 amplitude, as well as between age and Go-P3 
amplitude (Table 4.3). A trend-level significant negative correlation emerged 
between age and NoGo-P3 amplitude at FCz. No significant correlations 
emerged between age and amplitude of the CNV, NoGo-P3 at Cz and NoGo-
N2 (Table 4.3).  
 
In the preterm group, significant correlations emerged between age and Cue-P3 
amplitude, between age and Go-P3 amplitude as well as between age and 
NoGo-N2 amplitude (Table 4.3). No significant correlations emerged between 
age and amplitude of the CNV, NoGo-P3 at FCz and NoGo-P3 at Cz (Table 
4.3).  
 
In the control group, significant correlations emerged between age and Go-P3 
amplitude as well as between age and NoGo-N2 amplitude (Table 4.3). A trend-
level significant negative correlation emerged between age and NoGo-P3 
amplitude at Cz. No significant correlations emerged between age and 
amplitude of the Cue-P3, CNV and NoGo-P3 at FCz (Table 4.3). These 
correlations suggest that age has at least some effect on certain ERP measures 
and highlight the importance of additional analyses on more closely age-
matched groups. 
 
Table 4.3. Correlations between event-related potential (ERP) parameters and 
age across the ADHD, preterm and control groups of the full sample. 
Note: *p<0.05, **p<0.01; CNV=contingent negative variation. 
Full sample Site       ADHD  Preterm  Control  
Cue-P3 Pz -0.43*** -0.40** -0.14** 
CNV Cz 0.11** -0.03** 0.15* 
Go-P3 Pz -0.45*** -0.31** -0.28** 
NoGo-P3 FCz -0.37 ** 0.02* -0.16 * 
 Cz 0.05 * 0.12* -0.25 * 
NoGo-N2 Fz -0.07  * 0.21* 0.42* 
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4.4.2 Age-matched sample 
4.4.2.1 Cognitive-performance measures 
No significant effect of group emerged for RTV (t=-0.33, df=155, p=0.745). 
Moreover, groups did not differ on MRT (t=-0.46, d=155, p=0.643), number of 
total omission errors (t=-0.53, df=155, p=0.595) or number of total commission 
errors (t=-1.16, df=155, p=0.247). The moderate-to-large effect sizes for MRT, 
RTV and omission error between the ADHD and control groups (d=0.56-0.60), 
as well as between the ADHD and preterm groups (d=0.32-0.66) (Table 4.2) 
indicate that the lack of significant group differences likely results from an issue 
with statistical power.  
 
4.4.2.1.1 Cue condition 
No significant main effect of group emerged for Cue-P3 amplitude (z=-1.48, 
p=0.138). The random intercept model yielded a significant main effect of group 
for CNV amplitude (z=3.31, p<0.001) (Figure 4.1). Post-hoc tests revealed that 
the preterm group demonstrated significantly attenuated CNV amplitude 
compared to the control group (t=-2.90, df=138, p=0.004), with moderate effect 
size (d=0.49) (Table 4.2), but not compared to the ADHD group (t=-1.23, 
df=115, p=0.220). The ADHD and control groups did not differ significantly with 
regard to CNV amplitude (t=-1.32, df=87, p=0.191).  
 
4.4.2.1.2 Go condition 
A significant main effect of group emerged for Go-P3 amplitude (z=-3.43, 
p<0.001) (Figure 4.2). Post-hoc tests revealed significantly reduced Go-P3 
amplitude in the preterm group compared to the control (t=3.40, df=144, 
p<0.001) and ADHD groups (t=2.18, df=115, p=0.03), with moderate (d=0.57, 
d=0.46 respectively) effect sizes (Table 4.2). The ADHD and control groups did 
not differ with regard to Go-P3 amplitude (t=0.56, df=89, p=0.575).  
 
4.4.2.1.3 NoGo condition 
No significant main effect of group emerged for NoGo-N2 amplitude (z=-0.50, 
p=0.617). No significant main effect of group (z=-0.76, p=0.447) or recording 
site (FCz and Cz) (z=0.10, p=0.924) emerged for NoGo-P3 amplitude. 
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However, a significant group-by-recording site interaction emerged for NoGo-P3 
amplitude (z=5.80, p<0.001) (Figure 4.3). Post-hoc tests revealed that the 
preterm group showed significantly increased NoGo-P3 amplitude compared to 
the ADHD group at FCz (t=-2.85, df=107, p=0.005), with moderate effect size 
(d=0.59) (Table 4.2), but not at Cz (t=0.30, df=108, p=0.763). In addition, the 
preterm group demonstrated significantly reduced NoGo-P3 amplitude 
compared to the control group at Cz (t=3.53, df=147, p<0.001), with moderate 
effect size (d=0.59), but the two groups did not differ significantly at FCz (t=-
1.74, df=130, p=0.084). The ADHD group demonstrated significantly reduced 
NoGo-P3 amplitude compared to the control group at Cz (t=2.34, df=130, 




















Figure 4.1. (A) Grand average event-related potentials (ERPs) to Cue stimuli at the Cz electrode in the age-matched subsample, showing the 
CNV in the 1300-1650 ms window (ADHD, attention-deficit/hyperactivity disorder shown in black; the preterm group shown in blue; and the control 
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Figure 4.2. (A) Grand average event-related potentials (ERPs) to Go stimuli at the Pz electrode in the age-matched subsample, showing the Go-
P3 in the 250-500 ms window (ADHD, attention-deficit/hyperactivity disorder shown in black; the preterm group shown in blue; and the control group 


































Figure 4.3. (A) Grand average event-related potentials (ERPs) to NoGo stimuli at the FCz (above) and Cz (below) electrodes in the age-matched 
subsample, showing the NoGo-P3 in the 250-500 ms window (ADHD, attention-deficit/hyperactivity disorder shown in black; the preterm group shown 




















Here, we directly compared term-born adolescents with ADHD, adolescents 
born preterm and term-born control adolescents on cognitive-performance and 
ERP measures from the CPT-OX. Since we demonstrated differences between 
the full sample and the age-matched subsample, as well as an effect of age on 
certain ERP components, the following discussion of results is based on the 
age-matched subsample. We provide evidence for response preparation (CNV), 
response execution (Go-P3) and response inhibition (NoGo-P3) impairments in 
individuals born preterm. While the observed response execution (Go-P3) 
impairments represent preterm birth-specific deficits, response inhibition (NoGo-
P3) impairments were also observed in individuals with ADHD. With regard to 
response preparation (CNV), the ADHD group appears to lie intermediate 
between the preterm and control groups. The current study constitutes the first 
cognitive-neurophysiological comparison of attentional and inhibitory processing 
in term-born adolescents with ADHD and adolescents born preterm using the 
CPT-OX, and furthers our understanding of response preparation, execution 
and inhibition impairments in adolescents born preterm. 
 
Our ERP results show a significant group difference in the amplitude of the P3 
in response to Go stimuli, which was reduced in preterm-born adolescents 
compared to the other two groups. The Go-P3 has been linked to several 
attentional functions, such as evaluation of stimuli and resource allocation (Kok, 
2000; Polich & Kok, 1995), and may reflect aspects of executive response 
control (Albrecht et al., 2013). Our results indicate, therefore, that adolescents 
born preterm show impaired response execution compared to adolescents with 
ADHD and control adolescents. Although an association between preterm birth 
and lower mean IQ scores has consistently been reported (Kerr-Wilson et al., 
2012), our finding of a preterm birth-specific deficit is unlikely due to lower 
general cognitive ability since the preterm group of this study did not differ 
significantly from the control group on IQ scores and including IQ as a covariate 
had no effect on the results. However, since this is the first investigation of its 
kind, the findings of reduced Go-P3 amplitude in preterm-born adolescents 
require replication. In line with previous research, we found no Go-P3 
differences between the ADHD and control groups (Albrecht et al., 2013; 
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Banaschewski et al., 2003; McLoughlin et al., 2010; van Leeuwen et al., 1998), 
although Go-P3 reductions have been reported in a small number of ADHD 
studies (Strandburg et al. 1996; Overtoom et al. 1998; Banaschewski et al. 
2004; Lawrence et al. 2005). 
 
Response inhibition impairments, as indexed by abnormal NoGo-P3 amplitude, 
were observed in both preterm-born adolescents and adolescents with ADHD. 
A study investigating ADHD case-control differences on data partially 
overlapping with the current analysis previously reported attenuated amplitude 
of the NoGo-P3, as well as reduced CNV and Cue-P3 amplitude in adolescents 
with ADHD compared to control adolescents (Cheung et al., 2015a). The 
significant group-by-recording site interactions in the current study, supported 
by topographic maps of NoGo-P3 mean amplitude, indicate a degree of group-
specificity in relation to the response inhibition impairments. While both the 
ADHD and preterm groups demonstrated significantly reduced NoGo-P3 
amplitude compared to controls at the vertex, the preterm group showed a more 
frontally distributed NoGo-P3 component compared to adolescents with ADHD 
and controls, which was significantly increased compared to the ADHD group. 
These findings extend previous cognitive research, which has indicated deficits 
in response inhibition in individuals born preterm (Burnett et al., 2015; Mulder et 
al., 2009; Nosarti et al., 2007; Stålnacke et al., 2014; Taylor et al., 2004). The 
reduced P3 amplitude in response to NoGo stimuli in the ADHD group 
compared to controls replicates a pattern of impaired response inhibition that is 
well established in the ADHD literature (Albrecht et al., 2013; Doehnert et al., 
2013; McLoughlin et al., 2010; McLoughlin, Asherson, et al., 2011). Although 
ADHD symptom scores were increased in the preterm group compared to 
controls (as previously reported in chapter 3), further analyses will need to 
elucidate how the ADHD symptoms in the preterm group are related to 
performance on cognitive-neurophysiological measures such as the NoGo-P3, 
which presents shared impairments between the ADHD and preterm groups. 
Future research should also examine whether the performance of preterm-born 
individuals on the cognitive-neurophysiological measures investigated here is 
related to other psychiatric symptoms.  
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We further identified CNV abnormalities in the preterm group compared to the 
control group, suggestive of impaired attentional orienting and response 
preparation (van Leeuwen et al., 1998). The attenuated CNV amplitude in 
adolescents born preterm is in accordance with previous evidence of 
abnormalities in attentional orienting as indexed by a reduced P3a component 
during a distraction paradigm in children born preterm (Mikkola et al., 2010). 
The ADHD group demonstrated response preparation that was intermediate 
between that of the preterm and control groups. Previous studies have reported 
reduced CNV in children, adolescents and adults with ADHD (Albrecht et al., 
2013; Doehnert et al., 2013; McLoughlin, Asherson, et al., 2011). The lack of 
significant CNV abnormalities in the ADHD group is, therefore, inconsistent with 
previous work. However, not all studies have reported ADHD case-control 
differences in CNV amplitude (Tye, Asherson, et al., 2014; van Leeuwen et al., 
1998), possibly due to developmental changes in the amplitudes (Jonkman, 
Lansbergen, & Stauder, 2003; Jonkman, 2006; Segalowitz & Davies, 2004) and 
topographies of the CNV (Klein & Feige, 2005). The non-significant finding with 
regard to CNV in the ADHD group may, therefore, be due to developmental 
changes. This idea is supported by analyses of the full sample, which revealed 
reduced CNV amplitude with moderate effect size compared to the control 
group. 
 
The lack of a difference between the three groups with regard to NoGo-N2 
amplitude is inconsistent with previous research demonstrating abnormalities in 
NoGo-N2 amplitude in children born very preterm (<32 weeks) using an auditory 
oddball paradigm (Hövel et al., 2014; Mikkola et al., 2007), as well as in 
individuals with ADHD using flanker tasks (Albrecht et al., 2008; Johnstone et 
al., 2009; McLoughlin et al., 2009). However, the CPT-OX is a task with low 
conflict-monitoring demands and previous studies using the CPT-OX have also 
not been able to demonstrate an attenuated NoGo-N2 in individuals with ADHD 
(Albrecht et al. 2013; Doehnert et al. 2013; McLoughlin et al. 2010). Similarly, 
we found no difference in Cue-P3 amplitude between adolescents with ADHD 
and control adolescents. While these findings do not replicate some previous 
investigations showing a reduced Cue-P3 in children, adolescents and adults 
with ADHD (Albrecht et al., 2013; Doehnert et al., 2010; McLoughlin et al., 
2010; McLoughlin, Asherson, et al., 2011; Tye, Asherson, et al., 2014), they are 
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in line with other studies reporting no case-control difference in Cue-P3 in adults 
with ADHD (Dhar et al., 2010; Michelini et al., 2015). Age effects may play a 
role in the discrepancy between studies since developmental changes have 
been reported for the Cue-P3, suggesting that ADHD-control differences may 
decline with age (Doehnert et al. 2013). Further studies should investigate the 
differences between ADHD and preterm birth in tasks with higher conflict-
monitoring demands as well as in longitudinal studies to clarify potential age-
effects. 
 
While ERP measures of response inhibition and response execution 
differentiated the ADHD, preterm and control groups, cognitive-performance 
data did not suggest differences between the groups. Yet, the effect sizes 
between the ADHD and control groups, as well as between the ADHD and 
preterm groups, indicate that the lack of significant group differences likely 
results from a lack of statistical power to detect these differences. According to 
effect sizes, MRT, RTV and omission errors are increased in ADHD compared 
to both the preterm and control groups, consistent with previous research 
reporting lower accuracy and higher MRT and RTV in ADHD (Kuntsi & Klein, 
2012; Kuntsi et al., 2010). Differences between the ADHD and preterm groups 
observed at the neurophysiological but not at the cognitive-performance level 
may indicate greater specificity of the neurophysiological markers in detecting 
differences between these groups.  
 
Here, results were presented and interpreted without baseline correction since 
most previous ERP analyses on CPT-OX did not apply a baseline correction 
(Albrecht et al., 2013; Banaschewski et al., 2004; Doehnert et al., 2013; 
McLoughlin et al., 2010; McLoughlin, Asherson, et al., 2011), including the 
study partially overlapping with the current analysis (Cheung et al., 2015a). 
Additional analyses with baseline corrections were run in the age-matched 
sample to enable comparison to analyses where such corrections were applied. 
Baseline corrections did not affect the results with regard to group differences, 
except for group differences on the CNV, which became non-significant. Since 
the baseline correction process subtracts the mean prestimulus voltage from 
the ERP waveform, it is not surprising that group differences on the CNV, a 
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prestimulus ERP component that represents response preparation, became 
non-significant. 
 
Certain limitations should be taken into consideration. Our sample of individuals 
born preterm may not generalise to clinical samples or samples established 
through support groups, as it was drawn from the general population. Yet, a 
general population sample reduces the risk of referral and selection biases 
associated with clinical samples. In addition, as reflected in its above average 
IQ, the control sample may also not be fully representative of other typically 
developing adolescents. Furthermore, we were unable to examine component 
latency due to adopting a mean amplitude measure. A mean amplitude 
measure has the advantage of being more robust than a peak amplitude 
measure with regard to the high intra-individual variability across trials common 
in ADHD, which may reduce the amplitude of ERP components (McLoughlin, 
Makeig, et al., 2014). 
 
In conclusion, this study provides evidence for impairments in brain processes 
involved in response preparation, response execution and response inhibition in 
adolescents born preterm. While some of the impairments found in adolescents 
born preterm overlap with those found in term-born adolescents with ADHD, the 
preterm group also shows unique deficits, indicating more wide-ranging deficits 
in the preterm group compared to the ADHD group. This idea is supported by 
research suggesting that, as well as being a risk factor for ADHD, preterm birth 
presents a risk factor for other psychiatric disorders, such as schizophrenia, 
bipolar disorder and autism spectrum disorder (D’Onofrio et al., 2013; 
Samantha Johnson & Marlow, 2014; Moster et al., 2008; Treyvaud et al., 2013). 
The late third trimester (32–40 weeks’ gestation) serves as a critical period to 
lay the foundation of vital brain networks (Ball et al., 2014; van den Heuvel et 
al., 2014). It is, therefore, conceivable that preterm birth may result in trauma to 
the brain networks associated with ADHD, as well as networks associated with 
additional impairments. These results, as well as the findings that ADHD 
symptom scores are increased in the preterm group compared to controls, 
suggest that preterm birth may present a risk factor for both ADHD and 
additional impairments. As this is one of the first studies of this kind, these 
findings require replication in larger-scale studies. 
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Chapter 5. A longitudinal twin study of the direction of 
effects between ADHD symptoms and IQ 
  
RESEARCH ARTICLE
A Longitudinal Twin Study of the Direction of
Effects between ADHD Symptoms and IQ
Anna Sophie Rommel1, Frühling Rijsdijk1, Corina U. Greven1,2,3, Philip Asherson1,
Jonna Kuntsi1*
1 King’s College London, Medical Research Council Social, Genetic and Developmental Psychiatry Centre,
Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom, 2 Radboud University
Medical Centre, Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and




While the negative association between ADHD symptoms and IQ is well documented, our
knowledge about the direction and aetiology of this association is limited. Here, we examine
the association of ADHD symptoms with verbal and performance IQ longitudinally in a pop-
ulation-based sample of twins. In a population-based sample of 4,771 twin pairs, DSM-IV
ADHD symptoms were obtained from the Conners’ Parent Rating Scale-Revised. Verbal
(vocabulary) and performance (Raven’s Progressive Matrices) IQ were assessed online.
ADHD symptom ratings and IQ scores were obtained at ages 12, 14 and 16 years. Making
use of the genetic sensitivity and time-ordered nature of our data, we use a cross-lagged
model to examine the direction of effects, while modelling the aetiologies of the association
between ADHD symptoms with vocabulary and Raven’s scores over time. Although time-
specific aetiological influences emerged for each trait at ages 14 and 16 years, the aetiologi-
cal factors involved in the association between ADHD symptoms and IQ were stable over
time. ADHD symptoms and IQ scores significantly predicted each other over time. ADHD
symptoms at age 12 years were a significantly stronger predictor of vocabulary and Raven’s
scores at age 14 years than vice versa, whereas no differential predictive effects emerged
from age 14 to 16 years. The results suggest that ADHD symptoms may put adolescents at
risk for decreased IQ scores. Persistent genetic influences seem to underlie the association
of ADHD symptoms and IQ over time. Early intervention is likely to be key to reducing
ADHD symptoms and the associated risk for lower IQ.
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is associated with lower mean IQ scores. The
correlation between IQ and ADHD symptoms reported in general population samples ranges
from—0.2 to—0.4 [1,2]. A meta-analysis of 123 studies estimated a 7–11-point difference in
full-scale IQ between control individuals and individuals diagnosed with ADHD [3]. Although
PLOSONE | DOI:10.1371/journal.pone.0124357 April 15, 2015 1 / 16
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not significantly different, the effect size (ES) of verbal IQ (VIQ; ES = 0.67; 95% CI 0.58–0.76)
was larger than that of performance IQ (PIQ; ES = 0.58; 95% CI 0.48–0.68). A large family-
based study of 238 ADHD families (545 children) and 147 control families (271 children) also
found that children diagnosed with ADHD and their affected and unaffected siblings had
lower mean scores on VIQ, but not PIQ [4]. Moreover, lower VIQ than PIQ has been reported
for adolescents diagnosed with ADHD [5].
In a clinical sample, children with IQs< 70 showed more severe ADHD symptoms than
children with IQ> 70 [6]. Lower IQ is also associated with higher levels of externalising and
behavioural problems in individuals with ADHD [7]. IQ has been shown to positively impact
the response to pharmaceutical treatment in ADHD [8–11]. Therefore, IQ impacts on overall
outcome in individuals with ADHD and is a good predictor of life success in the general popu-
lation [12,13].
The heritability of ADHD symptoms is high at ~70% [14]. The extent of genetic factors
influencing ADHD symptoms are relatively stable, although new as well as stable genetic influ-
ences are seen at different developmental stages [15–17]. For IQ, a developmental pattern is ob-
served, whereby the extent of genetic influences on IQ gradually increases with age: heritability
is estimated at around 30–60% in middle childhood and increases to 50–80% in adolescence
and adulthood [18–20]. The largely genetic origin of the association of IQ and ADHD symp-
toms was initially shown in a large population-based sample of 5-year old twins, where 86% of
the phenotypic correlation between ADHD symptom and IQ scores and 100% of the associa-
tion between ADHD research diagnosis and IQ scores could be accounted for by genetic factors
[1]. The genetic correlations, which indicate the degree to which genetic influences contribut-
ing to one trait are shared with genetic influences contributing to another trait, were rA = -0.45
between IQ and ADHD symptoms and rA = -0.59 between IQ and ADHD research diagnosis
[1]. Significant genetic correlations have since been found in population-based twin samples of
similar age [21,22], and in twin samples aged 7 to 10 years [2,23].
Although the shared genetic origins of and negative correlation between ADHD and IQ are
well documented, little is known about the direction of effects or the genetic overlap between
these variables at different developmental stages. The first objective of this study was to estab-
lish the developmental pattern of the association of ADHD symptoms with VIQ and PIQ in a
population-based twin sample. While ADHD symptoms diminish in severity over the course
of puberty (~ages 12–16 years [24]), individuals with high levels of ADHD symptoms are at in-
creased risk of continuing problems related to ADHD during adolescence [25,26]. We are
therefore, interested in the developmental pattern of the association of ADHD symptoms with
VIQ and PIQ at ages 12, 14 and 16 years; a period of rapid developmental change for which
both ADHD and IQ data were available in our large twin sample.
Previous research suggests a greater negative association between ADHD symptoms and
VIQ than between ADHD symptoms and PIQ [3–5]. VIQ and PIQ are, thus, examined sepa-
rately, allowing us to explore potential strengths and weaknesses associated with ADHD symp-
toms. The second aim was to examine the genetic and environmental aetiologies of the
association of ADHD symptoms with VIQ and PIQ within time point, and their stability across
time. Making use of the inherently time-ordered nature and genetic sensitivity of the data, we
use a cross-lagged model to address these two objectives: namely, we establish the direction of
effects, while modelling the genetic and environmental variance and covariance structure of
the data separately for VIQ and PIQ.
ADHD and IQ
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Methods
Sample
Data came from the Twins Early Development Study (TEDS), a UK population-representative
sample of twins born in England and Wales between 1994 and 1996 [27]. Zygosity of the twins
was initially based on physical similarity ratings and later verified using genotyping. Partici-
pants were excluded following pre- or perinatal complications or if one or both twins suffered
from any severe medical condition (e.g. autism spectrum disorder, cerebral palsy, Downs’ syn-
drome). Uncertain sex or zygosity and failure to provide information at recruitment were also
exclusion criteria. After exclusion, 1,745 monozygotic (MZ) and 3,026 dizygotic (DZ) twin
pairs were included in the model-fitting analysis. 46.1% of the participants were male. All twins
(born in 1994, 1995 or 1996) were contacted simultaneously in order to simplify administra-
tion. Thus, twin ages ranged from 10.1 to 13.7 years of age at time point 1 (t1; mean age = 11.6
years, SD = 0.68), from 12.8 to 15.8 years of age at time point 2 (t2; mean age = 14.0 years,
SD = 0.60) and from 15.8 to 17.3 years of age at time point 3 (t3; mean age = 16.5 years,
SD = 0.27).
Ethics Statement
Ethical approval was obtained from the King’s College London, Institute of Psychiatry, Psy-
chology and Neuroscience ethics committee and all participants and/or their parents gave writ-
ten consent for participation in this study.
Measures
ADHD symptoms. ADHD symptoms were measured using the DSM-IV items on the
Conners’ Parent Rating Scale-Revised [28]. The scores on the nine-item hyperactive-impulsive
symptoms subscale were added to the scores on the nine-item inattentive symptoms subscale
to form a total DSM-IV ADHD symptoms subscale. At t1, parent booklets enclosing the Con-
ners’ Parent Rating Scale-Revised were sent in the post. At t2 and t3, similar parent booklets
were sent to the families as online versions designed to mimic the paper version’s appearance.
General cognitive ability. All IQ assessments were administered online. See Haworth
et al. [29] for details on how these web-based tests were created. A web-based multiple-choice
version of the WISC-III vocabulary subtest was used to measure VIQ at t1 and t2. At t3, an on-
line version of the Mill Hill Vocabulary scale was used as an indicator of VIQ because the
WISC is not designed to measure intelligence beyond age 16 years. In both the WISC-III vo-
cabulary subtest and the Mill Hill Vocabulary scale, the participant's task was to select the cor-
rect synonym for a word from a list of alternatives provided. Here, we refer to the outcome of
these measures as vocabulary scores. PIQ was measured using a web-based version of the Ra-
ven’s Progressive Matrices test [30] at all three time points. At age 16 years, these web-based IQ
tests were validated by comparing the online results for a subsample with their results on tradi-
tional paper-and-pencil tests. An average correlation of 0.72 between online and offline tests,
administered 2 months apart, was found, providing support for the validity of these web-based
tests [27].
Widespread access to internet connections in the UK has made online testing an attractive
possibility for collecting data on large samples. Studies have shown that web-based findings are
consistent with findings from traditional methods [31]. In our study, parents supervised the
testing by coming online first using a family username and password, watching a demonstra-
tion and completing a consent form. The twins each had a unique ID number as well as a
ADHD and IQ
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family number and completed the test in turn. Parents were urged neither to assist the twins
with answers nor to allow the twins to see each other’s answers.
Statistical analyses
All analyses were conducted in OpenMx [32]. This program deals with incomplete data (miss-
ing at random) by calculating the log likelihood of the data for each observation using raw
maximum likelihood estimation. Standard regression-based corrections for age and sex were
applied to raw scores [33] and residual scores were analysed. Means and variances within traits,
as well as phenotypic correlations across traits, were equated across twins in a pair and zygosity
group in order to generate phenotypic correlation coefficients representative of the entire sam-
ple while taking the non-independence of the data into account (i.e. data from related individu-
als). Separate analyses were conducted for vocabulary and Raven’s scores.
The cross-lagged twin model. Time-specific effects: The applied model specifies the time-
specific genetic and environmental components of (co)variance in a standard bivariate genetic
model using biometrical genetics theory [34]. Estimation of the additive genetic effects (A),
shared environment (C) and non-shared environment (E) for each trait is based on the fact
that MZ and DZ twins have different degrees of correlation for the genetic component (1 vs
0.5), but the same degree of correlation for shared (1) and non-shared environmental factors
(0). This is due to the expectation that MZ twins share 100% and DZ twins share on average
50% of their inherited DNA sequence; yet both MZ and DZ twins share many aspects of their
environment by virtue of being born at the same time and place and growing up in the same
family. The MZ:DZ correlation ratio indicates the relative importance of the A, C and E com-
ponents for each trait. In the bivariate twin analysis, MZ and DZ correlations are compared
across traits: i.e., one twin’s ADHD symptoms are correlated with the co-twin’s IQ score. If the
cross-trait cross-twin correlations are greater for MZ than for DZ twins, this implies that genet-
ic factors contribute to the phenotypic correlation between the two traits. Fig 1 depicts genetic
(A), shared environmental (C) and non-shared environmental (E) influences on ADHD symp-
toms and IQ. Non-shared environmental influences also include measurement error. Fig 1 also
presents genetic and environmental correlations (rA, rC; rE), which can range from −1 to 1, and
represent the extent to which genetic and environmental influences on ADHD symptoms and
the IQ subtests overlap (regardless of their individual heritabilities). Furthermore, phenotypic
correlations can be attributed to genetic and environmental influences. The proportion of the
phenotypic correlation between ADHD symptoms and the IQ subtests that is due to genetic in-
fluences at age 12 years, for example, can be derived by calculating [(a1 x rA1 x a2)/ (phenotypic
correlation at age 12 years x100)] (Fig 1).
Cross-lagged effects: The model specifies the across-time correlations by means of causal
cross-lagged paths, which connect different measures across time points (Fig 1: b12, b21, b34,
b43). The stability paths connect the same measure across time points (Fig 1: b11, b22, b33,
b44). The stability and cross-lagged paths take the form of partial regression coefficients, which
take into account the pre-existing association between ADHD symptoms and IQ, as well as
controlling for stability or cross-lagged effects.
In order to establish the extent to which the same or different aetiological factors influence
ADHD symptoms and IQ over time, genetic and environmental variances were divided into
variance specific to t2 and t3, and variance transmitted from t1 to t2, and from t2 to t3. Variance
can be transmitted via the stability paths. The genetic variance transmitted via the stability
path to ADHD symptoms from t1 to t2, for example, is calculated as a2
2 x b112 (Fig 1). Vari-
ance can also be transmitted via the cross-lagged paths. The genetic variance transmitted to
ADHD symptoms via the cross-lagged path from t1 to t2, for example, is calculated as a1
2 x
ADHD and IQ
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Fig 1. Cross-lagged twin model. Circles represent latent genetic (A), shared environmental (C) and non-shared environmental (E) factors for ADHD
symptoms and IQ at time 1 (age 12), time 2 (age 14) and time 3 (age 16). Paths from the latent A, C, E factors to the observed variables (a1–a6, c1–c6, e1–
e6) represent genetic and environmental contributions to ADHD symptoms and IQ scores. The environmental and genetic correlations between ADHD
symptoms and IQ for each time point are indicated below the arrows connecting the respective circles (rE, rC, rA). Stability paths (b11, b22, b33, b44) connect
the same traits across time. Cross-lagged paths (b12, b21, b34, b43) connect different traits across time.
doi:10.1371/journal.pone.0124357.g001
ADHD and IQ
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b212. Furthermore, variance can be transmitted via the covariation of ADHD symptoms and
IQ. The genetic variance transmitted to ADHD symptoms via the covariation of ADHD symp-
toms and IQ from t1 to t2, for example, is calculated as 2x (b21 x a1 x rA1 x a2 x b11). To exam-
ine the changes in genetic and environmental aetiologies of the association between ADHD
symptoms and IQ, the covariance between ADHD symptoms and IQ was divided into covari-
ance specific to t2 or t3 and covariance shared with the previous time point.
Results
Phenotypic correlations
The phenotypic across-trait correlations between ADHD symptoms and vocabulary scores
ranged from -0.16 to -0.24 (Table 1). The phenotypic across-trait correlations between ADHD
symptoms and Raven’s scores ranged from -0.18 to -0.22 (Table 2). Phenotypic within-trait
across-time correlations were high for ADHD symptoms (range: 0.57–0.77; Tables 1 and 2)
and moderate for vocabulary (range: 0.20–0.48; Table 1) and Raven’s scores (range: 0.35–0.63;
Table 2).
Genetic and environmental aetiologies
Heritabilities of ADHD symptoms were high at each of the three time points (range: 0.65–0.82;
Figs 2 and 3). Heritabilities of vocabulary (range: 0.24–0.29; Fig 2) and Raven’s scores (range
0.30–0.39; Fig 3) were moderate at all three time points. The genetic correlation between the
total variance of ADHD symptoms and vocabulary scores was significant at each time point
(rA1 = -0.29, rA2 = -0.31, rA3 = -0.20; Fig 2). At t1, t2 and t3, 74%, 61% and 50% of the phenotyp-
ic correlation between ADHD symptoms and vocabulary scores were attributable to genetic in-
fluences, respectively (Table 3). The genetic correlations between the total variance of ADHD
Table 1. Phenotypic correlations between ADHD symptom and vocabulary scores.
ADHD sympt1 Vocabulary1 ADHD sympt2 Vocabulary2 ADHD sympt3 Vocabulary3
ADHD sympt1 1
Vocabulary1 -.19 (-.20/-0.16) 1
ADHD sympt2 .77 (.77/.79) -.19 (-.21/-.16) 1
Vocabulary2 -.23 (-.27/-.21) .48 (.45/.50) -.23 (-.27/-.22) 1
ADHD sympt3 .57 (.56/.58) -.17 (-.19/-.15) .74 (.73/.75) -.24 (-.28/-.23) 1
Vocabulary3 -.16 (-.20/-.14) .20 (.19/.22) -.18 (-.23/-.16) .41 (.38/.44) -.16 (-.21/-.14) 1
95% conﬁdence intervals are provided in brackets.
doi:10.1371/journal.pone.0124357.t001
Table 2. Phenotypic correlations between ADHD symptom and Raven’s Standard Progressive Matrices scores.
ADHD sympt1 Raven’s1 ADHD sympt2 Raven’s2 ADHD sympt3 Raven’s3
ADHD sympt1 1
Raven’s1 -.21 (-.24/-.17) 1
ADHD sympt2 . 76 (.75/.77) -.21 (-.23/-.19) 1
Raven’s2 -.21 (-.24/-.18) . 54 (.47/.56) -.22 (-.26/-.20) 1
ADHD sympt3 . 59 (.57/.60) -.18 (-.19/-.13) .77 (.76/.78) -.20 (-.24/-.18) 1
Raven’s3 -.19 (-.20/-.15) . 35 (.29/.38) -.22 (-.24/-.17) .63 (.60/.65) -.22 (-.24/-.18) 1
95% conﬁdence intervals are provided in brackets.
doi:10.1371/journal.pone.0124357.t002
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Fig 2. Cross-lagged path model of vocabulary and ADHD symptom scores. 95% confidence intervals are provided in brackets. Values in square
brackets [ ] represent time-specific genetic and environmental contributions to ADHD symptoms and vocabulary scores. Asterisks indicate the significantly
greater path at the p = 0.05 level. Non-significant paths are indicated by dashed lines.
doi:10.1371/journal.pone.0124357.g002
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symptoms and Raven’s scores were also significant at all three time points (rA1 = -0.30, rA2 =
-0.35, rA3 = -0.33, Fig 3). At t1, t2 and t3, 81%, 77% and 68% of the phenotypic correlation be-
tween ADHD symptoms and Raven’s scores were attributable to genetic influences, respective-
ly (Table 4).
Fig 3. Cross-lagged path model of Raven’s and ADHD symptom scores. 95% confidence intervals are provided in brackets. Values in square brackets [ ]
represent time-specific genetic and environmental contributions to ADHD symptoms and Raven’s Progressive Matrices Scores. Asterisks indicate the
significantly greater path at the p = 0.05 level. Non-significant paths are indicated by dashed lines.
doi:10.1371/journal.pone.0124357.g003
ADHD and IQ
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For ADHD symptoms, 38–39% of genetic variance (i.e. of the heritability shown in Figs 2
and 3), 33–70% of shared environmental variance, and 50–80% of non-shared environmental
variance were due to time-specific aetiological influences at t2. At t3, 36–79% of genetic vari-
ance, 83–92% of shared environmental variance, and 61–84% of non-shared environmental
variance were due to time-specific aetiological influences (Tables 5 and 6). For vocabulary
scores, 68% of genetic variance, 67% of shared environmental variance and 81% of non-shared
environmental variance was attributable to time-specific aetiological influences at t2. At t3, 79%
of genetic variance, 92% of shared environmental variance and 84% of non-shared environ-
mental variance was attributable to time-specific aetiological influences (Table 5). For Raven’s
scores, 58% of genetic variance, 0% of shared environmental variance and 78% of non-shared
environmental variance was attributable to time-specific aetiological influences at t2. At t3, 53%
of genetic variance, 67% of shared environmental variance and 64% of non-shared environ-
mental variance was attributable to time-specific aetiological influences (Table 6). Thus, many
new genetic and environmental influences on ADHD symptoms, vocabulary and Raven’s
scores emerged at t2 and t3, which were not explained by environmental or shared influences at
t1 or t2 respectively.
Table 3. Proportions of the phenotypic correlations between ADHD symptoms and vocabulary scores due to genetic (A), shared environmental
(C) and non-shared environmental (E) influences.
Time 1 Time 2 Time 3
rph -0.19 -0.23 -0.16
% of rph due to Totala Time-speciﬁcb Totala Time-speciﬁcb
A 74% (0.14) 61% (0.14) 30% (0.07) 50% (0.08) 25% (0.04)
C 16% (0.03) 17% (0.04) 9% (0.02) 12.5% (0.02) 12.5% (0.02)
E 10% (0.02) 22% (0.05) 13% (0.03) 37.5% (0.06) 25% (0.04)
ADHD = attention deﬁcit hyperactivity disorder; rph = phenotypic correlation
aProportions of the phenotypic correlation due to total genetic or environmental inﬂuences (i.e. transmitted plus age-speciﬁc effects).
bProportions of the phenotypic correlation due to time-speciﬁc genetic or environmental inﬂuences speciﬁc to early adolescence.
Figures in parentheses refer to the absolute contributions of A, C and E respectively to the phenotypic correlations between ADHD symptoms and
vocabulary scores.
doi:10.1371/journal.pone.0124357.t003
Table 4. Proportions of the phenotypic correlations between ADHD symptoms and Raven’s Standard Progressive Matrice scores due to genetic
(A), shared environmental (C) and non-shared environmental (E) influences.
Time 1 Time 2 Time 3
rph -0.21 -0.22 -0.22
% of rph due to Totala Time-speciﬁcb Totala Time-speciﬁcb
A 81% (0.17) 77% (0.17) 36% (0.08) 68% (0.15) 32% (0.07)
C 5% (0.01) 0% (0.00) 0% (0.00) 0% (0.00) 0% (0.00)
E 14% (0.03) 23% (0.05) 14% (0.03) 32% (0.07) 23% (0.05)
ADHD = attention deﬁcit hyperactivity disorder; rph = phenotypic correlation
aProportions of the phenotypic correlation due to total genetic or environmental inﬂuences (i.e. transmitted plus age-speciﬁc effects).
bProportions of the phenotypic correlation due to time-speciﬁc genetic or environmental inﬂuences speciﬁc to early adolescence.
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Of the 61% of the phenotypic correlation between ADHD symptoms and vocabulary scores
at t2 that is due to genetic influences, a proportion of 30% was due to time-specific genetic in-
fluences at t2, while the remaining 31% were due to lasting genetic influences transmitted from
t1 (Table 3; 30% + 31% = 61%). At t3, 25% of the phenotypic correlation between ADHD symp-
toms and vocabulary scores were due to time-specific genetic influences, while the remaining
25% were due to lasting genetic influences transmitted from t2. A proportion of 9% of the phe-
notypic correlation between ADHD symptoms and vocabulary scores was due to time-specific
shared environmental influences at t2, while the remaining 8% were due to lasting shared envi-
ronmental influences transmitted from t1. At t3, 12.5% of the phenotypic correlation between
ADHD symptoms and vocabulary scores were due to time-specific shared environmental influ-
ences, while the remaining 12.5% were due to lasting shared environmental influences trans-
mitted from t2. A proportion of 13% of the phenotypic correlation between ADHD symptoms
and vocabulary scores was due to time-specific non-shared environmental influences at t2,
while the remaining 9% were due to lasting non-shared environmental influences transmitted
from t1. At t3, 25% of the phenotypic correlation between ADHD symptoms and vocabulary
scores were due to time-specific non-shared environmental influences, while the remaining
12.5% were due to lasting non-shared environmental influences transmitted from t2.
Of the phenotypic correlation between ADHD symptoms and Raven’s scores at t2, 36% were
due to time-specific genetic influences at t2, whereas the remaining 41% were due to lasting ge-
netic influences transmitted from t1 (Table 4). At t3, 32% of the phenotypic correlation between
ADHD symptoms and Raven’s scores was due to time-specific genetic influences, whereas the
Table 5. Transmission of genetic (A), shared environmental (C) and non-shared environmental (E) influences between ADHD symptoms and vo-
cabulary scores over time.
Time 2 Time 3
ADHD symptoms A C E A C E
Total ACE variance 0.75 0.03 0.22 0.65 0.11 0.24
Proportion of total ACE variance due to
ADHD symptoms (stability effect) 0.45 (60%) 0.02 (67%) 0.10 (45%) 0.40 (62%) 0.02 (18%) 0.12 (50%)
Vocabulary scores (cross-lagged effect) 0.00 (0%) 0.00 (0%) 0.00 (0%) 0.00 (0%) 0.00 (0%) 0.00 (0%)
Covariation between ADHD symptoms and Vocabulary scores
(common effects)
0.01 (1%) 0.00 (%) 0.00 (%) 0.01 (2%) 0.00 (%) 0.00 (%)
Time-speciﬁc inﬂuences 0.29 (39%) 0.01 (33%) 0.12 (55%) 0.24 (36%) 0.09 (82%) 0.12 (50%)
Vocabulary scores A C E A C E
Total ACE variance 0.28 0.09 0.63 0.24 0.13 0.63
Proportion of total ACE variance due to
Vocabulary scores (stability effect) 0.06 (21%) 0.03 (33%) 0.12 (19%) 0.04 (17%) 0.01 (8%) 0.10 (16%)
ADHD symptoms (cross-lagged effect) 0.02 (7%) 0.00 (0%) 0.00 (0%) 0.01 (4%) 0.00 (0%) 0.00 (0%)
Covariation between ADHD symptoms and Vocabulary scores
(common effects)
0.01 (4%) 0.00 (0%) 0.00 (0%) 0.00 (0%) 0.00 (0%) 0.00 (0%)
Time-speciﬁc inﬂuences 0.19 (68%) 0.06 (67%) 0.51 (81%) 0.19 (79%) 0.12 (92%) 0.53 (84%)
Note: Percentages in parentheses refer to the proportion of variance at the age indicated transmitted from the previous time point, i.e. transmitted from
time 1 to time 2 and from time 2 to time 3. For each trait, percentages within each column add up to 100%, and, thus, may not perfectly correspond to
proportions derivable from parameter estimates in this table, due to rounding error.
doi:10.1371/journal.pone.0124357.t005
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remaining 36% were due to lasting genetic influences transmitted from t2. At t2 and t3, there
were no shared environmental influences on the phenotypic correlation between ADHD symp-
toms and Raven’s scores. A proportion of 14% of the phenotypic correlation between ADHD
symptoms and Raven’s scores was due to time-specific non-shared environmental influences at
t2, while the remaining 9% were due to lasting non-shared environmental influences transmitted
from t1. At t3, 23% of the phenotypic correlation between ADHD symptoms and Raven’s scores
were due to time-specific non-shared environmental influences, while the remaining 9% were
due to lasting non-shared environmental influences transmitted from t2.
Overall, these results indicate that both stable aetiological factors and time-specific genetic
and environmental influences emerging for each trait at t2 and t3 (Tables 5 and 6) are involved
in the association between ADHD symptoms and vocabulary scores and the association be-
tween ADHD symptoms and Raven’s scores across time.
Phenotypic cross-lagged effects
All cross-lagged paths were small (Figs 2 and 3). This is a common finding [16,35–37], because
cross-lagged paths are partial regression coefficients (i.e. they explain the left-over variance
once the within-trait across-time stability has been accounted for). The full predictive relation-
ships between ADHD symptoms and the two indicators of IQ (vocabulary and Raven’s scores)
are stronger, as indicated by the phenotypic correlations (Tables 1 and 2 respectively).
The stability paths of ADHD symptoms (b11 = 0.75, b22 = 0.73) and vocabulary scores (b33 =
0.46, b44 = 0.39) were significant and moderate to high (Fig 2). All cross-lagged effects from
Table 6. Transmission of genetic (A), shared environmental (C) and non-shared environmental (E) influences between ADHD symptoms and Ra-
ven’s Standard Progressive Matrices over time.
Time 2 Time 3
ADHD symptoms A C E A C E
Total ACE variance 0.78 0.10 0.20 0.71 0.06 0.23
Proportion of total ACE variance due to
ADHD symptoms (stability effect) 0.47 (60%) 0.02 (20%) 0.09 (45%) 0.45 (63%) 0.01 (17%) 0.09 (39%)
Raven’s scores (cross-lagged effect) 0.01 (1%) 0.01 (10%) 0.01 (5%) 0.00 (0%) 0.00 (0%) 0.00 (0%)
Covariation between ADHD symptoms and Raven‘s scores
(common effects)
0.01 (1%) 0.00 (0%) 0.00 (0%) 0.01 (1%) 0.00 (0%) 0.00 (0%)
Time-speciﬁc inﬂuences 0.29 (38%) 0.07 (70%) 0.10 (50%) 0.25 (36%) 0.05 (83%) 0.14 (61%)
Raven‘s scores A C E A C E
Total ACE variance 0.31 0.04 0.59 0.30 0.06 0.64
Proportion of total ACE variance due to
Raven‘s scores (stability effect) 0.11 (36%) 0.04 (100%) 0.13 (22%) 0.12 (40%) 0.02 (33%) 0.23 (36%)
ADHD symptoms (cross-lagged effect) 0.01 (3%) 0.00 (0%) 0.00 (0%) 0.00 (0%) 0.00 (0%) 0.00 (0%)
Covariation between ADHD symptoms and Raven‘s scores
(common effects)
0.01 (3%) 0.00 (0%) 0.00 (0%) 0.02 (7%) 0.00 (0%) 0.00 (0%)
Time-speciﬁc inﬂuences 0.18 (58%) 0.00 (0%) 0.46 (78%) 0.16 (53%) 0.04 (67%) 0.41 (64%)
Note: Percentages in parentheses refer to the proportion of variance at the age indicated transmitted from the previous time point, i.e. transmitted from
time 1 to time 2 and from time 2 to time 3. For each trait, percentages within each column add up to 100% and, thus, may not perfectly correspond to
proportions derivable from parameter estimates in this table, due to rounding error.
doi:10.1371/journal.pone.0124357.t006
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ADHD symptoms to vocabulary scores, and vice versa, were significant, as shown by the 95%
confidence intervals. A χ2—test indicated that the cross-lagged path from ADHD symptoms at
t1 to vocabulary scores at t2 (b12 = -0.14) was significantly larger than the cross-lagged path from
vocabulary scores at t1 to ADHD symptoms at t2 (b21 = -0.04; χ
2 = 67.76, p<0.001, df = 1). The
cross-lagged path from ADHD symptoms at t2 to vocabulary scores at t3 (b34 = -0.10) was not
significantly different from the cross-lagged path from vocabulary scores at t2 to ADHD symp-
toms at t3 (b43 = -0.07; χ
2 = 2.30, p = 0.13, df = 1). Analyses of the relationship between vocabu-
lary and inattention scores, and the relationship between vocabulary and hyperactivity-
impulsivity scores, revealed the same pattern as above for both symptom dimensions (not pre-
sented here).
In the cross-lagged model of the association between ADHD symptoms and Raven’s scores,
the stability paths of ADHD symptoms (b11 = 0.76, b22 = 0.76) and Raven’s scores (b33 = 0.52,
b44 = 0.61) were similarly significant and moderate to high (Fig 3). All cross-lagged effects
from ADHD symptoms to Raven’s scores, and vice versa, were significant, as shown by the
95% confidence intervals. A χ2—test indicated that the cross-lagged path from ADHD symp-
toms at t1 to Raven’s scores at t2 (b12 = -0.10) was significantly larger than the cross-lagged
path from Raven’s scores at t1 to ADHD symptoms at t2 (b21 = -0.05; χ
2 = 15.19, p<0.001,
df = 1). The cross-lagged path from ADHD symptoms at t2 to Raven’s scores at t3 (b34 = -0.08)
was not significantly different from the cross-lagged path from Raven’s scores at t2 to ADHD
symptoms at t3 (b43 = -0.04; χ
2 = 2.36, p = 0.09, df = 1). Analyses of the relationship between
Raven’s and inattention scores, and the relationship between Raven’s and hyperactivity-impul-
sivity scores, revealed the same pattern as above for both symptom dimensions (not presented
here).
Discussion
In this cross-lagged analysis exploring the developmental patterns of the causal directions and
the aetiology of the association between ADHD symptoms and IQ, three key findings emerged
that together shed light on the aetiology of the longitudinal relationship between ADHD symp-
toms and IQ in the general population.
Firstly, time-specific genetic and environmental influences emerged for each trait at t2 and
t3. Yet, heritabilities remained high for ADHD and moderate for vocabulary and Raven’s scores
across the three time points. This finding suggests that ADHD and IQ are developmentally
complex phenotypes characterised by both continuity and change of the aetiological influences
across adolescence. The stable and dynamic nature of the genetic risks supports a “develop-
mentally dynamic” hypothesis of ADHD [38]. Considering ADHD in a developmental frame-
work implies that early intervention could help to reduce ADHD symptoms, as well as the
impact these symptoms may have on IQ. Future research should investigate the developmental
patterns of the association between ADHD symptoms and IQ at earlier as well as later stages
of development.
Secondly, we found that the (genetic) association of ADHD symptoms with vocabulary and
Raven‘s scores at t2 and t3 were determined by both time-specific genetic and environmental
influences emerging for each trait at t2 and t3 and the associations transmitted from previous
time points. Thus, the aetiological factors involved in the association of ADHD symptoms with
vocabulary and Raven’s scores were moderately stable across time points, despite the large
sample and, thus, increased power to detect time-specific aetiological influences. The stable
aetiological influences on the association of ADHD symptoms with IQ may indicate that en-
during molecular, and hence neurobiological, processes play an important role for the
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association. Future research should explore these processes, for example through molecular ge-
netic, neuropsychological and neuroimaging studies.
Thirdly, ADHD symptoms and vocabulary scores, and ADHD symptoms and Raven’s
scores, significantly predicted each other from t1 to t2 and from t2 to t3. However, ADHD
symptoms at t1 were a significantly stronger predictor of both vocabulary and Raven’s scores at
t2 than vice versa. No differential effects emerged for the cross-lagged paths from ADHD
symptoms at t2 to vocabulary or Raven’s scores at t3 and vice versa. The lack of differential ef-
fects may be explained by the fact that the direct effects of ADHD symptoms at t2 on vocabu-
lary or Raven’s scores at t3 and vice versa are likely attenuated by the indirect effects from the
associations at previous time points (which also explain the relationships). The developmental
patterns for the association of ADHD symptoms with these two IQ subscales were
highly comparable.
The cross-lagged effects are small, as is common [16,35–37], because cross-lagged paths ex-
plain the left-over variance once the within-trait across-time stability has been accounted for.
As indicated by the phenotypic correlations, the full predictive relationships between ADHD
symptoms and the two indicators of IQ (vocabulary and Raven’s scores) are stronger than the
cross-lag estimates. The significant negative cross-lagged associations between ADHD symp-
toms and the two IQ subscales, therefore, suggest ADHD symptoms could contribute to an in-
creased risk for worse life outcomes, as IQ has previously been shown to predict overall
outcome in individuals with ADHD [10,11] and is also a good predictor of life success in the
general population, predicting, for example, educational achievement and longevity [12,13].
Contrary to studies investigating VIQ and PIQ in individuals diagnosed with ADHD [3–5], no
differential effects emerged for VIQ and PIQ in our population-based twin sample. Future re-
search will have to substantiate these findings in the general population and in individuals di-
agnosed with ADHD in order to establish potential cognitive strengths and weaknesses
associated with ADHD to guide treatment and educational programmes.
One way in which ADHD symptoms may affect IQ scores is through education: the core
symptoms of ADHD—inattention, impulsivity and hyperactivity—may lead to difficulties in
following teachers’ instructions and lesson content and, thus, interfere with opportunities to
benefit from education. Data from the prospective, population-based Avon Longitudinal Study
of Parents and Children (n = 11,640) show that parent-rated hyperactivity and inattention
symptoms measured at age 3 had negative effects on academic outcomes at age 16 [39]. Fur-
thermore, ADHD symptoms were found to negatively affect academic achievement concur-
rently and longitudinally (after 5 years) in 192 12-year olds from the general population [40].
These studies suggest that high levels of ADHD symptoms predict poor academic outcomes
and lower levels of education, which in turn have been associated with lower scores onWechs-
ler intelligence subtests [41]. Recent research also suggests that the Raven’s Progressive Matri-
ces test is influenced by education [42,43]. Education may, thus, be a putative mechanism via
which ADHD symptoms affects IQ scores in the way our results suggest.
The study has some limitations. We investigated the association between ADHD symptoms
and IQ in a population-based sample of twins rather than a clinical sample. The associations of
ADHD symptoms with VIQ and PIQ are likely to be greater and may differentiate in individu-
als diagnosed with ADHD [3,4]. However, examining large unselected population samples de-
creases the risk of possible selection biases associated with clinical samples. Secondly, the
heritability estimates for the IQ subscales are lower than previously reported heritability esti-
mates of general cognitive abilities (g). This may be because g is a latent trait generated from
multiple measures and here, we separately analysed vocabulary and Raven’s scores as proxies
for VIQ and PIQ. In a genome-wide complex trait analysis of this sample the typical pattern of
genetic stability and increasing heritability for g were found, with DNA-estimated heritabilities
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increasing from 0.26 at age 7 to 0.45 at age 12 years, [44]. Thirdly, there was a change in the
specific test used to measure vocabulary from age 14 to 16 years. Yet, the test conducted at age
16 was analogous to the test conducted at ages 12 and 14 years; in both the participant’s task
was to select the correct synonym for a word from a list of alternatives. Their similarity is re-
flected in the comparable magnitudes of the stability paths from ages 12–14 years and ages 14–
16 years. Lastly, while a cross-lag model may allow us to examine the direction of effects, fur-
ther research is required to draw firm conclusions about the direction of causality.
These limitations notwithstanding, the prospective developmental design of our cross-
lagged analysis allowed us to explore the direction of effects for the negative association be-
tween ADHD symptoms and IQ scores, as well as the dynamic and stable nature of the aetiolo-
gical influences on these variables and their association. ADHD symptoms and IQ scores
significantly predicted each other over time. Yet, ADHD symptoms at age 12 years were a sig-
nificantly stronger predictor of both vocabulary and Raven’s scores at age 14 years than vice
versa. Time-specific aetiological influences emerged for each trait. However, the aetiological
factors involved in the association between ADHD symptoms and IQ were highly stable over
time. Future research will need to build on these results to investigate how early intervention
targeting ADHD symptoms may aid in reducing the risk for lower IQ.
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Is Physical Activity Causally Associated With Symptoms
of Attention-Deﬁcit/Hyperactivity Disorder?
Anna-Sophie Rommel, MSc, Paul Lichtenstein, PhD, Mina Rydell, PhD, Ralf Kuja-Halkola, PhD,
Philip Asherson, MD, PhD, Jonna Kuntsi, PhD, Henrik Larsson, PhD
Objective: Emerging evidence suggests that physical ac-
tivity (PA) enhances cognition and may be a protective
factor for attention-deﬁcit/hyperactivity disorder
(ADHD). Yet the impact of PA on ADHD symptoms has
been investigated only in a few undersized, non-
randomized, and retrospective studies. We examined the
effect of PA during late adolescence on ADHD symptoms
in early adulthood while controlling for unmeasured
genetic and shared environmental confounding.
Method: The effect of PA at age 16 to 17 years (baseline)
on ADHD symptoms at age 19 to 20 years (follow-up) was
examined using a within–monozygotic (MZ) twins ﬁxed-
effects model in 232 MZ twin pairs born in Sweden
between May 1985 and December 1986. Parents rated their
children’s DSM ADHD symptoms at baseline and follow-
up. Participants’ weekly energy expenditure (in metabolic
equivalent task minutes per week) was based on self-
reports at baseline of PA frequency, intensity, and
duration.
Results: Greater weekly energy expenditure in adoles-
cence was signiﬁcantly associated with reduced ADHD
symptom levels in early adulthood, even when controlling
for unmeasured confounding (all genetic and environ-
mental factors shared within MZ twin pairs) as well as
ADHD symptoms and body mass index (BMI) at baseline,
b ¼ "0.21, p ¼ .013 (95% CI ¼ "0.38 to "0.05). Similar
results were observed for the 2 ADHD subcomponents:
hyperactivity/impulsivity, b ¼ "0.21, p ¼ .022 (95%
CI ¼ "0.39 to "0.03), and inattention, b ¼ "0.19, p ¼ .049
(95% CI ¼ "0.36 to "0.0005).
Conclusion: In line with a causal hypothesis, PA was
inversely associated with ADHD symptoms, even after
adjusting for unmeasured confounding. These ﬁndings
suggest that PA in adolescence might decrease ADHD
symptoms in early adulthood. However, given the size of
the effect, the clinical value of this intervention needs to be
explored further.
Key Words: physical activity, ADHD, exercise, twin
modeling, TCHAD
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A ttention-deﬁcit/hyperactivity disorder (ADHD) is acomplex neurodevelopmental disorder characterizedby developmentally inappropriate and impairing
levels of hyperactivity, impulsivity, and/or inattention.1 Both
the symptoms and functional impairments associated with
ADHD persist from childhood into adolescence and adult-
hood in around 65% of individuals with the disorder.2 Across
the lifespan, ADHD is associated with a signiﬁcant risk of
lower academic and occupational achievement,3 interpersonal
problems, mental illness, and delinquency.4 Multimodal
treatment plans including psychostimulant medication, non-
psychostimulant medication, and psychological interven-
tions, tailored to the speciﬁc needs of the patient, are
recommended for the treatment of ADHD.5 Because of their
persistence, there is a continued need for treatment and
management of ADHD symptoms and impairments from
childhood through adolescence and into adulthood.
A robust evidence base stemming from randomized
controlled trials attests to the efﬁcacy of psychostimulant
and nonpsychostimulant medication in reducing the
symptoms of ADHD.6 Yet treatment with medication has its
limitations. Some individuals may not respond to medica-
tion, and complete normalization of symptoms is rare.7
Medication may be less effective for treating associated im-
pairments of ADHD, such as poor social skills8 and execu-
tive function (EF) deﬁcits,9 and its long-term effectiveness for
control of ADHD symptoms and impairments is yet to be
established.10 Adverse side effects on sleep, appetite, and
growth are also possible.11 Furthermore, some patients,
parents, and clinicians have reservations about medication
use,12 and the majority of individuals who are prescribed
medication stop taking it within the ﬁrst year.13 These po-
tential problems are acknowledged by the National Institute
for Health and Care Excellence (NICE) clinical guidelines,
which recommend that nonmedical interventions should be
considered as possible ﬁrst-line treatment where ADHD is
associated with moderate levels of impairment.5
A variety of nonpharmacological interventions, such as
psychological (cognitive training, neurofeedback, and
behavioral training) and dietary (restricted elimination
diets, artiﬁcial food color exclusions, and free fatty acid
supplementation) interventions, are also available. A recent
meta-analysis found blinded evidence that behavioral in-
terventions used to treat children and adolescents with
ADHD had beneﬁcial effects on important aspects of child
This article is discussed in an editorial by Dr. Jeffrey M. Halperin on
page 537.
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and parent functioning, namely decreasing comorbid child-
hood conduct problems and increasing positive parenting.14
Yet the evidence for the efﬁcacy of nonpharmacological
treatment interventions on reducing ADHD symptoms is
far from clear and is limited by the unblind status of
researchers and raters of behavior, as another recent meta-
analysis by the same group concluded.15 Blinded evidence
for small but signiﬁcant reductions in ADHD symptoms was
found only for free fatty acid supplementation and artiﬁcial
food color exclusion.15
Identifying new nonpharmacological treatments on the
basis of our growing understanding of the pathophysiology
as well as risk and protective factors of ADHD would
therefore be a signiﬁcant advance in the management of
ADHD. Animal research and studies in typically developing
children, adolescents, and adults suggest physical activity
(PA) and exercise as a putative treatment target, potentially
diminishing an individual’s level of ADHD symptoms and
associated impairments.16 Here, PA is deﬁned as any bodily
movement produced by skeletal muscles that requires en-
ergy expenditure, whereas exercise is a subcategory of PA
that is planned, structured, repetitive, and purposeful. Yet
more and better-quality evidence is needed to establish the
impact of PA on ADHD symptoms and its efﬁcacy in alle-
viating the symptoms and impairments associated with the
disorder.
Findings from a study investigating the correlation be-
tween cognitions and exercise quantity are consistent with
the notion that PA may be beneﬁcial for individuals with
high levels of ADHD symptoms and associated impair-
ments. Exercise quantity was measured each day over a
period of 1 week using an accelerometer in 18 boys diag-
nosed with ADHD. The study found that exercise quantity
was signiﬁcantly correlated with working memory, inhibi-
tion, and information processing.17 Yet the correlational and
nonrandomized design prohibits causal interpretations and
limits conclusions about efﬁcacy.
A study assessing the effects of a 10-week moderate-to–
high-intensity exercise program on ﬁtness, cognitive func-
tioning, and ADHD-related behavior in 10 children with
ADHD, compared to a no-intervention control group con-
sisting of 11 children with ADHD, reported signiﬁcant
improvements in muscular capacities, motor skills, level of
information processing, and parent- and teacher-rated social,
thought, and attention problems following the interven-
tion.18 No information is available as to whether this study
was randomized and blinded.
Three studies investigating the effect of PA in individuals
with ADHD have used a randomized prospective design.
One of these studies examined the effects of acute exercise on
EF.19 Thirty minutes of moderate-intensity running facili-
tated selective attention, processing speed, and set-shifting
in 20 children with ADHD who were randomly assigned
to the PA group, relative to 20 children with ADHD
assigned to the control condition of watching a PA-related
video.19 The second study explored the association be-
tween chronic PA and attention in 84 children with ADHD.
Compared to individuals who did not receive an interven-
tion, individuals randomly assigned to a moderate-intensity
10-week exercise program of 3 sessions per week improved
on teacher ratings of attention, motor skills, and academic
and classroom behavior.20 In the third randomized study,
teacher-rated cooperativeness and EF, as indicated by the
digit symbol test, were signiﬁcantly improved by 12 bi-
weekly exercise sessions, relative to behavioral educational
sessions, in 28 boys with ADHD.21 Although no signiﬁcant
changes were found with regard to hyperactivity scores,
inattention scores improved in the exercise group. These
randomized prospective studies thus suggest that PA has
positive effects on EF and behavioral symptoms associated
with ADHD. Yet none of these studies established whether
any short-term effects of PA were followed by longer-term
beneﬁts. Furthermore, none of these studies elaborate on
the blinding status of the researchers and informants.
The ﬁndings from the studies reviewed above provide
some support for the hypothesis that exercise has the po-
tential to act as a protective factor for ADHD symptoms and
associated impairments. Yet, concluding causality from
nonrandomized, retrospective, and cross-sectional data is
problematic. The studies looking at case-control differences
are limited by inadequate control conditions, and the results
may therefore be confounded by unmeasured genetic and
environmental factors that may lead to spurious associa-
tions. The nonblinded status of the researchers and raters of
behavior may further inﬂate the positive effects of exercise
on the various outcome variables due to the nonspeciﬁc ef-
fects evoked by a child’ s participation in a treatment pro-
gram.16 Furthermore, little is known about the
developmental inﬂuence of PA on ADHD symptoms. The
purpose of this study was to examine the effect of PA during
late adolescence on ADHD symptoms in early adulthood.
Both the symptoms and functional impairments associated
with ADHD often persist from childhood into adolescence
and adulthood.2 Although attention problems remain rela-
tively stable, symptoms of hyperactivity and impulsivity
tend to decline with age.22 PA may thus be particularly
beneﬁcial for the age group examined here, as PA seems to
affect inattention more than hyperactivity/impulsivity
symptoms.18,20,21 In light of these ﬁndings, the impact of PA
on ADHD symptoms is examined together and separately
for the 2 subcomponents of ADHD, inattention and hyper-
activity/impulsivity. Investigating the effect in 232 mono-
zygotic (MZ) twin pairs enables us to control for
unmeasured genetic and shared environmental confounding
factors that may inﬂuence the relationship between PA and
ADHD symptoms, allowing us to draw tentative causal in-
ferences about this relationship.
METHOD
Sample
Data came from the Swedish Twin Study of CHild and Adolescent
Development (TCHAD). TCHAD is an ongoing prospective longi-
tudinal twin study concerning health and behavior in twins from
childhood to early adulthood.23 The study is a subsample of the
Swedish Twin Registry and contains about 1,450 twin pairs born in
Sweden between May 1985 and December 1986. The twins and their
parents have been contacted on 4 different occasions using postal
questionnaires. The current study used data from waves 3 and 4.
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The TCHAD sample is representative of the Swedish population
with regard to educational level and employment status but
not ethnicity.23 In wave 3, the response rate was 74% for parents
(n ¼ 1,067), and 82% for twins (n ¼ 2,369). In wave 4, parents’
response rate was 40% (n ¼1,158), and the twins’ response rate was
59% (n ¼ 1,705).24 The zygosity of 1,312 twins was conﬁrmed by
DNA test during wave 4 when all twins were asked to provide a
DNA sample with the help of OraGenes DNA (DNA Genotek Inc.,
Ottawa, ON, Canada) self-collection kits. For 1,444 twins without a
DNA sample, zygosity was determined based on an algorithm
derived from discriminant analyses of twins’ and parents’ responses
to validated questionnaires.23 In cases of any contradictions between
the assignments (n ¼ 100, 3.4%), the zygosity was set to unknown,
and the twins were excluded from the analyses. The present study
included 232 monozygotic (MZ) twin pairs who had completed self-
report measures on PA at age 16 to 17 years and whose parents had
completed parent-report measures of ADHD symptoms at ages 16 to
17 and 19 to 20 years. The included MZ twins did not differ
signiﬁcantly from the individuals lost to follow-up with regard to
physical activity levels (t ¼ "0.53, df ¼ 767, p ¼ .60), ADHD
symptoms in adolescence (t ¼ "0.25, df ¼ 839, p ¼ .80), and ADHD
symptoms in early adulthood (t ¼ 0.69, df ¼ 497, p ¼ .49).
Approximately half (48.74%) of the participants were male. Ethical
approval was obtained from the Ethics Committee of the Karolinska
Institute, Stockholm, Sweden. No informed consent was required
because, according to Swedish regulations, response to the ques-
tionnaire constitutes consent.24
Measures
PA is deﬁned as any bodily movement produced by skeletal muscles
that requires energy expenditure. PA is a complex and multidi-
mensional exposure, and, when assessing its effect, the intensity,
duration, and frequency with which it is performed must be taken
into account.25 The twins provided self-ratings of their PA by
answering 3 multiple-choice questions enquiring about the intensity,
frequency, and duration of their leisure-time PA (Table 1). The in-
tensity indicated by the participant was converted into metabolic
equivalents of task (MET) using the Compendium of Physical
Activities.26 The average duration per PA session indicated by the
participant was converted into minutes per session, respectively.
PA frequency was converted into PA sessions per week. Weekly
energy expenditure (EE) of PA was then calculated using the
following formula, where higher scores indicate greater PA27:
Intensity ðMETÞ % Duration ðmin=timeÞ
% Frequency ðtimes=weekÞ
¼ weekly EE ðMET"min=weekÞ:
At age 16 to 17 years, parents completed a binary-coded checklist
(0¼ not true, 1¼ true) of 14 ADHD symptom items based onDSM-IV
criteria.28 Because of the changes in the DSM during the follow-up
period of the TCHAD study, the full set of all 18 DSM-IV ADHD
symptoms was not included.29 At age 19 to 20 years, parents pro-
vided ratings of their children’s ADHD symptoms based on the 18
DSM-IV items for ADHD28 via a Likert-type scale (0 ¼ not true;
1 ¼ sometimes true; 2 ¼ often true). At both time points, parents
were asked to check symptoms persisting for at least 6 months.
Separate scores for inattention and hyperactivity/impulsivity as
well as a total DSM-IV ADHD symptom score were established
from these ratings. Higher scores indicate greater symptom severity.
Participants also provided their weight (in kilograms [kg]) and
height (in meters [m]) at baseline. Each participant’s body mass
index (BMI) was calculated by dividing his/her body weight in
kilograms by his/her height in meters squared (kg/m2). Descriptive
statistics for these variables can be found in Table 2.
Statistical Analysis
The relationship between PA and ADHD symptoms was investi-
gated using a within-MZ twins ﬁxed-effect model,30 which models
within-MZ twin pair differences in ADHD symptoms as a function
of within-pair differences of weekly EE. Thus, the analysis allows the
effect of PA on ADHD symptom levels to be estimated while ac-
counting for unmeasured confounding factors (i.e., all genetic and
environmental factors shared within MZ twin pairs). This is due to
the fact that MZ twins share 100% of their inherited DNA sequence
and are expected to share many aspects of their environment by
virtue of being born at the same time and place and growing up in
the same family. As ADHD symptoms and BMI31 at baseline were
likely to be important confounders for the estimated effect of weekly
EE on ADHD symptoms at follow-up, we included them in the
model. Weekly EE and ADHD symptoms were studied as contin-
uous variables. Models were ﬁtted to standardized (z) weekly EE
and ADHD symptom scores. Analyses were performed separately
for inattentive, hyperactive/impulsive, and total ADHD symptoms.
All analyses were conducted in Stata 13 software.
RESULTS
The within–MZ twins, ﬁxed-effect model revealed that
greater weekly EE at age 16 to 17 years signiﬁcantly pre-
dicted reduced ADHD symptoms at age 19 to 20 years
(b ¼ "0.30, p < .001, 95% CI ¼ "0.46 to –0.15). Greater
weekly EE at age 16 to 17 years signiﬁcantly predicted
reduced ADHD symptoms at age 19 to 20 years even when
controlling for ADHD symptoms and BMI at baseline
(b ¼ "0.21, p ¼ .013, 95% CI ¼ "0.38 to "0.05). Dimension-
speciﬁc analyses indicated that, even when controlling for
baseline BMI and hyperactivity/impulsivity and inattention
symptom levels, respectively, greater weekly EE at age 16 to
17 years was signiﬁcantly associated with reduced hyper-
activity/impulsivity symptom levels at age 19 to 20 years
(b ¼ "0.21, p ¼ .022, 95% CI ¼ "0.39 to "0.03), as well as
with reduced inattention symptom levels at age 19 to 20
TABLE 1 Physical Activity Questionnaire Enquiring About the
Intensity, Frequency, and Duration of the Participant’s Leisure-
Time Physical Activity
Question 1 How often do you exercise or play sports in your
spare time?
Answers 1. Never
2. Less than once a month
3. 1e2 times a month
4. About once a week
5. 2e3 times a week
6. 4e5 times a week
7. Almost every day





Question 3 On average, how long are your exercise sessions?
Answers 1. Shorter than half an hour
2. Half an hour to less than 1 hour
3. One hour to less than 2 hours
4. Two hours or more
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years (b ¼ "0.19, p ¼ .049, 95% CI ¼ "0.36 to –0.0005).
Although the effect was slightly larger for hyperactivity/
impulsivity symptoms, this difference was not signiﬁcant, as
indicated by the overlapping 95% CIs. Because the analyses
were carried out using standardized (z) scores, the b co-
efﬁcients presented in this section represent a standardized
effect size measure such that a 1–standard deviation change
in EE leads to b change in standard deviation in ADHD
symptoms. The effect size is comparable to Cohen’s d.
DISCUSSION
In the present study investigating the effect of PA on ADHD
symptoms, higher levels of PA, indicated by higher weekly
energy expenditure, in late adolescence were associated with
lower ADHD symptom scores in early adulthood, even
when adjusting for baseline ADHD symptoms, BMI, and
unmeasured genetic and shared environmental confounding
factors. These results are in line with a causal hypothesis,
indicating that PA may represent a protective factor for
ADHD. By using a longitudinal design and focusing on
weekly energy expenditure rather than a particular kind of
exercise, we demonstrated that PA might have long-term
beneﬁcial effects on ADHD symptoms. These ﬁndings,
therefore, strengthen and extend the limited body of
research conducted to date that suggests that PA improves
symptoms and impairments associated with ADHD.16
Although previous research suggested a differential effect
of PA on inattention and hyperactivity/impulsivity symp-
toms,18,20,21 we found that PA in late adolescence had a
positive impact on both inattention and hyperactivity/
impulsivity symptom levels in early adulthood. Conse-
quently, PA may offer beneﬁts to individuals across devel-
opment. As ADHD is often chronic, with prominent
symptoms and impairment spanning from childhood into
adolescence and adulthood,2 these ﬁndings provide support
for the idea that PA may represent a promising protective
factor and treatment target for ADHD. The implementation
of lifestyle changes in the form of more PA incorporated into
daily routines, promoting an individual’s physical health,
behavior, and neuropsychological functioning, may have the
potential for ﬂattening the adverse trajectory of the disorder
and yielding long-term improvements. However, the effect
of PA on ADHD symptoms was small to moderate ("0.21)
in this population-based sample of twins, and further
research is needed to ﬁrmly establish the positive effect of
PA and its magnitude in clinical populations. Although the
pathways via which PA may inﬂuence ADHD symptoms
remain to be elucidated, the up-regulation of brain-derived
neurotrophic factor (BDNF) is 1 potential mechanism by
which PA could induce its positive effects on ADHD
symptoms. However, the strength of the association between
BDNF and ADHD in humans remains unclear.16
One limitation of this study lies in the use of continuous
ADHD symptom ratings in a population-based sample rather
than a focus on clinically diagnosed cases. Consequently, we
cannot be certain that these ﬁndings will generalize to clinical
populations of individuals diagnosed with ADHD, and no
ﬁrm conclusions about the clinical utility of PA onADHD can
yet be drawn. Furthermore, the analysis yielded a small to
moderate effect size ("0.21) with uncertain impact on in-
dividuals with high levels of ADHD symptoms and impair-
ments. However, the use of a large unselected sample may
also be regarded as a strength because it decreases the risk of
referral and selection biases associated with a clinical sample.
Another limitation of this study is thatwe couldnot control for
all factors thatwere not shared between theMZ twins and that
may have inﬂuenced PA, ADHD symptoms, or the associa-
tion between PA and ADHD symptoms. Yet we were able to
adjust for all shared genetic and environmental factors aswell
as for ADHD symptom levels and BMI at baseline (2 poten-
tially important unshared confounders of the association) by
using ﬁxed effects. The use of self-report to measure PA could
be considered a limitation of our study32 because individuals
with high levels of ADHD symptoms might report less accu-
rately on PA due to difﬁculties with time estimation, EF, and
workingmemory. Yet this issue is likely to be less pronounced
in our unselected general population sample. Furthermore,
our measure of ADHD symptoms has not been formally
validated. Although we used cross-informant data (i.e.,
parent-report for ADHD, self-report for PA), relying on a
single source of informant (e.g., lack of teacher report) to
assess ADHD symptoms may be regarded as another limita-
tion. However, DSM-based parent-rating scales have been
shown to predict interview-based diagnoses in childhood
and adulthood with adequate sensitivities and speciﬁcities,33
and our ADHD instrument has been used in several epide-
miological studies previously and has reproduced several
TABLE 2 Descriptive Statistics for Raw (Nonstandardized) Scores
Characteristic Mean SD Range
Weekly EE (MET-min/week) at age 16e17 44.47 30.46 0e153
Total ADHD symptoms at age 16e17 1.12 1.95 0e17
HI symptoms at age 16e17 0.32 0.88 0e9
IA symptoms at age 16e17 0.81 1.45 0e8
BMI at age 16e17 20.6 2.87 11.7e33.5
Total ADHD symptoms at age 19e20 2.50 3.48 0e28
HI symptoms at age 19e20 1.20 1.79 0e16
IA symptoms at age 19e20 1.30 2.18 0e18
Note: ADHD ¼ attention-deficit/hyperactivity disorder; BMI ¼ body mass index; EE ¼ energy expenditure; HI ¼ hyperactive/impulsive; IA ¼ inattentive; MET-min/
week ¼ metabolic equivalent of task minutes per week; SD ¼ standard deviation.
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well-established ﬁndings in the ADHD literature29,34-36.
Finally, this study lacked a randomized prospective design.
Future randomized control trials will therefore have to sub-
stantiate the potential of PA to act as a protective factor
for ADHD.
In line with a causal hypothesis, PA was inversely asso-
ciated with total ADHD, hyperactivity/impulsivity, and
inattention symptoms, even after adjusting for unmeasured
confounding factors, as well as ADHD symptom levels and
BMI at baseline, indicating that PA may represent a pro-
tective factor for ADHD and a novel treatment target. Yet
research into the efﬁcacy of PA as an intervention for ADHD
is in its infancy. Methodologically robust, blinded, ran-
domized controlled trials using objective measures of PA are
needed to investigate the effect of both acute and chronic PA
on ADHD. In addition, prospective longitudinal studies are
needed to establish whether any short-term effects are fol-
lowed by longer-term beneﬁts. In the future, the intensity,
frequency, and duration of PA required to yield beneﬁts for
individuals with ADHD will need to be established.
Whether PA lends itself to early intervention and prevention
strategies also remains to be elucidated. Studies will need to
afﬁrm whether and to what extent factors such as age, ﬁtness
levels, or ADHD symptom severity affect who is likely to
respond to a PA-based intervention. It remains to be seen
what the mechanisms are that underlie the positive effect of
PA on ADHD symptoms and how far the effect extends
beyond the core symptoms of ADHD. &
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Chapter 7. General discussion and conclusions 
7.1 Summary of aims 
The overall aim of this thesis was to study the association of attention-
deficit/hyperactivity disorder (ADHD) with bipolar disorder (BD) and preterm 
birth, and to investigate the risk or protective factors IQ and physical activity 
(PA), using a combination of cognitive-neurophysiological and genetically-
sensitive longitudinal designs. The objective of the first data-based chapter 
(chapter 2) of this thesis was a cross-disorder comparison between ADHD and 
BD. This cross-disorder comparison aimed to examine the cortical activity 
patterns that may underlie the symptom overlap between the two disorders 
using quantitative EEG (QEEG), in order to explore biomarkers, which may aid 
clinical differentiation of these disorders. The following two data-based chapters 
(chapters 3 and 4) aimed to investigate the cognitive-neurophysiological profile 
of adolescents born preterm using QEEG and ERP measures. By directly 
comparing the cognitive-neurophysiological profile of adolescents born preterm 
to the cognitive-neurophysiological profile of adolescents with ADHD and 
healthy controls, this thesis aimed to investigate whether the ADHD-like 
symptoms and cognitive impairments seen in preterm-born adolescents are 
identical to those linked to ADHD. In addition, chapters 3 and 4 aimed to 
examine the relationship of age with EEG spectral power and ERP components 
respectively in our sample of adolescents born preterm, term-born adolescents 
with ADHD and term-born controls. The next two data-based chapters then 
employed genetically-sensitive longitudinal designs to examine IQ and physical 
activity (PA) as risk and protective factors for ADHD. The aim of chapter 5 was 
to establish the developmental pattern of the association of ADHD symptoms 
with verbal and performance IQ and to examine the genetic and environmental 
aetiologies of the association of ADHD symptoms with verbal and performance 
IQ within time point, and their stability across time in a population-based twin 
sample. The final study (chapter 6) aimed to investigate the effect of PA during 
late adolescence on ADHD symptoms in early adulthood in a sample of 
monozygotic twins, while controlling for unmeasured genetic and shared 
environmental confounding factors that may influence the relationship between 
PA and ADHD symptoms. In this concluding chapter, the key findings of this 
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thesis will be summarised to draw together common themes and to link the 
findings to their wider implications for ADHD, BD and preterm birth. Strengths 
and limitations of the studies, as well as future directions, will also be outlined.  
 
7.2 Key findings 
7.2.1 Commonalities in EEG spectral power abnormalities between ADHD 
and bipolar disorder during rest and cognitive performance 
While ADHD and BD denote distinct psychiatric conditions, diagnostic 
delineation is impeded by considerable symptomatic overlap. Using a sample of 
20 women with adult ADHD, 20 women with BD and 20 control women, we 
investigated whether QEEG identifies differences or similarities between women 
with ADHD and women with BD during resting-state and task conditions. 
Compared to controls, both ADHD and BD participants showed higher frontal 
theta power during the resting-state condition. No significant differences 
emerged between the two clinical groups. Whereas control participants 
demonstrated an increase in frontal theta power from rest to cognitive task 
condition, no task-related change in frontal theta power was found in the ADHD 
and BD groups. These findings suggest commonalities in brain dysfunction 
between ADHD and BD. Theta power may play a role as a marker of 
neurobiological processes in both disorders. Furthermore, this study was the 
first to investigate the EEG patterns during both rest and task conditions in 
women with adult ADHD. The results support previous research in an all-male 
sample, which showed no differences in cortical activation between controls and 
individuals with ADHD during the cognitive task and no change in spectral 
power from resting-state to cognitive task condition (Skirrow et al., 2015), 
suggesting that cortical activation patterns are similar in men and women with 
adult ADHD.  
 
7.2.2 Altered EEG spectral power in adolescents with ADHD and preterm 
born adolescents during rest and cognitive performance  
Similar to chapter 2, chapter 3 aimed to investigate the commonalities and 
differences in brain dysfunction between ADHD and preterm birth using 
quantitative EEG in adolescents born preterm, term-born adolescents with 
ADHD and term-born controls during resting-state and cognitive task conditions. 
 166 
Preterm birth has been associated with a cognitive profile that resembles ADHD 
as well as with ADHD diagnosis per se. Few studies have directly compared 
individuals with ADHD and individuals born preterm on cognitive-
neurophysiological measures. Consequently, chapter 3 aimed to examine if 
similarities or differences in cortical arousal emerge between adolescents with 
ADHD and adolescents born preterm during a resting-state condition with eyes 
open and a continuous performance test with flankers (CPT-OX). Delta power 
was the only frequency band to demonstrate a significant group-by-condition 
interaction. While the ADHD group did not differ significantly from the preterm 
and control groups during rest with regard to delta power, during CPT-OX the 
ADHD group showed significantly increased delta power compared to both the 
preterm and control groups. The preterm group did not differ significantly from 
the control group with regard to delta power during EO or CPT-OX. The group 
differences were likely driven by differences in rest-to-task transition effects 
between the groups, namely a significant increase in delta power from EO to 
CPT-OX in the ADHD and control groups, and no change in delta power from 
EO to CPT-OX in the preterm group. These results provide some of the first 
QEEG evidence for differences in oscillation patterns in the delta range, 
especially with regard to rest-to-task transition effects between term-born 
adolescents with ADHD and adolescents born preterm. In addition, this study 
did not replicate previous findings with regard to rest-to-task transition effects in 
adults with ADHD (Skirrow et al. 2015, chapter 2). In samples of men (Skirrow 
et al., 2015) and women (chapter 2) with adult ADHD, we demonstrated that, 
compared to controls, theta power was significantly increased in individuals with 
ADHD during the resting-state condition but that theta did not differ between 
controls and individuals with ADHD during the CPT-OX. This pattern of findings 
was driven by a lack of change in EEG spectral power from resting-state to 
cognitive task condition in the ADHD group. Differences in sample ages may 
have contributed to the discrepancies between the current findings in 
adolescents (chapter 3) and previous findings in adults with ADHD (chapter 2; 
Skirrow et al., 2015), as suggested by the current analysis (chapter 3), which 
demonstrated a negative moderate-to-large relationship of age with EEG 
spectral power in the delta bands across all three groups. 
 
 167 
7.2.3 Neurophysiological impairments of attention and inhibition: a 
comparison of adolescents with ADHD and adolescents born preterm 
To further investigate commonalities and differences in brain dysfunction 
between ADHD and preterm birth, the next study (chapter 4) compared ERP 
measures associated with attentional and inhibitory processing in adolescents 
with ADHD and adolescents born preterm. Impairments in attentional 
processing and response inhibition have previously been demonstrated in both 
individuals with ADHD and individuals born preterm but it remained unclear 
whether the impairments in individuals born preterm reflect identical 
impairments in individuals with ADHD. This chapter, therefore, aimed to 
establish whether the attention and inhibitory control impairments associated 
with preterm birth reflect identical neurophysiological impairments in term-born 
individuals with ADHD. Go-P3 amplitude was reduced, reflecting impaired 
response execution, in preterm-born adolescents compared to both control 
adolescents and adolescents with ADHD. Moreover, in adolescents born 
preterm CNV amplitude was attenuated, reflecting impairments in response 
preparation, compared to controls but not compared to adolescents with ADHD. 
The preterm group demonstrated significantly reduced NoGo-P3 amplitude, 
reflecting impaired response inhibition, compared to the control group at Cz but 
the two groups did not differ significantly at FCz. The preterm group further 
showed significantly increased NoGo-P3 amplitude compared to the ADHD 
group at FCz but not at Cz. Compared to the control group, NoGo-P3 amplitude 
was attenuated in the ADHD group at Cz but not at FCz. These findings indicate 
impairments in attentional orienting, response execution and response inhibition 
in adolescents born preterm. While some of the impairments found in 
adolescents born preterm overlap with those found in term-born adolescents 
with ADHD, the preterm group also showed unique deficits, suggesting that the 
deficits seen in the preterm group may be more wide-ranging than the deficits in 
the ADHD group.  
 
7.2.4 A longitudinal twin study of the direction of effects between ADHD 
symptoms and IQ  
As well as being associated with the specific cognitive impairments outlined 
above, ADHD symptoms are associated with overall lower general cognitive 
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ability (i.e.IQ scores). While the negative association between ADHD symptoms 
and IQ is well documented, our knowledge about the direction and aetiology of 
this association is limited. Making use of the genetic sensitivity and time-
ordered nature of our twin data, we employed a cross-lagged model to explore 
the association of ADHD symptoms with verbal and performance IQ 
longitudinally in a population-based sample of 4,771 adolescent twin pairs. 
While time-specific aetiological influences emerged for each trait at ages 14 and 
16 years, the aetiological factors involved in the association between ADHD 
symptoms and IQ were stable over time. ADHD symptoms and IQ scores 
significantly predicted each other over time. ADHD symptoms at age 12 years 
were a significantly stronger predictor of vocabulary and Raven’s scores at age 
14 years than vice versa, whereas no differential predictive effects emerged 
from age 14 to 16 years. These findings indicate that ADHD symptoms may put 
adolescents at risk for decreased IQ scores. Persistent genetic influences seem 
to underlie the association of ADHD symptoms and IQ over time.  
 
7.2.5 Is Physical Activity Causally Associated With Symptoms of ADHD? 
Emerging evidence suggests that PA enhances cognition and may be a 
protective factor for ADHD. Yet, the impact of PA on ADHD symptoms had been 
investigated only in a few undersized, non-randomised, and retrospective 
studies. We investigated the impact of PA (measured as weekly energy 
expenditure) during late adolescence on ADHD symptoms in early adulthood in 
232 monozygotic twin pairs, while controlling for unmeasured genetic and 
shared environmental confounding using a within-monozygotic twins fixed-
effects model. Greater weekly energy expenditure in adolescence was 
significantly associated with reduced ADHD symptom levels in early adulthood, 
even when controlling for all genetic and shared environmental factors shared 
within monozygotic (MZ) twin pairs, as well as ADHD symptoms and BMI at 
baseline. We found similar results for the two ADHD sub-components 
hyperactivity-impulsivity and inattention. These findings are in line with a causal 
relationship and suggest that PA in adolescence might decrease ADHD 
symptoms in early adulthood. 
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7.3 Wider implications 
ADHD is best conceptualised in a developmental framework (Frick & Nigg, 
2012; Schmidt & Petermann, 2009). Although the supporting evidence is 
inconsistent (Cheung et al., 2015a; van Lieshout, Luman, Buitelaar, Rommelse, 
& Oosterlaan, 2013), one neurodevelopmental model of ADHD views the 
disorder as resulting from early aberrations in brain development that remain 
relatively static throughout an individual’s life. However, the plasticity of the 
brain and its interconnected neural circuits allow for recovery from ADHD 
symptoms and associated impairments over the course of development 
(Halperin & Schulz, 2006). Consequently, risk and protective factors may not 
only contribute to the initial development of the disorder, but may also play an 
important role in the developmental course and outcome of ADHD during 
adolescence and adulthood. 
 
7.3.1 Risk and protective factors  
While genetic factors play a key role in the susceptibility to ADHD (Burt, 2009; 
Wood, Buitelaar, et al., 2010), environmental factors also contribute to the 
development of the disorder and associated impairments (Thapar, Cooper, 
Jefferies, & Stergiakouli, 2012). The effects of genetic risks on development 
may depend on exposure to either adverse or enriched environments (Belsky & 
Pluess, 2009; Rutter, 2002), meaning that specific environmental factors may 
pose a risk for or provide protection from adverse long-term outcome in 
individuals with ADHD.  
 
Chapter 4 provides evidence for response preparation and response inhibition 
impairments shared between adolescents born preterm and term-born 
adolescents with ADHD, suggesting that preterm birth may be a risk factor for 
ADHD. However, chapters 3 and 4 also demonstrated differences in 
neurophysiological impairments between term-born adolescents with ADHD and 
adolescents born preterm. In chapter 3, different cortical activation patterns in 
the delta band emerged between adolescents with ADHD and adolescents born 
preterm, especially with regard to rest-to-task transition effects. In addition, 
chapter 4 indicates a distinct impairment in response execution in adolescents 
born preterm, as well as a more frontally distributed NoGo-P3 component, 
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reflecting response inhibition, compared to term-born adolescents with ADHD. 
These differences in neurophysiological impairments between term-born 
adolescents with ADHD and adolescents born preterm may indicate more wide-
ranging deficits in the preterm group. This idea is supported by research 
suggesting that, as well as being a risk factor for ADHD, preterm birth 
represents a risk factor for other psychiatric disorders, such as schizophrenia, 
bipolar disorder and autism spectrum disorder (D’Onofrio et al., 2013; Johnson 
& Marlow, 2014; Moster et al., 2008; Treyvaud et al., 2013). The late third 
trimester (32–40 weeks’ gestation) serves as a critical period to lay the 
foundation of vital brain networks (Ball et al., 2014; van den Heuvel et al., 
2014). It is, therefore, conceivable that preterm birth may result in trauma to the 
brain networks associated with ADHD, as well as other networks associated 
with additional impairments. These results, and the findings that ADHD 
symptom scores are increased in the preterm group compared to controls, 
suggest that preterm birth may present a risk factor for both ADHD and 
additional impairments. 
 
Investigation of the effects of risk and protective factors during adolescence is 
vital, since this period is one of rapid developmental change during which 
ADHD symptoms can diminish in severity (Willcutt, 2012). Moreover, individuals 
with high levels of ADHD symptoms are at increased risk of continuing 
problems related to ADHD during adolescence (Biederman et al., 2011; 
Rasmussen & Gillberg, 2000). Chapter 5 demonstrated that, during 
adolescence, IQ and ADHD symptoms significantly predicted each other over 
time. These findings suggest that ADHD symptoms affect IQ scores, 
conceivably because ADHD symptoms may interfere with opportunities to 
benefit from education and other ways to enhance general cognitive ability. In 
addition, these findings indicate that low IQ may be a risk factor for the 
persistence of ADHD symptoms over time. This idea is supported by previous 
research, which demonstrated that higher IQ predicts improved long-term 
cognitive and functional outcome (Brocki, Nyberg, Thorell, & Bohlin, 2007; 
Molina et al., 2009), as well as remittance from ADHD in adolescence (Cheung 
et al., 2015b). While future studies are needed to confirm our findings, these 
results emphasise the importance of early identification and intervention for 
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adolescents with ADHD who have lower general cognitive ability, as they are 
most at risk of adverse long-term outcome.  
 
An environmental factor that might influence the developmental trajectory or 
course of ADHD during adolescence and adulthood is physical activity. Our 
recent review, which indicated that exercise has the potential to act as a 
protective factor for ADHD symptoms and associated impairments (Rommel et 
al., 2013, see Appendix 1), received support from the analysis in chapter 6. 
Chapter 6 examined the effect of PA during late adolescence on ADHD 
symptoms in early adulthood in a population-based sample of MZ twins. In line 
with a causal hypothesis, PA showed an inverse association with ADHD 
symptoms, even after genetic and shared environmental factors, as well as 
baseline ADHD symptoms and BMI, were adjusted for. These findings raise the 
possibility that lifestyle factors have the potential to impact the trajectory of 
ADHD symptoms and to lower rates of ADHD persistence from adolescence to 
adulthood. 
 
It is conceivable that PA and other risk or protective factors impact on the 
ADHD trajectories via epigenetic processes (Cortessis et al., 2012), which 
developmentally regulate gene expression independently of the DNA sequence 
via modifications to DNA, histone proteins and chromatin (Henikoff & Matzke, 
1997) and which may set off a cascade of processes that could ultimately link to 
changes in brain function. 
 
7.3.2 Overlap between ADHD and associated traits and disorders 
By investigating ADHD within a developmental framework, one important aspect 
to consider is ADHD in adulthood and how adult ADHD may overlap with or 
differentiate from other adulthood disorders. While diagnostic manuals such as 
the DSM (American Psychiatric Association, 2013) describe clinical diagnoses 
in a categorical system based on behavioural symptoms, studies have 
established considerable evidence for pathophysiological within-disorder 
heterogeneity (Burdick et al., 2015; Sjöwall et al., 2013), as well as pathogenic 
overlap between disorders (Lee et al., 2013; Michelini et al., 2015); Skirrow et 
al., 2014, 2012). Consequently, diagnostic boundaries based on behavioural 
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symptoms do not seem to correspond seamlessly to findings from 
neuropsychological and genetic studies, and have been only moderately 
successful at predicting treatment outcome (Ostacher et al., 2015; Retz & Retz-
Junginger, 2014).  
 
The results in chapter 2 provide evidence for commonalities in brain dysfunction 
between ADHD and BD, with frontal theta power potentially playing a role as a 
marker of shared neurobiological processes in both disorders. In light of shared 
cognitive impairments and the overlapping symptomatology of ADHD and BD, 
these findings represent a move towards uncovering biological markers 
underlying the pathophysiology shared between the disorders. As highlighted by 
chapter 2, as well as chapters 3 and 4, EEG and ERP studies can help to 
elucidate impairments in specific components of neurocognitive systems. While 
initially based on categorical definitions of disorder, these approaches may 
further our understanding of the relationship between behaviour and cognitive-
neurophysiological abnormalities and provide insight into within-disorder 
heterogeneity as well as the commonalities and characteristic differences 
between disorders. By identifying syndromes and impairment based on 
pathophysiology, it may eventually be possible to move beyond diagnostic 
boundaries (Insel et al., 2010). This could lead to more objective and precise 
approaches to diagnosis and prognosis and may eventually result in improved 
interventions and long-term outcome (Casey et al., 2014).  
 
7.3.3 Age effects 
Differences in sample ages may have contributed to the rest-to-task transition 
effect discrepancies between the QEEG findings in the adult samples in chapter 
2 and previous work (Skirrow et al., 2015) and the QEEG findings in the 
adolescent samples in chapter 3. While chapter 2 and previous research on 
adults showed a lack of change in slow EEG spectral power (theta) from 
resting-state to cognitive task condition in the ADHD group (Skirrow et al. 2015, 
chapter 2), in chapter 3 a significant increase in delta power from EO to CPT-
OX was found in the ADHD group. The idea that this discrepancy can be 
attributed to age effects is supported by the negative moderate-to-large 
relationship of age with EEG spectral power in the delta band in chapter 3.  
 173 
 
Moreover, in chapters 3 and 4, even when statistically controlling for age, 
different patterns of findings emerged for the full sample, which was not 
matched on age, compared the age-matched subsample, further indicating age 
effects. Age has previously been shown to impact EEG spectral power in other 
studies of ADHD (Buyck & Wiersema, 2014; Liechti et al., 2013; Monastra et al., 
2001). Research indicates the possibility that developmental trajectories of EEG 
spectral power in individuals with ADHD may not be linear throughout the 
lifespan but may deviate in late childhood (Liechti et al., 2013) or adulthood 
(Poil et al., 2014). While one study demonstrated increased theta power during 
EO in adolescents with ADHD (mean age=12.81, SD=1.54), but not in children 
(mean age=9.47, SD=0.84) or adults with ADHD (mean age=42.7, SD=4.4) 
(Liechti et al., 2013), another study found an atypical developmental trajectory 
only in adults with ADHD (Poil et al., 2014). Age effects may, therefore, also 
explain the inconsistency in the ADHD EEG literature more generally. They 
further highlight that the use of increased theta:beta ratio as a marker of ADHD 
diagnosis (Snyder & Hall, 2006) is not only controversial but fraught with 
problems of stability and reliability (Arns et al., 2013; Jeste et al., 2015). Future 
research must be aware of age effects and the heterogeneity introduced by 
wide age ranges, particularly in adolescent samples. Longitudinal studies are 




7.4.1 Effects of medication 
Potential effects of medication are a typical challenge associated with 
psychiatric cross-disorder research. In chapters 2, 3 and 4, individuals with 
ADHD refrained from taking stimulant medication for 48 hours prior to the 
testing session. Consequently, the results of these studies cannot be attributed 
to any short-term effects of stimulant medication. Yet, long-term effects of 
medication use cannot be precluded. In chapter 2, individuals in the BD group 
and some individuals in the ADHD group were taking non-stimulant medication. 
For ethical reasons due to the potential risk of adverse effects from 
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discontinuation of treatment, participants were not asked to stop taking mood 
stabilisers, anti-psychotic medication or anti-depressants, which they had been 
prescribed. Although the understanding of the effects of medications on QEEG 
is still limited, no significant differences between medicated and unmedicated 
individuals with euthymic BD on QEEG have been found (Degabriele & 
Lagopoulos, 2009). It is, therefore, unlikely that the results in this study are a 
result of medication effects. However, medication cannot be excluded as a 
potential confounder factor and studies of non-medicated individuals are 
needed to elucidate the effects of medication on EEG power. 
 
7.4.2 Generalisability  
The age ranges of the samples included in this thesis were restricted to 
adolescence (chapters 3, 4, 5 and 6) or adulthood (chapters 2 and 6). It is, 
therefore, unclear whether results from this thesis can be generalised to earlier 
or later earlier stages in development. Maturational effects on EEG and ERP 
measures are well documented (Buyck & Wiersema, 2014; Clarke et al., 2001; 
Gasser, Verleger, et al., 1988; John et al., 1980; Doehnert et al., 2010, 2013; 
Fallgatter et al., 1999; Liechti et al., 2013; Matoušek & Petersén, 1973; Somsen 
et al., 1997; Zurrón et al., 2014). Furthermore, estimates of genetic and 
environmental effects, as in chapter 5, are always based on a specific 
population at a specific point in time (Plomin, DeFries, McClearn, & McGuffin, 
2008). To understand the neurophysiological impairments of ADHD and 
associated disorders, as well as the aetiological relationship between ADHD 
and risk and protective factors across the lifespan, replication of these 
investigations at different developmental stages is required. Longitudinal studies 
may contribute further to the understanding of stability and change in these 
impairments and associations.  
 
In addition, preterm (Kerr-Wilson et al., 2012) and control participants included 
in the analyses in chapters 2, 3 and 4 exhibited above average IQ and may, 
therefore, not be fully representative of more typical preterm and control 
samples. Whether the findings based on these groups generalise to more 
typical preterm-born individuals and typically-developing controls remains to be 
tested in future studies of individuals with more characteristic IQ profiles. 
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Moreover, the investigation in chapter 2 was conducted in a homogenous all-
female sample. Research in all-female ADHD samples is still limited because of 
the higher rates of ADHD symptoms and diagnoses consistently reported for 
boys (Willcutt, 2012). Yet, the increased representation of females and the 
approximately equal distribution of males and females in adults with ADHD 
(Biederman et al., 1994; Biederman et al., 2004; Rucklidge, 2010) necessitate 
this research. Although gender differences were not tested directly, the results 
replicate previous work in an all-male sample (Skirrow et al., 2015), rendering 
gender effects unlikely. 
 
Chapters 5 and 6 used population-based samples of twins to investigate the risk 
or protection factors IQ and PA. Consequently, the results may not generalise to 
clinical samples. The associations of ADHD symptoms with verbal and 
performance IQ, for instance, have been found to be greater (Frazier et al., 
2004; Rommelse et al., 2008) and may, therefore, differentiate in individuals 
diagnosed with ADHD. Yet, examining large unselected general population 
samples decreases the risk of possible selection biases associated with clinical 
samples. In addition, previous studies have demonstrated that the clinical 
disorder represents the extreme of a trait that varies continuously throughout 
the population rather than being qualitatively different (Frazier et al., 2007; 
Haslam et al., 2006; Larsson et al., 2012; Lubke et al., 2009), suggesting that 
the results may extend to clinical populations. Nevertheless, future research will 
have to examine how clinical impairment, the diagnostic requirement in addition 
to ADHD symptoms, influences the pattern of results. 
 
7.4.3 Rater effects 
In chapters 3 to 6 of this thesis, ADHD symptom ratings were based on parent-
report. Whereas multiple-informant accounts are the gold standard for a 
systematic evaluation of ADHD symptoms and to establish the pervasiveness of 
these symptoms across settings (American Psychiatric Association, 2013; 
Taylor et al., 2004; World Health Organization, 1992), parent-rated ADHD 
symptoms demonstrate the highest and most consistent heritability estimates 
compared to self- and teacher-ratings (Nikolas & Burt, 2010). Moreover, the 
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predictive validity of parent-report with regards to long-term outcome is more 
accurate than that of self-report in child and adolescent samples (Barkley et al., 
2002).  
 
The use of self-report to measure PA in chapter 6 may also be considered a 
limitation (Paulhus & Vazire, 2007), because due to difficulties with time 
estimation, executive function (EF) and working memory, individuals with high 
levels of ADHD symptoms might report less accurately on PA. Yet, in our 
unselected population-based twin sample this issue is likely to be less 
pronounced. In addition, the use of cross-informant data (i.e. parent-report for 
ADHD symptoms and self-report for PA) can be seen as a strength.  
 
7.5 Future directions 
7.5.1 Replication  
The research conducted for this thesis, especially in chapters 2, 3 and 4, was 
the first of its kind and requires replication in large, independent samples before 
firm conclusions can be drawn. Future studies should include samples at 
different developmental stages to understand the change and stability of 
cognitive-neurophysiological abnormalities in individuals with ADHD and BD 
across the lifespan. Findings from these studies may inform the research on 
maturational effects on EEG and ERP measures as well as age-related decline. 
In addition, longitudinal investigations may elucidate these issues further. 
Longitudinal studies may also further our understanding of the discrepancy in 
QEEG findings between individuals with adult ADHD and adolescents with 
ADHD in chapters 2 and 3. In addition, ADHD and BD symptoms as well as 
gestational age lie along a continuum and should be explored as continuous 
variables, for example by investigating whether a dose effect in the degree of 
prematurity exists in relation to ADHD-like symptoms or ADHD diagnosis.  
 
7.5.2 Advanced EEG analysis approaches 
High variability in performance measures and cognitive-neurophysiological 
responses has been demonstrated in ADHD (Castellanos et al., 2005; Frazier-
Wood et al., 2012; Kuntsi & Klein, 2012; Uebel et al., 2010). Yet, most EEG and 
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ERP analyses involve the enhancement of the signal-to-noise ratio by means of 
averaging data, at the expense of trial-by-trial variations for the individual. As a 
result, the underlying intra-individual variability in cognitive-neurophysiological 
responses in ADHD is not fully reflected in EEG and ERP findings.  
 
Approaches such as time-frequency analysis and individual-level ICA have the 
potential to directly explore the degree of intra-individual variability in EEG or 
ERP responses on a trial-by-trial basis, enabling the investigation of lapses of 
attention thought to underlie RTV (Kuntsi & Klein, 2012). The use of these state-
of-the-art techniques may further increase the low signal-to-noise ratio in 
cognitive-neurophysiological data and afford finer resolution. Lastly, time-
frequency analysis and individual-level ICA may help to elucidate the 
significance of EEG spectral power by allowing for the exploration of the various 
cognitive processes underlying task performance (Lenartowicz et al., 2014; 
McLoughlin, Makeig, et al., 2014; McLoughlin, Palmer, et al., 2014). This last 
point may be particularly important to understand findings such as the increased 
delta (chapter 3) power in individuals with ADHD during cognitive task 
performance, which could reflect compensatory mechanisms (Lenartowicz et 
al., 2014).  
 
7.5.3 Sibling model fitting 
Another future direction, using the preterm and control sibling pairs, is structural 
equation model-fitting to explore the extent to which the covariance between the 
cognitive-neurophysiological variables and ADHD symptoms can be explained 
by familial or non-shared influences. We further plan to investigate the degree 
to which a separation between a non-shared insult pathway to cognitive-
neurophysiological impairments is observed among the preterm-born 
adolescents and a familial pathway is observed among the adolescents with 
ADHD. As well as looking at preterm birth as a categorical condition, we will 
conduct the analyses using continuous proxies of preterm birth, namely 
gestational age and birth weight.  
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7.5.4 Investigation of the effects of physical activity in ADHD 
Better-quality evidence is required to firmly establish the nature and extent of 
positive effects of PA on individuals with ADHD. Both acute and chronic effects 
of PA on ADHD need to be investigated in large, adequately powered, blind 
sham-controlled randomised clinical trials. In addition, follow-up studies are 
needed to establish whether any short-term effects are followed by longer-term 
benefits of both acute and chronic PA. As PA can elicit gene expression 
changes mediated by alterations in DNA methylation (Barrès et al., 2012; Nitert 
et al., 2012; Rönn et al., 2013; Voisin, Eynon, Yan, & Bishop, 2014), the 
possibility emerges that some of the positive effects of PA could be caused by 
epigenetic mechanisms. Consequently, we aim to investigate the effects of 
acute exercise and habitual physical activity on cognition and brain function, as 
well as the potential underlying molecular mechanisms, in our sample of young 
adults with childhood ADHD and the population-based controls as well as their 
siblings (the ADHD and control sibling pairs used in chapters 3 and 4). We plan 
to investigate whether individuals with higher levels of current habitual PA and 
aerobic fitness show greater improvement on the cognitive-neurophysiological 
test battery and ADHD symptoms over time. Moreover, we will test whether the 
effects of PA and fitness on cognitive-neurophysiological performance and 
ADHD symptoms remain after controlling for familial factors. Lastly, in a 
randomised controlled trial we plan to explore whether acute exercise induces 
cognitive-neurophysiological, epigenetic, cortisol and skin conductance 
changes. Future prospective longitudinal studies are also needed to establish 
whether any short-term effects are followed by longer-term benefits. In the 
future, the intensity, frequency, and duration of PA required to yield benefits for 
individuals with ADHD will need to be established. Studies will need to affirm 
whether and to what extent factors such as age, fitness levels, or ADHD 
symptom severity affect who is likely to respond to a PA-based intervention.  
 
7.6 Overall conclusions 
In summary, this thesis employed a combination of cognitive-neurophysiological 
as well as genetically-sensitive longitudinal designs to study the relationship of 
ADHD with bipolar disorder and preterm birth, as well as the risk or protective 
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factors of IQ and physical activity. The findings suggest commonalities in brain 
dysfunction between ADHD and BD, with frontal theta power potentially playing 
a role as a marker of shared neurobiological processes in both disorders. Term-
born individuals with ADHD and individuals born preterm demonstrated both 
differences and similarities in brain function. While we found deviating 
abnormalities in EEG spectral power between ADHD and preterm birth, 
differences as well as similarities in ERP components emerged, pointing to 
more wide-ranging impairments in preterm birth. The results from this thesis 
further suggest that ADHD symptoms may put adolescents at risk for decreased 
IQ scores, and vice versa. These findings highlight the need for early 
identification and intervention for those adolescents with ADHD who have lower 
general cognitive ability, to reduce ADHD symptoms and the risk for lower IQ 
and associated long-term consequences. PA, on the other hand, may represent 
a protective factor for ADHD and a novel treatment target, showing an inverse 
association with total ADHD, hyperactivity-impulsivity and inattention symptoms, 
even after adjusting for unmeasured confounding factors, as well as ADHD 
symptom levels and BMI at baseline. Overall, by using a combination of 
cognitive-neurophysiological and genetically-sensitive longitudinal designs, we 
demonstrated certain commonalities in brain dysfunction between ADHD and 
BD. Whereas preterm birth and lower IQ present risk factors for ADHD, physical 
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Protection From Genetic Diathesis in Attention-
Deﬁcit/Hyperactivity Disorder: Possible
Complementary Roles of Exercise
Anna-Sophie Rommel, M.Sc., Jeffrey M. Halperin, Ph.D., Jonathan Mill, Ph.D.,
Philip Asherson, Ph.D., M.D., Jonna Kuntsi, Ph.D.
Objective: The degree of functional impairment and adverse developmental outcomes in in-
dividuals with attention-deﬁcit/hyperactivity disorder (ADHD) likely reﬂect interplay between
genes and environment. To establish whether physical exercise might reduce the level of ADHD
symptoms or ADHD-related impairments, we conducted a comprehensive review of the effect
of exercise in children with ADHD. Findings on the impact of exercise in animals and typically
developing human beings, and an overview of putative mechanisms involved, are also
presented to provide the context in which to understand this review. Method: The electronic
databases PubMed, OVID, and Web of Knowledge were searched for all studies investigating
the effect of exercise in children and adolescents with ADHD, as well as animal models of
ADHD behaviors (available in January 2013). Of 2,150 initially identiﬁed records, 16 were
included. Results: Animal studies indicate that exercise, especially early in development,
may be beneﬁcial for ADHD symptom reduction. The limited research investigating the effect
of exercise in children and adolescents with ADHD suggests that exercise may improve executive
functioning andbehavioral symptoms associatedwithADHD.Althoughanimal research suggests
that brain-derived neurotrophic factor (BDNF) and catecholamines (CAs) play a role inmediating
these effects, the association between BDNF and ADHD remains unclear in human beings. -
Conclusions: The potential protective qualities of exercise with regard to reducing symptoms
and impairments commonly associated with ADHD may hold promise for the future. Further
research is needed to ﬁrmly establish whether there are clinically signiﬁcant effects of exercise on
the severity of ADHD symptoms, impairments, and associated developmental outcomes.
J. Am. Acad. Child Adolesc. Psychiatry, 2013;52(9):900–910. Key Words: attention-deﬁcit/
hyperactivity disorder (ADHD), epigenetics, exercise, physical activity, protective factors
A ttention-deﬁcit/hyperactivity disorder(ADHD) is a complex neurodevelopmentaldisorder characterized by developmen-
tally inappropriate and impairing levels of hy-
peractivity, impulsivity, and/or inattention.1
ADHD is associated with multiple cognitive
impairments, including lower average IQ,2 im-
pairment in attentional processing, response
inhibition, and other aspects of executive func-
tioning,3 which share genetic/familial risks
with ADHD.3,4 Genetic factors play a pivotal
role in the susceptibility to ADHD, with 60%
to 75% or more of the variance in ADHD
symptoms attributable to genetic variation.5,6
Environmental factors are also likely to con-
tribute to the development of the disorder and
to the associated emotional, behavioral, and
academic difﬁculties.7 Moreover, the effects of
genetic risks on development may depend on
exposure to either adverse or enriched environ-
ments, leading to either negative or positive
long-term outcomes.8,9 Such gene–environment
interactions mean that speciﬁc environments
may be more or less beneﬁcial to the long-term
outcomes in children with ADHD.
Several environmental risk factors have been
linked to ADHD.7 Yet, less attention has been
paid to protective factors that might reduce levels
of ADHD symptoms and impairments associated
This article is discussed in an editorial by Dr. Samuele Cortese
on page 894.
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with the disorder. We deﬁne protective factors as
inﬂuences that increase adaptive functioning
following environmental adversity or genetic
risk. Here, we investigate exercise as a factor that
may diminish an individual’s level of ADHD
symptoms or the impairments associated with the
disorder by modifying the effects of genetic and
environmental risks on developmental outcomes.
We examine exercise as a factor that may
diminish an individual’s likelihood of developing
ADHD or the impairments associated with the
disorder. The idea that exercise may have
protective qualities for individuals with ADHD
gains support from animal research examining
the impact of exercise on neural functioning,
brain growth, and development, as well as from
human studies indicating that exercise positively
affects executive functioning and inhibitory
control in adults and in typically developing
children. Preliminary research has also been car-
ried out to explore the utility of exercise as a
protective factor or alternative treatment strategy
in ADHD. Before providing a comprehensive
review of the role of exercise in ADHD, we will
provide the context in which to understand this
review by presenting research ﬁndings on the
impact of exercise on cognition in animals and in
typically developing human beings, and an
overview of the putative mechanisms involved.
NEUROBIOLOGY OF ADHD
The precise neurobiological mechanisms underly-
ing ADHD are poorly understood. Their
complexity is likely due to the interplay of various
structural, functional, and developmental brain
alterations in individuals with ADHD, such as
abnormalities in the white matter ﬁbers that con-
nect gray matter regions, hypoactivity of frontal
regions, and aberrant or delayed brain develop-
ment.10 Dysregulation of dopaminergic and
noradrenergic neurotransmission has also been
widely implicated in the pathophysiology of
ADHD.11 The catecholaminergic system has been
the key target for pharmacotherapy in ADHD.12
In molecular genetic studies of ADHD, 1 of the
most robust ﬁndings to date is the association with
the 7-repeat allele of the dopamine D4 receptor
gene,13 and catecholamines (CA) are known to play
a pivotal role in the regulation of psychomotor ac-
tivity, motivation, inhibition, and attention,14 all of
which are compromised in ADHD.12 (For compre-
hensive reviews of the neurobiology and genetics
of ADHD, see Cortese10 and Faraone et al.15)
One recent theory has focused on BDNF as a
factor that has an impact on the dopaminergic
function underlying aspects of ADHD.14,16–19 The
idea that BDNF interacts with the dopaminergic
dysfunctions seen in individuals with ADHD was
initially suggested by research showing that
stimulant medications increase the expression of
BDNF in the rat brain,19 in addition to studies
suggesting that there is an association between
genetic variants in BDNF and risk for ADHD. In
a community-based cohort of 1,236 Swedish in-
dividuals assessed at ages 8 to 9, 13 to 14, and 16
to 17 years, the presence of the Val66Met poly-
morphism in BDNF gene was associated with
increased hyperactive–impulsive ADHD symp-
tom counts at ages 8 to 9 and 13 to 14 years.19
However, the overall evidence for the genetic
association of BDNF with ADHD is far from
clear. A recent meta-analysis of published and
unpublished data from 4 different centers (con-
ducted as part of the International Multicentre
Persistent ADHD CollaboraTion [IMpACT])
investigated the association of ADHD with the
most frequently reported BDNF polymorphism,
Val66Met, in a total sample of 1,455 ADHD adults
and 2,247 sex-matched controls.20 The investiga-
tion of these 4 populations yielded no signiﬁcant
association between BDNF genotype and ADHD.
Like several studies before,21–23 the investigation
of these 4 populations yielded no signiﬁcant
association between BDNF and ADHD, high-
lighting the known difﬁculties in replicating
candidate gene association studies; potentially
related to heterogeneity of the genetic effects
across development or related to different clinical
subgroups.
The conception of exercise as a potential pro-
tective factor for ADHD is suggested by animal
literature investigating the positive impacts of
physical activity on neurobiological mechanisms
implicated in ADHD. In healthy rodents, exercise
has been found to augment several factors often
compromised in ADHD: neural plasticity,24
cerebral blood ﬂow,25 levels of synaptic protein,26
and extracellular dopamine and norepinephrine
levels in the central nervous system.27 Further-
more, physical exercise has been shown to lead to
an increase in rodent serum and brain levels of
BDNF, which is part of vital neurodevelopmental
processes central to the survival and differentia-
tion of noradrenergic28 and dopaminergic29 neu-
rons.30–34 This upregulation of BDNF is one
potential mechanism bywhich exercise induces its
positive effects. BDNF levels in the hippocampus
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have been directly linked to the enhancedmemory
and learning processes that are observed with ex-
ercise treatments in rodents.35 One process ex-
pected to mediate the upregulation of BDNF
involves epigenetic inﬂuences on gene expression.
Epigenetic processes, which developmentally
regulate gene expression independently of the
DNA sequence via modiﬁcations to DNA, histone
proteins, and chromatin,36 have been shown to be
sensitive to a range of environmental inﬂuences.37
Indeed, both acute38 and chronic39 exercise have
recently been found to elicit gene expression
changes linked to changes in DNA methylation.
However, the strength of the association between
BDNF and ADHD in human beings and its po-
tential role in eliciting the established positive
effects of exercise on cognition and psychological
health40 remain unclear.
COGNITIVE EFFECTS OF EXERCISE IN
HUMAN BEINGS
Beyond the animal literature, an emerging body of
evidence highlights the beneﬁts of exercise for
human beings.40 Research on the effect of exercise
in human beings has found, for example, that
older adults who were more aerobically ﬁt or who
took part in exercise programs demonstrated
greater task-related activity in areas of the brain
implicated in ADHD; namely, regions of the pre-
frontal and parietal cortices, with the largest
ﬁtness-induced beneﬁts occurring for executive
functions.41 Furthermore, there is evidence that, in
human beings, exercise facilitates catecholamin-
ergic neurotransmission,42,43 augments serum
BDNF levels,31,34 enhances cognitive perfor-
mance, and affects cerebral structures positively
by increasing cortical tissue density and brain
volume.41,44 A meta-analysis of 44 studies, which
investigated the effects of both acute and chronic
exercise on cognition in children, yielded an
overall effect size (ES) of 0.32. Despite the ES being
only moderate, these ﬁndings indicate a signiﬁ-
cant positive effect of exercise on cognitive per-
formance. As the ES of exercise was greater in the
children who were classiﬁed as “mentally
impaired” (0.42), this moderate overall ES may
point to greater beneﬁcial effects of exercise in
children with developmental disorders.45 Other,
more recent reviews of the effects of exercise on
neurotypical children’s intelligence, cognition,
and academic achievement conﬁrmed the posi-
tive effect of exercise, especially on executive
functioning (EF),40,46,47 a cognitive domain often
impaired in individuals with ADHD.48 Chronic
and acute exercise was reported to improve
inhibitory control, whereas the effects on atten-
tion, perception, and visuo-motor coordination
were more limited.
ROLE OF EXERCISE IN ADHD
Animal and neurotypical human studies provide
support for the notion that exercise enhances
brain structure, cognitive performance, and neu-
ral functioning. As enhanced neural functioning
has been suggested to be associated with a
remission of ADHD symptoms,49,50 exercise may
hold promise for preventing the emergence of
ADHD during childhood and as an early inter-
vention in children presenting with high levels of
ADHD symptoms, potentially inducing lasting
changes in ADHD symptom severity. Our aim
here, therefore, is to offer a review of the litera-
ture investigating the effect of exercise in ADHD,
including cognitive impairments as well as
ADHD symptoms, and to provide a rationale for
further research in this area.
SELECTION CRITERIA
A comprehensive review was conducted to
ensure a thorough search of the literature. The
electronic databases PubMed, OVID and Web of
Knowledge were searched. Key words searched
included attention deﬁcit hyperactivity disorder,
ADHD, attention deﬁcit disorder, ADD, and hyper-
kinetic syndrome with either sport*, exercise, or
physical activity. The inclusion criteria for studies
reviewed here were as follows: the paper was
written in English; published in an internationally
peer-reviewed journal before January 2013; par-
ticipants were children and/or adolescents diag-
nosed with ADHD or animal models of ADHD
behaviors; (d) an empirical study (including
correlational, observational and longitudinal
designs) of aerobic exercise. Using these search
terms and inclusion criteria, 2,150 records were
identiﬁed. After screening these records for
eligibility as shown in Figure 151, 16 studies were
included in the comprehensive review. An over-
view of these studies can be found in Table 1.52–67
EFFECTS OF EXERCISE IN ANIMAL
MODELS OF ADHD BEHAVIORS
The impact of voluntary exercise on attentional
functioning in spontaneously hypertensive rats
(SHR), an animal model of ADHD behaviors,
has been investigated in 3 studies by the same
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research group. The ﬁrst and second study ex-
plored exercise effects in adult52 and adolescent54
SHRs, respectively. The third study compared
the effects of exercise on adult SHRs to the effects
of the stimulant drugs methylphenidate (MPH)
and atomoxetine (ATMX).55 In all studies, the
rats in the exercise groups had free access to a
shared running wheel for a few weeks before
and throughout the study. The exercise group
was compared to other SHRs with no access to
a running wheel (nonexercising SHRs). Wistar-
Kyoto rats (WKY) were used as an animal
model of neurotypical behaviors, as they are the
most appropriate controls for rat models of
ADHD behaviors.68 During the orienting proce-
dure, all rats received repeated presentations of a
visual stimulus (light). Hopkins et al.52 showed
that nonexercising adult SHRs demonstrated
more unconditioned orienting behavior, as indi-
cated by rearing up on the hind legs, than WKY.
Exercise reduced orienting in female but not male
adult SHRs.
Exercising adolescent SHRs, similar to exer-
cising female adult SHRs, exhibited levels of
unconditioned orienting behavior resembling
that in WKY.54 Nonexercising adolescent SHRs
showed higher levels of unconditioned orienting
behavior. The authors propose that this indicates
their difﬁculty in ignoring irrelevant stimuli.
Treatment with MPH (0.125 mg/kg), ATMX
(0.125 mg/kg), or exercise also reduced orienting
behavior in female adult SHRs to the level
observed in WKY rats, with exercise just as
effective as MPH or ATMX. Taken together, these
ﬁndings suggest that exercise has a greater effect
in females and earlier on in development.
Unfortunately, ES could not be established from
the data available. These ﬁndings should be
conﬁrmed using quantiﬁable measures of exer-
cise and a standardized measure of attention,
such as a multiple-choice serial reaction time test.
The effects of involuntary exercise and MPH
on activity levels and spatial learning memory
in relation to dopamine synthesis and BDNF
expression have also been explored in SHRs.53
Rats in the MPH group received 1 mg/kg MPH
orally once a day for 28 days, whereas rats in the
exercise group were made to run on a treadmill
FIGURE 1 Flow diagram depicting the number of records identified, included and excluded in the comprehensive
review, and the reasons for exclusions. Source: Moher et al. (2009).51 ADHD ¼ attention-deficit/hyperactivity disorder.
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TABLE 1 Overview of All Studies on Exercise and Attention-Deficit/Hyperactivity Disorder (ADHD) Included in the Comprehensive Review
Reference Design Intervention/Measure of Physical Activity
Sample Size
(Males: Females)
Mean Age (SD) in
Years Unless Stated Cohen’s d
Hopkins et al. (2009)52 Case-control (3 groups) SHR exercise group: 24-hour access to running
wheel, 2 weeks before and throughout study
SHR no-exercise group: no intervention
WKY group: no intervention
69 SHRs (37:32), 29
WKYs (14:15)
8 weeks Orienting behavior;
data not available
Kim et al. (2011)53 Case-control SHR exercise group: low-intensity treadmill running
30 minutes per day, 5 times per week, for 28 days
SHR MPH-treated group: 1 mg/kg MPH orally per
day for 28 days







Robinson et al. (2011)54 Case-control SHR exercise group: 24-hour access to running
wheel, 3 weeks before and throughout study
SHR non-exercise group: no intervention
WKY controls: no intervention
32 SHRs (16:16), 16
WKYs (8:8)
28e32 days Orienting behavior;
data not available
Robinson et al. (2012)55 Case-control SHR exercise group: 24-hour access to running
wheel, 3 weeks before and throughout study;
saline injection
SHR controls: saline-injection SHR MPH-treated
group: 1.0 ml/kg 10 minutes before
behavioral task
SHR atomoxetine-treated group: 1.0 ml/kg













Exercise group: 3 sessions/week for 10 weeks
(aerobic exercise)
Controls: no intervention





Chang et al. (2012)57 Case-control, randomly
assigned
Exercise group: acute moderate-intensity exercise
(30 minutes)
Controls: watched exercise-related video
(30 minutes)


































































Reference Design Intervention/Measure of Physical Activity
Sample Size
(Males: Females)
Mean Age (SD) in
Years Unless Stated Cohen’s d
Gapin et al. (2010)58 Within-group
comparison
Daily step counts and minutes per day spent
in moderate-to-vigorous intensity exercise
over 7 days
18 (18:0) 10.6 (1.5) Tower of London
task: 0.57
Kang et al. (2011)59 Case-control Exercise group: medication and sports therapy
(twelve 90-minute sessions over 6 weeks)
Controls: medication and behavior control
education





Kiluk et al. (2009)60 Within-group
comparison




Clinical comparison Twenty 90-minute sessions (including discussions,
individual sports activity, team games)
32 (32:0) 10.9 (1.6) Total CBCL:0.45
McKune et al. (2003)62 Case-control, allocation
to groups
Exercise group: ﬁve 1-hour sessions per week for
5 weeks
Controls: no intervention
19 (13:6) 11 (1.9) CRS-Parent;
data N/A
Medina et al. (2010)63 Between-group (MPH
users vs. non-users)
comparison
Aerobic exercise for 30 minutes 25 (25:0) 9.5 (2.9) Hit RT SD: 0.49






40 (28:12) 9.6 (0.5) Response
accuracy: 0.94
Tantillo et al. (2002)65 Case-control Two exercise bouts (ﬁrst maximal intensity, second
submaximal intensity), 1 rest condition (silent
cartoon); on consecutive days
43 (21:22) 10 (1.6) Acoustic startle
eye-blink response
latency: 1.14
Verret et al. (2012)66 Case-control Exercise group: Three 45-minute sessions per week
for 10 weeks (moderate-to-vigorous aerobic,
muscular, and motor-skills exercise)
Controls: no intervention




Wigal et al. (2003)67 Case-control Two separate cycle ergometer sessions on different
days within 1 week
18 (18:0) 8.5 (0.5) Catecholamine
response; data
N/A
Note: CBCL ¼ Child Behavior Checklist; CRS ¼ Conners’ Rating Scale; EF ¼ executive function; ES ¼ effect size; SHR ¼ spontaneously hypertensive rat; MPH ¼ methylphenidate; N/A ¼ not available;



































































for 30 minutes per day 5 times per week for
28 days. Both MPH and exercise alleviated hy-
peractivity effectively (see Table 1 for ES) and
improved spatial learning memory, an effect
seemingly mediated by the augmentation of
dopamine levels and BDNF expression. These
animal studies suggest that exercise could have a
positive impact on symptoms of ADHD, espe-
cially early in development, potentially mediated
by effects on BDNF and CAs.
EFFECTS OF EXERCISE ON INDIVIDUALS
DIAGNOSED WITH ADHD
Although evidence for effects of exercise on
symptoms and impairments associated with
ADHD is limited, interest in novel treatment
approaches is growing. It is, thus, encouraging
that both chronic and acute exercise have been
linked to improvements in EF in school-aged
children with ADHD. One study investigating
the effects of acute exercise on EF reported that
30 minutes of moderate-intensity running facili-
tated performance on the color–word condition
of the Stroop task and certain aspects of the
Wisconsin Card Sorting Test in 20 children with
ADHD who were randomly assigned to the ex-
ercise group, relative to 20 children with ADHD
assigned to the control condition of watching an
exercise-related video.57 However, it should be
noted that exercise did not have an effect on all
measures of EF, and that ES were small to
moderate. Another study looking at the impact
of acute exercise used a within-participant
design to assess the effect of a 20-minute,
moderate-intensity bout of exercise in 20 chil-
dren diagnosed with ADHD and 20 healthy
matched controls.64 After exercise, both the
ADHD and the control group exhibited greater
response accuracy on a version of the Eriksen
Flanker Task, measuring inhibitory control,
relative to a seated reading condition. Acute
exercise, thus, seems to have at least some effect
on certain tasks assessing EF. The effect also
seems to be universal and not speciﬁc to ADHD.
The impact of chronic exercise on EF has been
assessed by measuring the amount of moderate-
to high-intensity exercise performed by children
with ADHD each day over a period of 1 week
using an accelerometer.58 Exercise quantity sig-
niﬁcantly predicted performance on the Tower of
London task, and was positively associated with
working memory, inhibition, and information
processing in 18 boys with ADHD. Similarly, a
6-week prospective trial of 12 biweekly sessions
demonstrated that EF, as measured by the Korean
version of the Wechsler Digit symbol substitution
test, was signiﬁcantly improved by exercise rela-
tive to behavioral educational sessions in 28 boys
with ADHD.59 Teachers also noted signiﬁcant
improvements in the cooperativeness of boys in
the exercise group, compared to boys who
received behavioral education. Although no sig-
niﬁcant changes were found with regard to hy-
peractivity scores, inattention scores improved in
the exercise group.
A study examining the association between
attention and chronic exercise in 84 individuals
with ADHD used a moderate-intensity, 10-week
exercise program of 3 sessions per week, which
included upper limb, lower limb, trunk, and
neck aerobic exercises, in addition to free
running.60 Individuals were randomly assigned
to 2 equal groups: the exercise group and the
control group, which did not receive an exercise
intervention.56 In this study, exercise signiﬁ-
cantly improved teacher ratings of attention,
motor skills, and academic and classroom
behavior. Correspondingly, another study
assessed the effects of a 10-week, moderate- to
high-intensity exercise program on ﬁtness,
cognitive functions, and ADHD-related behavior
in 10 children with ADHD, and compared the
effects to a no-intervention control group con-
sisting of 11 children with ADHD. This study
reported signiﬁcant improvements in muscular
capacities, motor skills, level of information
processing, and parent- and teacher-rated social,
thought and attention problems after the inter-
vention.66 The effect of chronic exercise on
behavior ratings was further investigated in a
nonrandomized, 5-week exercise program in 19
children with ADHD.62 Although no signiﬁcant
group differences were found between the
exercise and no-exercise control group with re-
gard to changes in parent-rated Conners’ Rating
Scale (CRS) scores, total behavior, attention,
emotional, and motor skills were rated as having
improved for both groups after the intervention.
These ﬁndings suggest nonspeciﬁc treatment
effects, conceivably due to rater expectation,
rather than real effects of exercise. This last view
is consistent with a recent meta-analysis on
nonpharmacological interventions for ADHD,
which found that the ES for nonpharmacological
interventions depended on the rater’s blinding
status.69 Although some studies of the effect of
chronic exercise on EF used nonblinded ratings
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and must be interpreted with caution, others are
more convincing because of their use of rela-
tively blinded raters, such as teachers and the
objective cognitive tests that were used.
Another study focused on the association of
exercise with different aspects of mental health
seen in children with ADHD. In a retrospective
study, participation in 3 or more sports was
reported to be signiﬁcantly associated with a
reduced number of anxiety and depressive
symptoms and rates of co-occurring mood disor-
ders in children with ADHD compared to control
individuals with learning disabilities.60 Yet, parent
report of the number of sports that a child plays is
an arbitrary measure, as children playing 1 sport
might be more dedicated to that sport and not
necessarily less ﬁt than children participating in
more than 1 sport. As association does not imply
causation, the correlation between the number of
sports played and anxiety and depression symp-
toms could alternatively reﬂect that children who
are less anxious are more likely to be engaged in a
greater number of different sports, or that
depressed children have less need for social
interaction and, thus, participate in fewer sports.
However, a study exploring a sport-based group
therapy program in boys with ADHD and boys
with other behavioral disorders supported the
ﬁnding that sports participation (20 sessions 90
minutes each over 1 school year) improves anxiety
and other behavioral scores.61 Yet, the intervention
included group discussions as well as exercise,
and it remains unclear how large the effect of each
aspect of the intervention was on the outcome
measure. Furthermore, the lack of a neurotypical
control group does not allow for conclusions about
speciﬁc effects of the intervention.
To elucidate the putative mechanism under-
lying the effects of exercise, 3 studies have
investigated the relationship between CA levels
and exercise in individuals with ADHD; yet,
ﬁndings are inconclusive and contradictory.
Among the ﬁrst to investigate the impact of ex-
ercise in individuals with ADHD, Tantillo et al.65
studied the rate of spontaneous eye blinks (SEB),
the acoustic startle eye-blink response (ASER),
and motor impersistence, as noninvasive mea-
sures sensitive to dopamine agonists, in 8- to 12-
year-olds with and without ADHD. Although
SEB and ASER had previously been used as
sensitive measures of dopamine function in chil-
dren with ADHD,70,71 no clear link between
ASER and ADHD has been established in human
beings. Both the ADHD and control group
underwent 2 bouts of exercise and 1 rest condi-
tion on consecutive days. The main ﬁndings were
increased SEB rate, decreased latency of ASER,
and improved motor persistence after exercise in
boys with ADHD, whereas such improvements
were not observed in controls. Although the
authors concluded that exercise augments dopa-
mine levels in children with ADHD but not in
neurotypical controls, the alternative interpreta-
tion is that the physiological effect is consistent
across groups but emerges as signiﬁcant only in
those showing pathological levels of ADHD
symptoms. In a more direct investigation of CA
levels in response to exercise, Wigal et al.67
compared 10 children with combined subtype
ADHD, to 8 age- and sex-matched controls on
their CA levels after 2 separate cycling ergometer
sessions. CA levels were measured by a radio-
enzymatic technique based on the conversion of
the CA to radiolabeled metanephrine and nor-
metanephrine. This CA assay uses an extraction
technique that eliminates substances that may
inhibit the radioenzymatic assay, and concen-
trates the CA to provide a more sensitive assay.
Although epinephrine and norepinephrine levels
rose in both groups after the exercise sessions, the
response was less strong in children with ADHD
and, in contrast to controls, their dopamine levels
did not increase signiﬁcantly, contrary to the
previous study. The most recent study that
examined the relationship between high-intensity
exercise, CA levels, and sustained attention in 25
children with ADHD demonstrated that exercise
signiﬁcantly improved response time and
normalized impulsivity and vigilance measures,
independent of CA.63 Participants, who were
divided into stimulant medication users and
nonusers, were assessed on Conners’ Continuous
Performance Test–II (CPT) at diagnosis, after ex-
ercise, and after a 1-minute stretching session
(control measure). As chronic use of MPH was
associated with signiﬁcant physiological and
attentional effects, a comparison of stimulant
users and nonusers on CPT performance sug-
gested that the improvements in cognition seen
after exercise were not CA dependent; however,
CA levels were not measured directly, and no
straightforward conclusion can be drawn from
these ﬁndings. Furthermore, practice effects
may be expected, because the CPT was repeated
after only a 1-minute stretching session. Al-
though these ﬁndings must be approached with
caution because of these and other crucial study
design limitations outlined below, the research
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investigating the effect of exercise on ADHD
provides preliminary evidence of the potential for
exercise to reduce emotional, behavioral, and
neuropsychological problems seen in children
with ADHD.
Overall, based on the limited body of research
conducted to date, we can conclude that exercise
emerges as a potentially promising intervention
for improving EF and behavioral symptoms
associated with ADHD. Yet, many of the ﬁndings
remain inconclusive and warrant further investi-
gation. ES varied from small for auditory
sustained attention66 to large for response accu-
racy64 (Table 1). Conﬂicting ﬁndings have also
been presented for the putative mechanism
involved. This may be explained by several
limitations. Concluding causality from non-
randomized, retrospective, and cross-sectional
data is problematic. Not all of the studies
reviewed here are case-control studies, and those
that do look at case-control differences are limited
by small sample sizes and inadequate control
conditions. The nonblinded status of the re-
searchers and scorers may further inﬂate the
positive effects of exercise on the various outcome
variables due to the nonspeciﬁc effects evoked by
a child’s participation in a treatment programme.
Finally, the heterogeneous nature of and various
treatment approaches to ADHD are seldom taken
into account, complicating the interpretation and
generalizability of the results.
ADHD is best considered in a developmental
framework. One neurodevelopmental model of
ADHD views the disorder as resulting from early
aberrations in brain development that remain
relatively static throughout an individual’s life
time72; however, the plasticity of the brain and its
interconnected neural circuits allow for recovery
from ADHD symptoms and associated impair-
ments over the course of development. Thus,
experience-dependent neurodevelopmental pro-
cesses, such as synaptic pruning or myelination,
if facilitated early in childhood, could be used
to aid the recovery from ADHD symptoms or to
mitigate symptomatic escalation over the course
of development. As exercise has been found to
enhance neural growth and development and
to improve cognitive and behavioral functioning
in neurotypical individuals and study animals,
we reviewed the literature on the effects of
exercise in children and adolescents with ADHD
and animal models of ADHD behaviors.
A limited number of undersized, non-
randomized, retrospective, and cross-sectional
studies have investigated the impact of exercise
on ADHD and the emotional, behavioral, and
neuropsychological problems associated with the
disorder. The ﬁndings from these studies provide
some support for the notion that exercise has the
potential to act as a protective factor for ADHD.
However, better-quality evidence is needed, to
ﬁrmly establish the nature and extent of positive
effects of exercise on children with ADHD. Re-
searchers will need to examine both acute and
chronic effects of exercise in large, adequately
powered, blind, sham-controlled, randomized
clinical trials. In addition, follow-up studies are
needed to establish whether any short-term
effects are followed by longer term beneﬁts of
both acute and chronic exercise. Although it
remains unclear which role, if any, BDNF plays in
the pathophysiology of ADHD, enhanced neural
functioning has been suggested to be associated
with the reduction of remission of ADHD
symptoms.49,50,73 As exercise can elicit gene
expression changes mediated by alterations in
DNA methylation,38 the possibility emerges that
some of the positive effects of exercise could be
caused by epigenetic mechanisms, which may set
off a cascade of processes instigated by altered
gene expression that could ultimately link to a
change in brain function. &
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Appendix 2. Baseline corrected ERP analysis for the 
age-matched sample 
Cue condition 
The random intercept model did not yield a significant main effect of group for 
Cue-P3 amplitude (z=-0.86, p=0.392) or CNV (z=1.14, p=0.256).  
 
Go condition 
A significant main effect of group emerged for Go-P3 amplitude (z=-4.80, 
p<0.001). Post-hoc tests revealed that the preterm group showed significantly 
reduced Go-P3 amplitude compared to the control (t=4.35, df=144, p<0.001) 
and ADHD (t=2.42, df=115, p=0.02) groups, with large (d=0.79) and moderate 
(d=0.53) effect sizes respectively. The ADHD and control groups do not differ 
with regard to Go-P3 amplitude (t=1.42, df=89, p=0.156).  
 
NoGo condition 
The random intercept model yielded no significant main effect of group for 
NoGo-N2 (z=1.64, p=0.102). No significant main effect of group (z=-0.96, 
p=0.337) or recording site (FCz and Cz) (z=-2.45, p=0.014) emerged for the 
NoGo-P3. However, a significant group-by-recording site interaction emerged 
for the NoGo-P3 (z=5.52, p<0.001). Post-hoc tests revealed that the preterm 
group showed significantly increased NoGo-P3 amplitude compared to the 
ADHD group at FCz (t=-2.36, df=107, p=0.020), with moderate-to-large effect 
size (d=0.59), but not at Cz (t=0.82, df=108, p=0.415). In addition, the preterm 
group demonstrated significantly reduced NoGo-P3 amplitude compared to the 
control group at Cz (t=3.28, df=147, p=0.001), with moderate effect size 
(d=0.62), but the two groups did not differ significantly at FCz (t=-1.86, df=130, 
p=0.065). The ADHD group demonstrated significantly reduced NoGo-P3 
amplitude compared to the control group at Cz (t=2.14, df=130, p=0.010), with 
moderate effect size (d=0.44), but not at FCz (t=0.89, df=90, p=0.378).  
 
  
